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Design and Optimization of an Integrative Periodontal Ligament Scaffold 
Nancy M. Lee 
Periodontitis is a chronic inflammatory infection caused by the overgrowth of bacteria harbored in 
tooth-retained plaque. It is estimated to affect 50% of American adults over 30, with an increased 
incidence of up to 70% for those over 65. The disease is characterized by the destruction of the 
periodontal tissues, including the periodontal ligament (PDL), root cementum, and alveolar bone. As the 
PDL provides tooth anchorage by connecting the root cementum to the alveolar bone, damage to this 
tissue results in a loss of integration with the surrounding bone and cementum, eventually leading to 
complete tooth detachment. This is the primary reason for tooth extractions and/or loss. Current 
treatments for periodontitis fail to achieve consistent PDL regeneration and integration of soft and hard 
tissues, thus alternative approaches are needed to improve long term outcomes. This thesis focuses on 
the development of a biomimetic, fiber-based, polymer composite scaffold that will enable the 
regeneration and integration of the hard and soft tissues comprising the periodontium, while also 
controlling residual infection at the wound site. This work is guided by the hypothesis that a multi-phased 
scaffold optimized in structure and composition to promote tissue regeneration and integration, as well as 
control the presence of pathogenic organisms, will augment integrative periodontal healing. 
The first aim of this thesis investigated scaffold design parameters for ligament regeneration, 
exploring polymer chemistry, fiber alignment, and antibiotic dose for the support of PDL cell growth and 
matrix biosynthesis. In addition, the efficacy of antibiotic-containing scaffolds in controlling the growth of 
periodontal pathogens was evaluated. With the overarching goal of supporting hard tissue integration, 
aim two optimized scaffold fiber diameter, mineral composition and dose, as well as method of mineral 
incorporation in order to promote PDL cell viability, growth, differentiation, and mineralized matrix 
deposition. In the third aim of this thesis a composite scaffold was fabricated, combining the optimized 
elements from the previous two aims into a multi-phased system that is mimetic of the native periodontal 
structure. The composite scaffold was then evaluated for tissue healing as well as for integrative potential 




that a scaffold with optimal structure and composition for PDL growth and integration supports enhanced 
periodontal healing as assessed through functional evaluation and tissue biosynthesis.  
In summary, the studies in this thesis led to the development of a novel, anti-infective, multi-
phased scaffold which promotes integrative periodontal ligament healing. The broader implications of this 
work, which includes the elucidation of cell-biomaterial interactions and the implementation of complex 
scaffold design strategies, can be extended toward the integrative and functional repair of other 
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1.1. Specific Aims 
The periodontium is comprised of the tissues that surround and support the teeth, including the 
root cementum, periodontal ligament (PDL), alveolar bone, and gingiva (Figure 1.1). The PDL is a soft 
tissue that anchors the cementum to alveolar bone, allowing the periodontium to function in providing 
tooth anchorage. Periodontitis or periodontal disease is a chronic inflammatory infection elicited from the 
overgrowth of bacteria harbored in tooth-
retained plaque. It is estimated to affect 50% of 
American adults over 30 and nearly 70% of 
those over 6551. The disease is characterized by 
the destruction of tooth-supporting structures, 
attachment loss, and often times complete tooth 
detachment75. The socioeconomic burdens of 
the disease are vast, as it represents one of the 
major causes of adult tooth loss146. 
The ultimate goal of periodontal therapies is the regeneration of both mineralized and soft tissues, 
as well as achieving physiologic tissue integration, thereby reestablishing tooth anchorage7,26. 
Anatomically, the periodontal attachment is characterized by a soft-to-hard tissue interface representing a 
fibro-osseous insertion. Current therapeutic options for treatment of periodontitis are lacking because of 
the inability to adequately achieve the integration of multiple tissues26,39,130. Conventional anti-infective 
therapies simply focus on controlling the growth of microbial pathogens123,176,200. Tissue engineering 
strategies, guided by the processes of natural tissue development and healing, and inspired by the 
structure-function relationship of the native periodontium, have emerged as dynamic, biologically active 
alternatives to the management of periodontal defects. These approaches include the use of 
synthetic30,85,115,142,143 and natural2,106,197 scaffold materials, cell-based approaches78,127,204, gene 
therapy89,90 and growth factors63,125,158,199,212. However, these strategies are limited in their ability to 
achieve integration of the soft and hard tissues, a necessity for functional tissue regeneration. 
Specifically, these approaches fail to capture the complex structure of the native tissue on a physiological 
scale and there is a lack of focus on addressing the underlying cause of the disease–the host response to 
Figure 1.1: Tooth Structure and Histology of Periodontium 
highlighting collagen distribution within the periodontium.  
C: Cementum, P: PDL, B: Alveolar Bone 




microbial pathogens. This thesis focuses on the development of a multi-phased polymer fiber scaffold 
system that will facilitate the regeneration and integration of the hard and soft tissues comprising the 
periodontium, while also controlling infection at the wound site. This work is guided by the hypothesis 
that a multi-phased scaffold optimized (polymer chemistry, fiber architecture, antibiotic incorporation, fiber 
diameter, and ceramic incorporation) to promote tissue regeneration and integration, as well as control 
the presence of pathogenic organisms at the wound site will result in the reestablishment of the 
periodontal attachment apparatus. 





Design and optimize a fiber-based scaffold for the regeneration of the ligament 
phase of the periodontium that will also control residual infection at the wound site 
The growth, differentiation, and biosynthesis of PDL cells can be enhanced by varying 
scaffold: 
a. Polymer chemistry  
b. Fiber alignment 
An antibiotic releasing scaffold will: 
a. Reduce the count of periodontal pathogens  




Design and optimize a scaffold for integration with the hard tissues of the 
periodontium  
The osteogenic differentiation of PDL cells can be modulated by varying scaffold: 
a. Fiber diameter  
b. Calcium phosphate composition  
c. Method of calcium phosphate incorporation into scaffolds 
d. Calcium phosphate dose 





Develop and evaluate a composite multi-phased scaffold as an integrative 
periodontal ligament graft  
A composite multi-phased scaffold with properties optimized from Aims 1 and 2 will 
support cell growth, differentiation, and biosynthesis for the formation of functional PDL-
cementum and PDL-alveolar bone interfaces in: 
a. In vitro culture 





The scaffold should be optimized to guide the resident cells of the periodontium toward the regeneration 
of a physiologically oriented PDL that is integrated with cementum and alveolar bone. This thesis aims to 
develop such a scaffold system by elucidating the fundamental understanding of how substrate properties 
affect cell response and contributes to coordinated, complex tissue healing and integration. Specifically, 
polymer type, fiber architecture, and incorporation of antibiotics will be explored for optimization of 
parameters relating to PDL regeneration (Aim 1, Chapters 3-4), while fiber diameter, mineral composition, 
method of mineral incorporation, and dose, as well as biocompatibility with both osteoblasts and 
cementoblasts will be investigated for reestablishment of the soft-to-hard tissue attachment (Aim 2, 
Chapters 5-8). These studies will yield a biomimetic multi-phased scaffold to be fabricated and evaluated 
in vitro using a tooth-in-bone explant model (Aim 3, Chapters 9-10). 
 Aim 1 focuses on scaffold design and optimization for regeneration of the PDL. Specifically, a 
polymer fiber-based system will be utilized to mimic the mature human PDL, which is predominately 
composed of fiber bundles (principle fibers)79. The effect of polymer chemistry and fiber organization on 
the growth, differentiation, and biosynthesis of primary PDL-derived cells is explored toward this end 
(Chapter 3). Synthetic polymers such as poly(lactic-co-glycolyic acid) (PLGA) and polycaprolactone 
(PCL), can be electrospun into fibers resembling the structure and architecture 122,184 of the native PDL. 
Given that these two materials differ in their chemistry, degradation kinetics and mechanical properties, it 
is anticipated that PDL cells cultured on these materials should respond differently, as has been observed 
for other cell types including smooth muscle cells188, chondrocytes107 and mesenchymal stem cells33,107. 
Similarly, it has been shown that cell response can be modulated by the underlying substrate topography, 
namely fiber organization (aligned and unaligned). This has been demonstrated for a number of cell types 
including human tendon122 and ligament103 fibroblasts, as well as human184 and bovine9 mesenchymal 
stem cells. As the native PDL matrix is composed of connective elements of organized and random 
orientations79, it is anticipated that PDL cell response can be modulated by varying the underlying 
substrate architecture. The optimal substrate for ligament regeneration should promote PDL cell growth, 
the deposition of a biomimetic matrix rich in collagen I and III32,81, and the expression of the PDL markers 




 A major complication for periodontal therapies is the presence of plaque-associated pathogens. 
As a means of controlling the growth of microbial pathogens, Aim 1 will also investigate the incorporation 
of antibiotics into the fiber scaffold optimized in Chapter 3. Clinically used barrier (guided tissue 
regeneration, GTR) membranes can be heavily colonized by bacteria76,166,198 due to exposure to the oral 
cavity during implantation76,166. Plaque colonization of barrier membranes has been associated with 
decreasing attachment gains136,160,166,206. To address this, an antibiotic delivery system that is efficacious 
in reducing the growth of anaerobic pathogens commonly associated with the disease1,174 is developed in 
Chapter 4. The antibiotic containing scaffold is then evaluated to ensure that there are no adverse effects 
to PDL cell viability, proliferation, matrix production and expression of PDL markers also in Chapter 4. 
Success criteria for these studies include the fabrication of antibiotic-loaded fibers that support sustained 
release169,206. The fibers should also reduce the growth of pathogens while demonstrating no adverse 
effects to PDL cells according to the cell response exhibited in Chapter 3.  
 The objective of Aim 2 is to investigate scaffold design parameters for integration with the hard 
tissues of the periodontium. The PDL contains cells that can synthesize and remodel the three connective 
tissues of the periodontium167. This aim explores strategies to guide the growth, differentiation, and 
biosynthesis of PDL-derived cells for the regeneration of, and integration with the mineralized tissues of 
the periodontium, as well as demonstrate biocompatibility with resident cells of the periodontal hard 
tissues. In Chapter 5, the effect of fiber diameter is explored, in which nano- and micron-sized fiber 
scaffolds are compared. The diameter of the collagen fiber bundles that comprise the periodontium vary 
depending on location within the tissue. Close to the cementum, the bundles are 3-10 μm, while near the 
alveolar wall they range from 10-20 μm, and within the ligament itself the bundles are 1-4 μm in 
diameter21. As fiber diameter has been shown to regulate cell morphology13, proliferation, matrix 
production, and gene expression52, the effect of fiber diameter will be explored as a mechanism to guide 
cell differentiation and biosynthesis to promote interface tissue healing. The incorporation of calcium 
phosphate (CaP) ceramics and method of CaP incorporation (electrospun versus surface coating) into 
scaffolds will then be explored as mechanisms to guide interface regeneration (Chapter 6). The 
incorporation of hydroxyapatite (HA) compared to an amorphous, nonstoichiometric CaP (simulated body 




effect of SBF incorporated into fibers through electrospinning in comparison to a surface coating via 
immersion in SBF77 is then explored. Ceramic dose is varied and evaluated for PDL cell response in 
Chapter 7. Finally osteoblasts will be cultured on the scaffold optimized from the previous studies in Aim 2 
to ensure biocompatibility and maintenance of cell phenotype (Chapter 8). Completion of this aim should 
successfully result in a system optimized to promote the differentiation of PDL-derived cells toward an 
osteogenic phenotype, including the expression of osteoblastic markers131 (bone sialoprotein, osteocalcin, 
osteopontin) and the deposition of a mineralized matrix. 
 Aim 3 focuses on the evaluation of a composite scaffold to promote functional tissue repair. A 
sol-gel sintering method is utilized to fabricate the multi-phased scaffold, incorporating optimized 
elements from Aims 1 and 2 to facilitate the regeneration and integration of multiple tissues in a 
coordinated manner (Chapter 9). The response of periodontal ligament cells to the scaffold will then be 
evaluated in vitro. Finally, a tooth-in-bone explant model is developed in Chapter 10, in which the 
optimized scaffold is evaluated for tissues healing and integration with native bone in vitro. Completion of 
these studies will successfully result in the fabrication of a composite multi-phased scaffold. Scaffold 
morphology and mineral distribution are characterized, and evaluation of in vitro cell response and in the 
tooth-in-bone explant model is expected to result in soft and hard tissue regeneration and integration with 
native tissue. 
Toward the development of scaffold strategies to promote the regeneration of an integrated and 
functional periodontium, the studies in this thesis emphasize: 1) the design and optimization of a scaffold 
mimetic of the PDL and the soft-to-hard tissue insertion, 2) the sustained and localized delivery of 
antibiotics and 3) the development and evaluation of a novel multi-phased scaffold for integrated tissue 
regeneration. The innovation in this approach lies in the rational design of a complex scaffold system that 
will facilitate the regeneration of multiple tissues in a coordinated manner, as well as promote the 
integration of these tissues. Additionally, the scaffold will encompass an anti-infective element to further 
promote predictable and optimal tissue regeneration. It is anticipated that the optimized scaffold will 
support cell growth, tissue-relevant matrix deposition, and the differentiation of regenerative competent 
PDL fibroblasts and progenitor cells, while also supporting relevant cell phenotypes, as well as control for 




interactions between biomaterial substrates and cells, which will provide insight into the factors that guide 
cell differentiation into tissue specific-lineages, as well as the presentation of complex scaffold design 
strategies; factors that can be utilized for the regeneration of other soft-to-hard tissue interfaces and 
complex tissue systems.  
1.2. Background and Significance 
1.2.1 Periodontal Disease and Periodontal Infections 
1.2.1.1 Periodontitis 
Periodontitis is an infectious disease characterized by the 
progressive destruction of the tooth-supporting tissues, including the 
periodontal ligament, cementum, and alveolar bone. It is a chronic 
inflammatory infection in response to bacterial accumulations or 
dental plaques on the teeth. In its most severe form, it can result in 
tooth loosening and complete tooth loss75. In fact, it is one of the 
primary reasons for tooth extractions and/or loss34,138. The 
socioeconomic burden presented by the disease is vast, as it afflicts 
a substantial percentage of the population even at young ages. In a 
survey conducted in 2009-2010, it was estimated to affect one out of every two adults51. The statistic 
increases to nearly 70% for adults aged 65 years and older51. Furthermore, as the aging population grows 
Figure 1.3: Healthy and 
Diseased Tooth (AAP, 2011) 




and is retaining more teeth than previous populations, the number of people developing periodontal 
disease will increase in the following decades108. The estimated average cost for full mouth periodontal 
surgery required to gain access to plaque on root surfaces is about $4000-$5000, which totals in over a 
billion dollars in health care costs if only a fraction of patients receive treatment108. As an auxiliary 
complication, growing evidence has linked chronic periodontitis with a number of systemic conditions 
such as diabetes, stroke and coronary artery disease17,96,102, further underscoring the need to treat and 
manage the disease. 
1.2.1.2 Periodontal Infections and Antimicrobial Strategies 
Periodontal infections are distinct from other bacterial ecosystems in that a mineralized, and 
thereby nonshedding structure is in part exposed to the external environment, as well as located within 
the connective tissues108. The tooth thus provides a stable surface for the colonization and accumulation 
of bacteria. Over 500 distinct microbial species can be found in a single dental plaque124. Below the 
gingival margin, the bacterial count can exceed 108 in deep periodontal pockets1. While the host can live 
in symbiosis with the diverse microflora in the oral cavity without exhibiting symptoms of periodontal 
infection, occasionally a subset of bacteria will be introduced, overgrow or exhibit new properties, leading 
to destruction of the periodontium. Such infections typically involve anaerobic bacteria, wherein the 
pathogens most commonly associated with the disease include Porphyromonas gingivalis and 
Actinobacillus actinomycetemcomitans1,174. 
The chronic presence of 
plaque bacteria leads to a host 
immune-inflammatory response that 
results in the destruction of both hard 
and soft tissues, which are the clinical 
signs of periodontitis. One of the first 
changes that occur during 
periodontitis is the migration of the 
junctional epithelium downward along 
Figure 1.4: Junctional Epithelium in Healthy and Diseased States 
The junctional epithelium forms a collar around the cervical portion of 
the tooth. In a diseased state, the downward migration of the junctional 





the tooth root surface (Figure 1.4). The junctional epithelium plays a crucial role in maintaining tooth 
homeostasis, essentially sealing off the periodontal tissues from the oral environment. Furthermore, the 
downward migration of the junctional epithelium along the tooth root increases the free surface area of 
the epithelium to bacterial plaque exposure131.  
Ultimately, for healing and regeneration to occur the bacterial pathogens and their associated 
virulence factors must be eliminated135. While simple in principle, there are numerous complicating 
factors, paramount of these is the environment of the periodontium, which provides an array of reservoirs 
where pathogens can persist. The development of techniques that can effectively deliver antimicrobial 
agents to these locations is a key factor for any viable therapy. Conventional anti-infective therapies have 
focused on eliminating inflammation and controlling the growth of microbial pathogens through systemic 
antibiotics. The utility of systemic antibiotics however, is limited by the dilution effect, requiring high 
dosages in order to be effective69, which can potentially result in systemic side-effects, as well as the 
development of resistant bacterial strains. Localized delivery mechanisms, including subgingival irrigation 
and the implantation of drug formulations into periodontal pockets allow for lower doses of antimicrobials 
to be administered. Although achieving and maintaining therapeutic drug levels for an adequate time has 
presented challenges68,180. It has been suggested that 7-10 days of exposure is required to achieve long 
term changes in the bacterial flora181. Recently, mechanisms to achieve the sustained release of 
antibacterial agents28,37,70,94 have been explored, these will be discussed in detail in a subsequent section. 
1.2.2 Periodontal Ligament Formation and Development 
 The development of the periodontal ligament 
occurs prior to tooth eruption and closely follows root 
formation. Following crown formation, the tooth root 
begins to develop as the cells of the inner and 
external enamel epithelium proliferate. These cells 
join at the cervical loop, forming the enamel organ 
(Figure 1.5). The apical growth of these cells forms 
Hertwig’s epithelial root sheath between the dental 
Figure 1.5: Developing Tooth, the dental follicle will 





papilla and the dental follicle80. This sheath forms a structure that encases the dental papilla, separating it 
from dental follicle cells. The dental papilla gives rise to odontoblasts and the dental pulp, while the dental 
follicle forms the cementum, periodontal ligament and alveolar bone. Dental follicle cells are comprised of 
mesenchymal cells. During root formation these cells gain polarity and become more metabolically active, 
synthesizing and depositing collagen fibrils and glycoproteins in the developing periodontal ligament41. 
Undifferentiated stem cells are present in both the developing and mature periodontal ligament, and 
retain the ability to differentiate into osteoblasts, cementoblasts and fibroblasts. 
The principle fiber bundles of the periodontium begin as loose unstructured collagenous tissue 
extending between the bone and cementum72. As the crown approaches the suprajacent oral mucosa, 
highly active fibroblasts become elongated and polarized as they produce collagen fiber bundles, known 
as fringe fibers, at the surface of the newly formed root41. Similar fibers may be observed on the adjacent 
surface of the developing alveolar process79. During tooth eruption, as the ligament matures, the fringe 
fibers merge across the width of the ligament, forming the principle fiber bundles, and establishing 
continuity across the ligament space, securing the attachment of the tooth to the bone41. With eruptive 
tooth movement and occlusal contact, the initial attachment system thickens and matures, establishing 
the six distinct groups (transseptal, alveolar, horizontal, oblique, apical, interradicular) of principle fibers72. 
1.2.3 Structure and Function of the Periodontium 
1.2.3.1 Periodontal Ligament 
The periodontium is a complex multi-tissue system, 
comprised of hard and soft connective tissues that are anchored 
to one another. Periodontal ligament (PDL) fibers insert into the 
tooth root cementum on one end, and into the alveolar bone on 
the other end, forming a fibro-osseous structure which imparts 
functionality to the periodontium, namely anchoring the tooth to 
the jaw and withstanding masticatory forces. The bulk PDL 
ranges in width from 0.15 to 0.38mm131, and is comprised mainly 
of collagen I with some collagen III (~ 20% of the total collagen 
Figure 1.6: Schematic of the Tissues 
and Cells of the Periodontium  






content21) also present32,81. These fibers are organized as bundles that exhibit a well-defined architecture, 
and are grouped into 6 distinct classes (transseptal, alveolar, horizontal, oblique, apical, interradicular) 
based on their orientation, distribution, and function173. Collectively they are termed the principle fibers of 
the periodontium. These dense fiber bundles terminate in Sharpey’s fibers that insert into the mineralized 
tissues at either end of the PDL.  
Compared to other ligaments in the body, the PDL is highly vascularized. As such, it functions to 
provide nourishment to the teeth131,146, as well as serving as a cell reservoir for tissue homeostasis and 
regeneration112. The PDL is a very cellular tissue, with cells occupying about 50% of its volume21. The 
cellular constituents (Figure 1.6) include fibroblasts, cementoblasts and cementoclasts, osteoblasts and 
osteoclasts, epithelial cell rests of Malassez, monocytes and macrophages131,191, as well as 
undifferentiated mesenchymal cells that have demonstrated potential to restore lost periodontal 
supporting tissues including bone and cementum18,167. Fibroblasts represent the most prominent cell type 
in the PDL and are phenotypically distinct from fibroblasts from other tissues177,178, demonstrating 
cementoblast-like and/or osteoblast-like properties54,106. Their primary function is the maintenance and 
modification of the collagenous matrix of the PDL, as they reside elongated and oriented parallel to the 
long axis of fiber bundles79. 
1.2.3.2 Cementum 
 The cementum is a thin, 50-200 µm, calcified, avascular connective tissue that covers the tooth 
root. As the site of attachment for the principle fibers of the PDL, its primary function is to provide 
anchorage of the tooth to the alveolar bone75. While cementum has been the least investigated of the 
periodontal tissues, its role is critical for periodontal regeneration because Sharpey’s fiber attachment to 
the root necessitates new cementum formation79.  
There are four types of cementum distinguished by the presence or absence of cells, and the 
origin of collagen fibers contained within the matrix75,131. Acellular extrinsic fiber cementum is located on 
the cervical half to two-thirds of the root and encases the principle fibers of the periodontium, forming 
Sharpey’s fibers. Cellular intrinsic fiber cementum, located along the apical third or half of the root and in 
furcation areas, contains matrix elements secreted by cementoblasts and not by PDL fibroblasts. This is 




become entrapped in lacunae within the newly formed mineralized matrix. The two other types of 
cementum include acellular, afibrillar cementum, found almost exclusively on the enamel near the 
cementoenamel junction, and cellular cementum with both intrinsic and extrinsic fibers (cellular mixed 
stratified cementum). 
 Although cementum is similar to bone in its organic, mineral and chemical composition, there are 
key differences between the two tissues. The mineral content of the tissues differ, with cementum 
consisting of about 50% mineral and 50% organic matrix131,165 while bone is about 70% mineral. There 
are also marked differences in growth rate, with human lamellar bone increasing at 1-1.5 µm/day163 
compared to 0.005-0.01 µm/day for acellular extrinsic fiber cementum27 and 0.1-0.5 µm/day for cellular 
mixed stratified cementum24. Furthermore, cementum does not undergo the extensive remodeling that is 
characteristic of bone. The cellularity of cementum is lower than that of bone. The cementum lacks a 
vascular system unlike bone, thus transport limitations may contribute to why cementocyte lacunae in the 
deeper portions of the tissue often appear empty. Finally, the formation of cementum is normally limited to 
the areas around teeth, while the formation of woven bone via intramembranous ossification does not 
depend on a hard substrate. Accordingly it has been demonstrated that cementoblasts and cementum 
can arise wherever viable dentin is exposed to the soft tissue of the periodontal ligament79. 
1.2.3.3 Alveolar Bone 
 The alveolar process is the thickened ridge of the jaw bone that contains the tooth sockets 
(alveoli) for teeth. It consists of compact bone (oral and facial cortical plates), trabecular bone (occupying 
the central part of the alveolar process), and the alveolar bone proper which forms the walls of the tooth 
socket. Alveolar bone is referred to as bundle bone, consisting of successive layers of intrinsic fiber 
bundles that run more or less parallel to the socket, in which the collagen fiber bundles of the PDL insert 
almost perpendicularly (Sharpey’s fibers). These Sharpey’s fibers, like in the cementum, are mineralized 
only at their periphery.  
The bone of the socket wall is constantly remodeled in response to functional demand. This 
remodeling is similar to bone in general. During tooth migration, bone resorption on one surface of the 
tooth socket is balanced by bone formation along the opposite side. This bone balance, along with the 




surface and the alveolar socket throughout life. The PDL plays a critical role in this remodeling. When 
forces are applied to teeth in the absence of a periodontal ligament, the rate and extent of bone 
remodeling is limited19, suggesting that the PDL is the medium of force transfer. Correspondingly, in the 
complete absence of a tooth, the alveolar bone is rapidly lost, underscoring its dynamic nature and the 
interdependence of the periodontal tissues functioning as a multi-tissue unit131. 
 Alveolar bone resorption, typically resulting from the host inflammatory response to periodontal 
pathogens, is a major cause of tooth mobility and loss. Progenitor cells present in the PDL are 
responsible for the repair, restoration, as well as maintenance of this tissue. As such, mechanisms that 
will guide lineage specific cell differentiation are required to achieve targeted regenerative therapies. 
1.2.4 Current Treatment Options for Periodontal Regeneration 
Currently available periodontal treatment therapies, including scaling and root planing, open flap 
debridement (OFD), barrier membranes (guided tissue regeneration, GTR), bone grafts, and growth 
factors have been burdened by poor clinical predictability26,148,156. In scaling root planning, and OFD the 
wound typically fills with epithelial cells, as these are the first cells to reach the area, resulting in a core of 
fibro-epithelial tissue rather than tissue regeneration39. GTR membranes, which function as a barrier to 
epithelial down-growth, thereby maintaining a space for fibroblast and progenitor cell migration, have 
demonstrated superiority to OFD126, however outcomes are often variable50,88,132 and limited to a specific 
class of defects148. Bone grafts aim to restore the height of the alveolar bone around the diseased tooth. 
However, these materials are limited in their osteoinductive capabilities and generally become encased in 
dense fibrous connective tissue59. Furthermore, the formation of solely bone does not represent true 
periodontal regeneration, which necessitates heterogeneous tissues regeneration and integration. More 
recently, the application of bioactive molecules, including growth factors and cytokines, aimed to stimulate 
reparative cells and or recruit progenitor cells to the wound site has been explored39,62,191, these are 
discussed in detail in the subsequent section. Progress still needs to be made in regards to the controlled 
and sustained delivery of these molecules and many have utilized scaffolding matrices toward this 
end106,142,143,197. Others have explored the use of gene therapy to achieve the sustained and targeted 




full capacity, research is still needed to clarify the underlying mechanisms of action for targeted use of 
these bioactive molecules10, as well as achieving suitable release and delivery kinetics. 
In severe cases of periodontitis tooth extraction may be required. With the loss of natural teeth, 
periodontal ligament cells are lost as well, precluding the regeneration of the periodontium118. Dental 
implants are often used to restore lost teeth, although due to the lack of periodontal cells, healing around 
implants is limited to a direct bone-to-implant connection, or osseointegration163 Without a periodontal 
ligament, dental implants lack the functional mobility and resilience of natural teeth. Thus with implant 
loading, this rigid connection results in stress transfer to the bone and high stress concentrations172,193. As 
a result the bone may become overloaded, resulting in fracture or resorption and ultimately implant 
failure. Physiologically, the periodontal ligament reduces stress through the damping of occlusal forces 
similar to a shock-absorbing action, without the regeneration of the periodontal ligament, this functionality 
is not restored. In fact, one of the major causes of implant failure after osseointegration is due to 
overloading and excessive stress192. 
1.2.5 Bioactive Cues 
Growth factors, which modulate cell proliferation, migration, differentiation, and biosynthesis, 
have been widely utilized to achieve periodontal regeneration in both preclinical and clinical studies. 
These biological active molecules have demonstrated modulatory effects on PDL cells, cementoblasts, 
and osteoblasts191. Growth factors which have shown promise for periodontal healing include platelet 
derived growth factor64 (PDGF), insulin-like growth factor (IGF), basic fibroblast growth factor125 (FGF), 
transforming growth factor162 (TGF), bone morphogenetic protein212 (BMP), and enamel matrix derivative 
(EMD, proteins belonging to the amelogenin family)38,191. In particular PDGF and IGF treatment has 
resulted in enhanced regeneration in canines and monkeys with periodontal disease65,159. Bone 
morphogenetic proteins have also demonstrated promise for periodontal healing, in which cementum 
regeneration with inserting Sharpey’s fibers was achieved157,158,199}. Also of note is enamel matrix 
derivative (EMD), which consists of proteins in the amelogenin family, known to play an important role in 
cementogenesis and the development of periodontal attachment39. Clinically available Emodgain©, a 




enhanced periodontal wound healing and cementum regeneration. However the effects on bone healing 
as well as the mechanisms of action are still not well understood. 
1.2.6 Tissue Engineering Approaches 
Given the shortcomings of therapeutic treatments for periodontitis, especially in the inability to 
achieve the integration of multiple tissues26,39,130, tissue engineering strategies guided by strategic 
biomimicry have emerged as alternatives to the management of periodontal defects, these studies are 
summarized in Table 1.1. Early approaches utilized synthetic calcium phosphates (CaP) such as beta 
tricalcium phosphate (β-TCP)133 and hydroxyapatite (HA)3, which have long been used to restore bone 
defects associated with periodontal diseases. Later groups have explored the use of HA/β-TCP 
constructs as carriers for transplantation of PDL stem cells167,179, while these methods have demonstrated 
biocompatibility and favorable bone healing, PDL regeneration requires optimization as these scaffolds 
are not biomimetic in structure or composition to the native tissue. 
Scaffolds produced from natural materials including gelatin and collagen have been widely 
utilized in the clinic due to non-antigenicity and favorable cell-biomaterial interactions. These materials 
also have some processing capabilities and can also be broken down by the cell’s natural machinery, 
such as metalloproteinases and tryptic enzymes, corresponding with the remodeling activity of cells 
during the formation of new tissues. Zhang et al. demonstrated that PDL cells exhibit enhanced cell 
attachment and proliferation on electrospun gelatin nanofibers in comparison to monolayer cutlure210. 
Collagen sponges have also been utilized as carriers for autologous PDL cells129,137 and autologous 
cementum-derived cells137 in canine periodontal defects. Compared to construct free controls, the studies 
demonstrated enhanced cementum regeneration129, and greater connective tissue attachment137. Yang et 
al. expanded green fluorescence protein+ rat bone marrow mesenchymal stromal cells (BM-MSCs) on 
gelatin microcarrier beads ex vivo, and transplanted them into surgically-created periodontal defects in 
rats203. Donor-derived BM-MSCs were found integrated into newly formed bone, cementum and PDL. 
Additionally, in comparison to the bead alone and defect alone controls, the cell-bead transplant group 





On the other hand, animal-derived biomaterials present clinical challenges such as the potential 
for infection transmission, difficultly of handling and material inconsistencies. Synthetic biomaterials have 
the advantage of a highly reproducible processing capability, with tunable features such as mechanical 
properties, architecture, biodegradability, and permeability. They can be processed to mimic the native 
extracellular matrix (ECM) and engineered with features that promote important cell functions such as 
adhesion, proliferation and differentiation. Zhao et al. fabricated porous PLGA sponges and used the 
scaffold as a carrier for immortalized cementoblasts211. After six weeks of implantation into surgically 
created defects in rats, histological analysis revealed new mineralized tissue formation along with the 
maintenance of the PDL region, although organization of collagen fibers was minimal. Additionally the 
model does not represent a critical-size defect for periodontal regeneration. Despite promising results, the 
PLGA sponge utilized does not represent a biomimetic substrate, as the native ECM of the PDL consists 
of networks of fiber bundles. Fiber-based scaffolds with controllable alignment can serve as a more 
biomimetic substrate and potentially aid in more organized tissue regeneration. Inanc et al. cultured PDL 
cells on electrospun unaligned PLGA nanofibers85. Cell adhesion, viability, and osteogenic differentiation 
potential were demonstrated in vitro. Shang et al. compared the response of rat PDL cells on aligned, 
unaligned, and cross aligned PLGA nanofibers168. Cells elongated along the length of the fibers after 3 
days of culture for the aligned and cross aligned groups. Cell proliferation and migration was also 
significantly greater on aligned compared to unaligned nanofibers. Building upon these results, longer 
term and more comprehensive studies are required to elucidate the underlying mechanism of cell-
biomaterial interactions for the design of substrates with regenerative capabilities. Furthermore these 
studies only focused on the regeneration of the ligament phase of the periodontium, whereas achieving 
full regeneration requires strategies targeting both the repair and physiologic integration of soft and hard 
tissues. 
To address the requirements of multi-tissue regeneration, more complex bi-phasic scaffold 
designs have been explored. Vaquette et al.194 fabricated a fused deposition modelling (FDM)–PCL-β-
TCP scaffold which was heat-fused to an electrospun PCL scaffold, resulting in a biphasic design. The 
FDM phase was intended to mimic bone and the electrospun scaffold the PDL. For subcutaneous 




the bone compartment. In vivo analysis revealed some degree of bone, PDL, and cementum 
regeneration. Building upon these results, Costa et al.45 employed a similar scaffold but with the FDM 
phase coated with a calcium phosphate layer to enhance osteoconductivity. After subcutaneous 
implantation, the scaffold demonstrated enhanced bone formation, vascularization, as well as periodontal 
attachment. While these studies demonstrate the implementation of more complex scaffolds, the designs 
still require optimization. The architecture of the scaffolds is not biomimetic, as the FDM membrane 
consisted of fibers on the order of microns and the electrospun scaffolds consists of unorganized fibers. 
Additionally, the results from these studies are dependent on the ability of the cell sheets to attach to the 
scaffold—cell sheets may not be clinically viable as they are difficult to handle86 and require a copious 
amount of cells. 
Recently three-dimensional (3D) printing, which allows for precise regional control of scaffold 
architecture, has been explored. Park et al. designed a hybrid scaffold consisting of a PDL interfacial 
structure with perpendicularly oriented channels fabricated from polyglycolic acid fused to a porous PCL 
bone region142. The scaffold was seeded with human PDL cells, a human tooth dentin slice fitted to the 
PDL dimension and the scaffold-dentin complex implanted subcutaneously in mice. After 6 weeks, 
interfacial regeneration of parallel- and obliquely-oriented fibers was formed, along with cementum-like 
tissue, ligament, and bone structures. Following up on this work, the same group utilized computed 
tomography to fabricate scaffolds custom fit to anatomical defects143,144. The scaffold was designed to 
contain fiber guiding channels, an interface region, and a bone region. Cell-seeded constructs were 
evaluated in athymic rats and results indicated an oriented and organized fiber and interface architecture, 
as well as greater tissue infiltration compared to scaffolds containing a random architecture. Additionally, 
Lee et al. developed a PCL-HA (90:10 wt %) region-specific scaffold consisting of three phases with 
differing microchannel geometry: Phase A 100 µm for dentin/cementum, Phase B 600 µm for PDL, and 
Phase C 300 µm for alveolar bone104. Growth factors were delivered to the various phases in a 
spatiotemporal manner via encapsulation in PLGA microspheres. Scaffolds were seeded with dental pulp, 
PDL, or alveolar bone stem/progenitor cells and after four weeks of incubation in vitro, distinctive tissue 
phenotypes were formed on each of the phases. Utilizing complex scaffold design, these studies 




biosynthesis. On the other hand, 3D printed scaffolds with features on the order of tens to hundreds of 
microns do not reflect the structure of the native tissue, which include collagen bundles in the order of 
nanometers. Targeted studies that can elucidate the complex mechanisms of cell interactions with 
substrates that are mimetic of the PDL, alveolar bone and cementum on a physiologic scale are required 
for the rational design of scaffolds that can successfully repair periodontal defects. 
Following periodontal procedures, antibiotics are often used to reduce bacterial recolonization. 
The localized delivery of antibiotics into periodontal pockets may be advantageous in comparison to 
systemic administration, which can result in side effects and development of microbial resistance. One 
important consideration for localized delivery is achieving a release profile that can provide a sustained 
antibacterial effect. The incorporation of antibiotics in resorbable polymers has been explored toward this 
end36,97,169,208,213. Goodson et al. was the first to study local drug delivery applied to periodontal therapy, 
incorporating tetracycline into ethylene vinyl acetate fibers and achieving sustained release in vitro for 9 
days71. Reise et al. fabricated electrospun poly(L-lactide-co-D/L lactide) fibers loaded with different 
concentrations of metronidazole (MET) and demonstrated antibacterial efficacy against three pathogenic 
periodontal bacterial strains for up until 28 days155. Similarly, Bottino et al. fabricated electrospun 
polydioxanone fibers containing MET or ciprofloxacin29. Antibiotic loaded fibers demonstrated an 
inhibitory effect on periodontal pathogens, while they did not impair the growth of periodontal beneficial 
bacteria. Moving toward a more complex scaffold design, Bottino et al. developed a graded scaffold via 
layered electrospinning of a poly(DL-lactide-co-ε-caprolactone) core surrounded by two protein/polymer 
composite layers: poly(lactic acid) (PLA) + 10wt% hydroxyapatite (HA) and PLA + 25wt% MET 
antibiotic30. The graded scaffold is intended to interface with bone on the HA side to enhance 
osteoconductivity, and epithelial tissue on the MET side to prevent bacterial colonization. Fabrication 
conditions were optimized to yield uniform fibers and the mechanical integrity of the layers was 
demonstrated. These studies show the antibacterial efficacy of localized drug delivery systems, as well as 
the ability to fabricate complex scaffolds that incorporate tissue engineering design principles with anti-
infective therapies. On the other hand, these studies neglected to demonstrate the biocompatibility of 
antibiotic loaded polymers with periodontal-relevant cells or the regenerative capabilities of these 




Table 1.1: Summary of Studies Utilizing Tissue Engineering Scaffolds Note tissue formation was 
determined by histological staining, immunohistochemistry or gene expression for matrix components  
Mineral Scaffolds 
Study Scaffold Composition / Design Tissues Formed 
Alliot-Licht et al.3 HA particles (<20 µm) -- 
Nery et al.133 HA-β-TCP varying ratios Bone 
Seo et al.167 HA-β-TCP Carrier Cementum, PDL, Sharpey’s fibers 
Sonoyama et al.179 Mixed stem cells from apical papilla with HA-
β-TCP and coated outside with PDL-stem 
cells 
Cementum, PDL, Sharpey’s fibers 
PDL 
Natural Material Scaffolds 
Study Scaffold Composition / Design Tissues Formed 
Nakahara et al. 129 Collagen sponge Cementum, Bone 
Zhang et al 210 Gelatin nanofibers -- 
Kumada et al.101 Self-assembling peptides with RGD binding 
and laminin cell adhesion motif 
-- 
Yang et al.203 Gelatin beads Cementum, PDL, Sharpey’s fibers 
Nunez et al.137 Collagen Sponge Cementum, PDL, Bone 
 
Synthetic Material Scaffolds 
Study Scaffold Composition / Design Tissues Formed 
Zhao et al.211 PLGA Sponge Cementum, PDL, Bone, Sharpey’s 
fibers 
Inanc et al.85 PLGA fibers (unaligned) -- 






Study Scaffold Composition / Design Tissues Formed 
Vaquette et al.194 Fused deposition modelling PCL-β-TCP heat-fused to electrospun PCL unaligned fibers Cementum, PDL, Bone 
Costa et al.45 
Fused deposition modelling PCL-β-TCP with 
CaP coating heat-fused to electrospun PCL 
unaligned fibers 
PDL, Bone 
Park et al.142 3D printed perpendicular PGA channels fused 
to porous PCL  
Cementum, PDL, Bone 
Park et al.143 Custom fit to anatomical defect with fiber 
guiding channels, interface and bone regions 
Cementum, PDL, Bone 
Lee et al.104 PCL-HA(90:10wt%) with varied channel 
geometry Phase A: 100 µm, Phase B: 600 µm, 
Phase C: 300 µm. PLGA microspheres 





Cementum, PDL, Sharpey’s fibers 
Sundaram et al.187 Bilayered PCL (nano and microfibers) and 







Study Scaffold Composition / Design Observations 
Goodsen et al.71 Ethylene vinyl acetate fibers with 
tetracycline (25% w/w) 
Sustained release for 9 days  
Kim et al.97 
 
Electrospun PLGA fibers with Mefoxin® 
(cefoxitin sodium) (5% w/w) 
Antibiotic released from scaffolds active and 
effective in inhibiting Staphylococcus aureus 
growth 
Chang et al.36 PCL fibers with Gentamicin sulphate 
(5%, 10%, 20% w/w) 
Sustained release for up to 50 days. Antibiotic 
activity against Staphylococcus epidermidis 
retained after 2 weeks 
Shifrovitch et al.169 PLGA, PDLGA, PDLLA films with 
Metronidazole (2%, 10% w/w) 
Films showed a burst release followed by 
sustained release or a biphasic release profile. 
Demonstrated decrease in bacteria viability and 
biocompatibility with human gingival fibroblasts 
Zamani et al.208 PCL nanofibers with Metronidazole 
Benzoate (5%, 10%, 15% w/w) 
Drug release from fibers dependent on the ratio of 
solvents (DCM:DMF) and drug concentration.  
Low burst and sustained release for 19 days 
Bottino et al.30 Electrospun Poly(DL-lactide-co-ε-
caprolactone) core with PLA + 10wt% 
HA and PLA + 25% MET outer layers 
Optimized nanofiber fabrication conditions to yield 
bead free fibers and demonstrated mechanical 
stability of construct 
Zheng et al.213 HA particles loaded with amoxicillin 
dispersed into PLGA nanofibers (1% 
w/w) 
Sustained antibiotic release, reduced growth of 
Staphylococcus aureus, and demonstrated 
cytocompatibility with fibroblasts 
Reise et al.155 PLA fibers with metronidazole (0.1-
40% w/w) 
Demonstrated antibacterial efficacy for 28 days 
against pathogenic bacteria 
Bottino et al.29 Polydioxanone fibers with 
metronidazole or ciprofloxacin (5%, 
25% w/w) 
Inhibitory effect on periodontal pathogens and no 
effect on growth of periodontal beneficial bacteria 
1.3 Summary 
Current periodontitis treatment options are lacking because of the inability to restore functionality 
to multiple tissues, while conventional anti-infective therapies focus only on eliminating inflammation by 
controlling the growth of microbial pathogens. Tissue engineering scaffolds, have demonstrated success 
for single tissue regeneration, but applications in multi-tissue restoration and integration are still lacking. 
Furthermore these scaffolds fail to recapitulate the native tissue on a physiologic scale and do not 
address the underlying cause of the disease—the microbial infection. While some groups have begun to 
explore anti-infective scaffolds, these systems are still in their infancy, and the biocompatibility and 




The regeneration of the periodontium includes the repair of cementum, restoration of the alveolar 
bone and the attachment of periodontal ligament fibers to the mineralized tissues, which current tissue 
engineering approaches fail to accomplish. Complex scaffold design inspired by the native ECM is 
necessary to facilitate the regeneration of multiple tissues in a coordinated manner. Finally, a major 
complication in periodontal therapy is the presence of plaque associated bacteria. As such, methods to 
control infection at the wound site are essential to achieving predictable and optimal periodontal 
regeneration. Guided by these strategies, the studies proposed in this thesis include: 1) the design and 
optimization of a scaffold mimetic of the periodontium, specifically the PDL and the soft-to-hard tissue 
insertion 2) the localized delivery of antibiotics and 3) the development and evaluation of a novel multi-
phased scaffold for integrated tissue regeneration. The scaffold phases for PDL and insertion regions will 
first be optimized individually and then subsequently joined together, forming a composite multi-phased 








Figure 1.7: Schematic of Fiber-Based Interface Scaffold for Repair of Periodontal Defects. Healthy tooth, 
zoomed image is picrosirius red stain highlighting the tissues which comprise the periodontium: alveolar bone (B), 
periodontal ligament (P) and cementum (C). Diseased tooth, showing inflammation (I) and tissue loss, forming a 
periodontal pocket or defect (D). Fiber-based scaffold implanted into periodontal defect with regions optimized for 


























2.1 Characterization of Biochemical Composition of Periodontium 
The periodontium refers to the tissues that support and invest the teeth including the soft 
collagenous periodontal ligament and two mineralized tissues, the cementum, which lines the tooth root, 
and the alveolar bone. The hallmarks of periodontal disease include soft tissue destruction, bone loss and 
loss of attachment to the cementum, ultimately leading to tooth loss if left untreated. The objective of this 
study is to histologically characterize the native periodontium to gain insight into the soft and hard tissue 
structures as well as the interface between the soft and hard tissue. This will provide insight into 
biomaterial scaffold design and tissue-engineering based strategies to regenerate damaged tissue and 
restore the structures of the native periodontal complex. 
2.1.1 Matrix and Cell Nuclei: Hematoxylin and Eosin, and Masson’s Trichrome 
 A hematoxylin and eosin (H&E) stained section of the tooth-PDL-bone complex is shown in 
Figure 2.1. Overall, the tooth root is comprised predominately of dentin, with the collagenous dental pulp 
chamber located in the center of the root. Dentin is a cellularized tissue, and nuclei are visible in the pulp. 
The tooth root is surrounded by a layer of collagenous PDL approximately 150-200 µm in width. Located 
on the other side of the PDL is another hard tissue, the alveolar bone. Contained within the bone is bone 
marrow which is highly cellularized. 
 Highlighted regions boxed in 1, 2, and 3 represent areas of interest in the tissue sample, showing 
the periodontium complex in detail including the cementum-PDL-bone and the associated hard to soft 
tissue attachments. The fibrous PDL is highly vascularized as evidenced by the presence of void spaces 
where blood vessels would typically reside. Cell nuclei can also be seen in the PDL, in which cells appear 
to be concentrated at the interface areas with the cementum and bone. These regions are believed to be 
the most active metabolically79 which could explain the high density of cells. The hard to soft tissue 
interfaces are characterized by PDL fibers that insert into mineralized tissue forming what are known as 
Sharpey’s fibers. The fiber bundle insertions at the alveolar bone side are typically thicker but less dense 
than the insertions at the cementum side, in which bundles are narrower but the density of insertions 
greater. Also located within the PDL are epithelial cell clusters known as the epithelial rests of Malassez. 
They are vestiges of the Hertwig’s root sheath, present during tooth formation. These clusters are located 




demineralized, collagen fibers can be visualized in the alveolar bone. The bone is often referred to as 
having a woven structure, in which the principle fibers of the periodontium insert perpendicularly into the 
bone and the intrinsic fibers of the bone run parallel to the tooth root. Cells can also be visualized in the 
alveolar bone. The detailed image in 2 clearly shows a layer of cementum lying atop the dentin on the 
tooth root.  The cementum is an avascular calcified tissue ranging in 50-200 µm in width. It contains both 
intrinsic and extrinsic elements as well as some cellular components. 
 Similar observations are made with Trichrome stained samples (Figure 2.2). The fibrous nature of 
the PDL is clearly visualized in the detailed images, and the mineralized tissues, bone and dentin, stain 
red. 
2.1.2 Picosirius Red 
 A picosirius red stained section is shown in Figure 2.3 and polarized light microscopy images for 
fiber alignment are shown in Figures 2.4.  Stained sections reveal a collagen rich matrix as well as the 
fibrous bundles that appear to emanate from the alveolar bone, traverse the PDL space and insert into 
the cementum. Although there is an overall orientation to the principle fibers of the periodontium, they do 
have a wavy or undulating appearance in the resting state. This undulation provides from slack to the 
fibers in order to accommodate for tooth movement. The cementum is visible in the detailed images and 
appears to be heterogeneous in nature as indicated by the variation in staining and thickness.  This is 
characteristic of the tissue in which four types of cementum exist: acellular afibrillar cementum, cellular 
intrinsic fiber cementum, acellular extrinsic fiber cementum and cellular mixed stratified cementum. 
Cementum is continuously produced throughout a person’s lifetime, allowing for compensation for the 
physiological drift of teeth41. 
 PDL fiber orientation, especially the Sharpey’s fiber insertions are clearly visible under polarized 
light microscopy (Figure 2.4). Alignment analysis was performed on PDL fibers and mean vector angle 
(52°), angular deviation (36°), and mean vector length (0.23) all indicate that the bulk PDL fibers are 
relatively unaligned. Histological analysis indicates that PDL fiber bundles also maintain their continuity as 
they insert into the mineralized regions, in which fiber bundles can be traced into the alveolar bone as 




150 µm into the alveolar bone. Also seen in the alveolar bone are collagen fibers intrinsic to the bone 
running parallel to the tooth root.  
2.1.3 Von Kossa 
 Von Kossa stain was used to visualize mineralized tissue. The image compliments the previously 
described histological stains. The dentin, cementum and alveolar bone are positively stained, while void 
spaces remain in the non-mineralized tissues, dental pulp, PDL, and bone marrow. 
2.2 Characterization of Cells Harvested from the Periodontal Ligament 
The PDL contains a heterogeneous cell population including osteoblasts, osteoclasts, 
cementoblasts, fibroblasts, epithelial cell rests of Malassez, monocytes, macrophages, and 
undifferentiated mesenchymal cells131. During wound healing, the ligament contributes cells not only for 
its own repair but also to restore lost bone and cementum93. Cells with stem characteristics have been 
isolated from the human PDL and demonstrated the ability to synthesize and remodel all three connective 
tissues of the periodontium167. 
The PDL cells used for all studies in this thesis are primary cells isolated from explant culture of 
human PDL tissue. The cell isolation methods have been developed to enrich for cells that are mobile 
and that can grow while attached to substrates. These cells likely represent a mix of fibroblast an 
progenitor cells. Characterization of the cell population used for the presented studies was performed, 
including surface marker analysis using fluorescence activated cell sorting (FACS) and differentiation 
studies. The expression of CD146 and STRO-1, markers common to mesenchymal stem cells11,53,60, as 
well as the expression of the hematopoietic markers, CD-36 and CD-45128, were assessed. 
2.2.1 Surface Marker Analysis and Differentiation 
Positive expression of progenitor cell markers STRO-1 and CD-146 was recorded, indicating the 
presence of progenitor cells, while the expression of hematopoietic markers was similar to background 
values (Table 2.1). To demonstrate differentiation potential, PDL cells were cultured in osteogenic 
medium for 14 days. Positive alizarin red and von Kossa staining, and mineral nodules are visible (Figure 




2.3 Materials and Methods 
2.3.1 Tissue Histology 
 Tooth samples were obtained from healthy patients undergoing tooth extraction for orthodontic 
reasons (IRB Exempt).  Samples were stored in saline for transport, rinsed twice in PBS, and fixed in 90% 
ethanol for 14days. Using a low speed saw the crown of the tooth was removed and the tooth sectioned 
longitudinally. Half the samples were decalcified with 10% ethylenediaminetetraacetic acid (EDTA, 
Sigma) in tris-buffer at a pH of 7.3 for 2 months, followed by dehydration with an ethanol series. The 
dehydrated samples were embedded in paraffin (Paraplast X-tra Tissue Embedding Medium, Fisher 
Scientific) and 7 µm sections were obtained (Reichert-Jung RM 2030 Microtome, Leica). Calcified 
samples were embedded in poly-methylmethacrylate (PMMA, Sigma). The samples were sectioned (7 
µm) with a Leica sliding microtome (SM2500S, Leica Microsystems Inc.) using a tungsten carbide blade 
(Delaware Diamond Knives Inc.) 
 Sections were stained for cell nuclei, collagen, and mineral content. To visualize cell nuclei, 
samples were stained with Weigert’s Hematoxylin for five minutes followed by eosin for two minutes for 
matrix staining. Additionally, for matrix and nuclei visualization samples were also stained using Golder’s 
Masson Trichrome. Samples were stained with Weigert’s Hematoxylin for seven minutes, followed by 
ponceau-acid fuchsin for eight mintes, after two rinses in 0.5% acetic acid, samples were stained with 
light green for two minutes. To visualize collagen content, samples were stained in 0.1% direct red for 
one hour before rinising in 0.01N hydrochloric acid. Collagen alignment was evaluated by imaging 
picrosirius red-stained samples with polarized light.  To visualize mineral content, calcified sections were 
stained with von Kossa (5% silver nitrate) and exposed to ultraviolet light (365 nm) for 15 minutes. Cover-
slipped (Cytoseal XYL) samples were imaged with a brightfield microscope (Zeiss Axiovert 25, Olympus 
DP72 (polarized light)). Images were stitched together in Photoshop (Adobe) using the auto-align and 
auto-blend tools. After stitching, the area surrounding the stained section was digitally cleaned. 
2.3.2 PDL Fiber Alignment Quantification 
For fiber alignment analysis picrosirius red stained images at 32X magnification (n=6) were 
evaluated using customized circular statistics (Fiber3)44. Circular statistics parameters include: the mean 




horizontal orientation; the mean vector length (MVL, 0≤r≤1), 0 indicates a random and 1 indicates an 
aligned morphology; and angular deviation (AD) which characterizes the dispersion of the non-Gaussian 
angle distribution of fibers (0°≤θ≤40.5°), 0° represents aligned and 40.5° a random distribution. 
2.3.3 Fluorescence Activated Cell Sorting 
Cells harvested from human PDL tissue through explant culture were trypsinized and 
resuspended in FACS buffer (PBS pH 7.4 with 2% FBS, 0.05% Sodium Azide, 2mM EDTA) to 1x107 
cells/mL. Twenty microliters of directly conjugated antibodies (BD Biosciences) was added to 100 µl of 
cell suspension, and the solution was gently mixed and left to incubate on ice for 1 hour. After incubation, 
cells were pelleted, the supernatant decanted and resuspended in ice cold PBS to rinse. Cells were 
rinsed once more and resuspended in 500 µl of PBS for flow cytometric analysis (BD-FACSCanto, BD 
Biosciences). Cells were analyzed for CD146 (phycoerythrin, PE), CD45 (fluorescein isothiocyanate, 
FITC) and CD36 (FITC). For STRO-1 analysis, anti-STRO1 mouse IgM (Abcam) primary antibody was 
added to 1x107 cells at a dilution of 1:25 and allowed to incubate for 1 hour on ice. The antibody was 
removed and cells rinsed twice in PBS. Secondary antibody (goat anti-mouse IgM, Abcam) was added at 
a 1:100 dilution and allowed to incubate for 1 hour on ice. Cells were rinsed twice and resuspended in 
500 µl of PBS for analysis. 
2.3.4 Osteogenic Differentiation Medium 
 For differentiation studies, after 7 days of culture in F/S medium, cells were cultured in osteogenic 
medium for 14 days. Osteogenic medium consists of F/S medium supplemented with 50 µg/mL ascorbic 





Figure 2.1: Characterization of the Periodontium: Matrix and Cell Nuclei H&E The top left is an 
overall view of a transverse section of tooth-PDL-bone. Detailed images are provided for the boxed 
regions. The PDL is both cellularized and vascularized (void spaces). Ligament fibers insert 
perpendicularly into the tooth root cementum and alveolar bone. C: Cementum, B: Bone. Hematoxylin 







Figure 2.2: Characterization of the Periodontium: Matrix and Cell Nuclei Trichrome The top is an 
overall view of a transverse section of tooth-PDL-bone. Detailed images are provided for the boxed 
regions. The PDL is both cellularized and vascularized (void spaces). Ligament fibers insert 
perpendicularly into the tooth root cementum and alveolar bone. Bone and dentin stain positive for 
vasculature. C: Cementum, B: Bone. Masson’s Trichrome staining green: collagen, purple: nuclei, red: 





Figure 2.3: Characterization of the Periodontium: Collagen The top left is an overall view of a 
transverse section of tooth-PDL-bone. Detailed images are provided for the boxed regions. Ligament 
fibers insert perpendicularly into the tooth root cementum and alveolar bone, the density of fibers are 
greater at the cementum insertion while fibers are thicker at the alveolar bone insertion. C: Cementum, 





Alignment Parameter Value 
Mean Vector Angle 51.83 ± 27.05 
Angular Deviation 35.60 ± 2.14 
Mean Vector Length 0.23 ± 0.09 
Figure 2.4: Characterization of the 
Periodontium: Collagen Fiber Alignment 
Polarized light microscopy shows the presence of 
oriented PDL fiber bundles which traverse the 
ligament space and insert perpendicularly into the 
cementum and alveolar bone (left and right 
respectively). Picrosirius red staining.10X. 
Alignment parameters, Mean Vector Angle (0° = aligned), Angular Deviation (0° = aligned) and Mean 
Vector Length (1 = aligned) were quantified, and indicate that the bulk PDL fibers display a relatively 







Figure 2.5: Characterization of the 
Periodontium: Mineralized Tissues Dentin, 
cementum, and alveolar bone stain positive with 
von Kossa indicating the presence of mineral, 
while the dentin, PDL, and bone marrow are 
negative. C: Cementum, B: Bone. (1) 10X 


















24.1 % 32.7 % 8.2 % 9.3 % 9.8 % / 10.4 % 
Figure 2.6: Characterization of the Periodontium: 
Differentiation of PDL-Derived Cells Alizarin red (left) and von 
Kossa (right) stains of cells after 14 days of culture in osteogenic 
medium indicates the presence of mineral 
Table 2.1: Characterization of the Periodontium: FACS Analysis of PDL-Derived Cells STRO-1 
and CD-146 are mesenchymal stem cell markers, while CD-34 and CD-45 are hematopoietic markers 
(n=6) 















CHAPTER 3: EFFECT OF POLYMER CHEMISTRY 


















The first study of this thesis focuses on the development of a fiber-based scaffold that supports 
the regeneration of the ligament phase of the periodontium. Specifically, a biodegradable polymer fiber 
scaffold fabricated via electrospinning will be utilized, as the mature human PDL is composed 
predominately of collagenous fiber bundles on the order of nanometers to micrometers in diameter21. 
Furthermore, these fiber bundles are organized into definite planes and thus display an orientational 
architecture79. Current tissue engineering approaches fail to mimic both the scale and architecture of the 
native tissue. Accordingly, studies are required to determine pivotal design parameters for the 
regeneration of the PDL. Thus, in this study, the effect of polymer chemistry and fiber organization will be 
explored for support of the growth, differentiation, and biosynthesis of PDL derived cells.  
3.1.1 Background and Motivation 
Biomaterial-based strategies which provide 3D templates and biomimetic ECM environments 
have been utilized for periodontal tissue regeneration85,143,145.  Such materials have been widely 
employed for tissue regeneration because of their biocompatibility, biodegradability, favorable cell-
material interactions and mechanical properties.  Two materials are PLGA and PCL, synthetic polymers 
which can be processed into nanofibers resembling the structure as well as the organizational 
architecture122,184 of the native PDL.  PLGA is a copolymer of glycolic acid and lactic acid. It is a bulk 
eroding polymer that degrades by ester hydrolysis and is therefore biodegradable. PCL is a semi-
crystalline, hydrophobic, polyester, and is bioresorbable, albeit at a slow (2-4 years) rate43. Its 
hydrophobic nature results in poor wettability and a lack of cell attachment. Thus surface modification 
techniques, such as plasma treatment, are often required to enhance cell attachment. As PLGA and PCL 
differ in their chemistry, degradability, and mechanical and viscoelastic properties, it is anticipated that 
PDL cells cultured on these materials should respond differently, as has been observed for other cell 
types including smooth muscle cells188, chondrocytes107 and mesenchymal stem cells33,107 Similarly, it has 
been reported that the response of a variety of cell types including fibroblasts103,122,202, osteoblasts119 and 
mesenchymal stem cells9,184 can be modulated by the underlying substrate topography, namely fiber 




3D environment; an interaction mediated by cytoskeletal actin stress fibers114 and focal adhesions which, 
in turn, control downstream signaling pathways61. 
While significant advances have been made in scaffold-based approaches for periodontal 
regeneration30,85,168,211, including complex stratified scaffolds104,142-144 (Table 1.1), these models fail to 
recapitulate the native architecture and neglects the mechanical properties of the native PDL matrix. 
Studies harnessing the fundamental understanding of how substrate composition and alignment affect 
cell response are necessary for rational scaffold design.  
3.1.2 Objectives 
The effect of polymer type (PLGA vs. PCL) and fiber organization (aligned vs. unaligned) on the 
response of human PDL derived cells will be explored. These polymers were selected as both are used in 
FDA approved devices, and have been explored extensively for tissue engineering applications. As 
polymer type and fiber organization can individually influence cell response due to differences in surface 
chemistry, mechanical and viscoelastic properties, degradation, and substrate architecture, it is 
hypothesized that a combination of biomaterial type and fiber organization will influence cell behavior. 
Findings from this study will help to identify an optimal substrate for the ligament and mineral phases of 
the scaffold to be further optimized in subsequent studies of this thesis. 
3.2 Materials and Methods 
3.2.1 Human Periodontal Ligament Cell Isolation and Culture 
Healthy human teeth were obtained from the College of Dental Medicine, Columbia University. 
Human PDL cells were derived from explant cultures of tissues obtained from patients undergoing tooth 
extraction (IRB Exempt). The excised teeth with PDL attached were stored in pre-warmed (37°C) biopsy 
medium, consisting of Dublecco’s modified Eagle’s medium (DMEM, Cellgro-Mediatech), 10% fetal 
bovine serum (FBS, Atlanta Biologicals), 2% amphotericin B (AmpB, Cellgro-Mediatech), 1% penicillin 
streptomycin (P/S, Cellgro-Mediatech), and 0.5% gentamicin/sulfate (G/S, Cellgro-Mediatech), for no 
longer than 1 hour post-extraction prior to PDL tissue harvest. Under sterile conditions, the teeth were 
rinsed in fresh biopsy medium and the PDL was separated from the tooth root using a sterile scalpel 




allowed to adhere to the culture dish under humidified conditions at 37ºC, 5% CO2 for 15-20 min, after 
which fully supplemented medium (F/S medium: 10% FBS, 1% non-essential amino acids (NEAA, 
Cellgro-Mediatech), 1% P/S, 0.1% AmpB, and 0.1% G/S) was added. Media was changed every 3-4 
days. Once confluence was reached, the tissues were removed and placed onto new culture plates. 
These first migration cells were discarded. Upon subsequent migrations, once the cells surrounding the 
tissues reached confluence, the cells were removed by trypsin/EDTA (Cellgro-Mediatech) treatment and 
replated. Only second and third migration cells were used for the experiments described here.  
3.2.2 Scaffold Fabrication 
3.2.2.1 PLGA-Unaligned 
A 43% (w/v) PLGA (85:15, Mw ≈ 123.6kDa, Evonik Industries) polymer solution was made by 
dissolving polymer granules in an acetone (Sigma-Aldrich)-N,N-dimethylformamide (DMF, Sigma-Aldrich) 
solution (1:4). The solution was mixed overnight. Prior to electrospinning, 100% ethanol was added, and 
the solution was vortexed for an additional 1-1.5 hours. The entire solution was loaded into a 5 mL 
syringe with a 26 gauge stainless steel blunt-tip needle and electrospun at 8-10 kV. The polymer solution 
was dispensed using a syringe pump (Harvard Apparatus) set to a flow rate of 0.35 mL/hr. Fibers were 
collected on a grounded stationary plate placed at a distance of 13 cm from the needle tip. Approximately 
1.5 mL of polymer solution was electrospun to fabricate scaffolds of thickness ranging from 0.08-0.11 mm 
as measured with a digital caliper. 
3.2.2.2 PCL-Unaligned 
A 16% (w/v) PCL solution was prepared by dissolving PCL (Mn = 70,000-90,000, Sigma-Aldrich) 
into 3:1 solution of dichloromethane (DCM, Sigma-Aldrich):DMF. The solution was mixed overnight, 
vortexed for ~1 hour prior to electrospinning, and then loaded into a 5 mL syringe attached with a 23 
gauge stainless steel blunt-tip needle. A voltage of 7-9 kV was applied to the needle tip and a pump flow 
rate of 1 mL/hr was used. Fibers were collected on a grounded stationary plate placed 15 cm from the 
needle tip. Approximately 2 mL of polymer solution was electrospun to fabricate scaffolds of thickness 





A 54% (w/v) polymer-DMF solution was prepared, and the solution mixed overnight. Prior to 
electrospinning, 100% ethanol was added and the solution vortexed for an additional 1-1.5 hours. The 
entire solution was loaded into a 5 mL syringe with an 18 gauge stainless steel blunt-tip needle. A voltage 
of 8-10 kV was applied to the needle tip and a pump flow rate of 1 mL/hr was used. Fibers were collected 
on a grounded rotating mandrel (2500 rpm) placed 13 cm from the needle tip. The entire polymer solution 
was electrospun to fabricate scaffolds of thickness ranging from 0.09-0.14 mm as measured with a digital 
caliper. 
3.2.2.4 PCL-Aligned 
An 18% (w/v) PCL solution was prepared by dissolving PCL into 3:2 mixture of DCM:DMF. The 
solution was mixed overnight, vortexed for ~1 hour prior to electrospinning, and the entire solution loaded 
into a 5 mL syringe with a 23 gauge stainless steel blunt-tip needle. A voltage of 9-10 kV was applied to 
the needle tip and a pump flow rate of 1 mL/hr was used. Fibers were collected on a grounded rotating 
mandrel (2500 rpm), 13 cm from the needle tip. The entire polymer solution was electrospun to fabricate 
scaffolds of thickness ranging from 0.08-0.11 mm as measured with a digital caliper. 
3.2.3 Scaffold Characterization 
3.2.3.1 Mechanical Testing 
As-fabricated scaffolds were evaluated for tensile mechanical properties (n=6). Scaffolds were 
cut to 1 cm x 5 cm, and the thickness of each sample was recorded as the average of three points 
measured using digital calipers. For loading, the scaffolds were secured with custom clamps and 
mounted on a mechanical testing device (Instron Model 8841) with an average gauge length of 3 cm. The 
samples were loaded at a strain rate of 5 mm/min until failure. The elastic modulus was calculated using 
the linear portion of the stress-strain curve. The stress and strain at failure was used to calculate the 
ultimate tensile strength and ductility respectively. 
3.2.3.2 Scanning Electron Microscopy, Fiber Diameter and Fiber Alignment Measurement 
Fiber diameter and morphology of as-fabricated scaffolds were determined. Scaffolds were 
imaged using scanning electron microscopy (SEM, 1 kV, 10 µA Hitachi 4700). Prior to imaging, a 




108auto). Fiber diameter was measured using ImageJ (National Institutes of Health). Fiber diameter 
values are an average of measurements taken from 3 independent regions of the mesh imaged at 1 and 
2.5 K (n=6images/group), with 20 measurements per image. For fiber alignment analysis, SEM 
micrographs (n=6) were evaluated using customized circular statistics (Fiber3)44. Circular statistics 
parameters include: the mean vector angle (MA), which represents the average fiber alignment in the 
matrix (|θ|≤90°), 0° representing a horizontal orientation; the mean vector length (MVL, 0≤r≤1), 0 indicates 
a random and 1 indicates an aligned morphology; and angular deviation (AD) which characterizes the 
dispersion of the non-Gaussian angle distribution of fibers (0°≤θ≤40.5°), 0° represents aligned and 40.5° 
a random distribution. 
3.2.4 Cell Seeding and Culture 
Electrospun scaffolds were cut to 1 x 1.8 cm and secured using custom-made clamps, resulting in 
an effective cell culture surface area of 1 cm2. PLGA scaffolds were UV 356 nm (each side 15 min) and 
incubated (37°C, 5%CO2) overnight in F/S medium with 20% FBS to promote cell attachment. For PCL 
scaffolds, to enhance surface reactivity scaffold were air plasma treated (Harrick Plasma PDC-32G) at 
high RF setting for 1 min. Scaffolds were then sterilized by UV radiation and soaked overnight in F/S 
medium with 20% FBS. 
Human PDL cells (passage 4-5) were seeded on scaffolds at a density of 30,000 cells/cm2 (3 M 
cells/mL, 10 µl), and allowed to attach for 20 min under humidified conditions at 37ºC, 5% CO2 before the 
addition of F/S medium supplemented with 50 µg/mL ascorbic acid (Sigma-Aldrich). Monolayer culture 
seeded at 30,000 cells/well on a 48 well (1 cm2) plate served as controls. Cells were maintained at 37°C, 
5% CO2 and media was exchanged every 2-3 days.  
3.2.5 Live/Dead Cell Viability and Alignment 
Cell viability (n=3) was visualized using Live/Dead staining (Molecular Probes). Both monolayer 
and scaffolds were stained following the manufacturer’s suggested protocol. Samples were imaged using 
confocal microscopy (Olympus Fluoview FV1000) at excitation wavelengths of 488 nm and 568 nm. For 




using customized circular statistics (Fiber3)44. Samples were evaluated for circular statistics parameters 
including MA, MVL, and AD. 
3.2.6 Cell Proliferation 
Cell proliferation (n=5) was determined by measuring total DNA content using the PicoGreen 
dsDNA assay (Invitrogen) following the manufacturer’s protocol. Scaffolds were rinsed twice in PBS and 
stored in 500 µl of 0.1% Triton-X (Sigma-Aldrich) at -30°C. Immediately before the analysis, samples 
were thawed and homogenized (Microson XL-2000) for 20 sec. Fluorescence was measured using a 
Tecan microplate reader with an excitation wavelength of 485 nm and an emission wavelength of 535 nm. 
A conversion factor of 8 pg DNA/cell was used to determine cell number. 
3.2.7 Collagen Production 
Collagen production (n=5) was quantified using a modified hydroxyproline assay153. Samples 
were first dessicated (CentriVap, Labconco, Kansas City, MO) and digested for 18 hr at 65°C in a solution 
of 20 µL/mL papain (Sigma-Aldrich), buffered in 0.1 M sodium acetate, 10 mM cysteine HCl, and 50 M 
ethylenediaminetetraacetate.  A 250 µl aliquot of the digest was concentrated by dessication.  Samples 
were subsequently hydrolyzed in 10 µl of 10N NaOH and autoclaved for 25 min.  The hydrolysate was 
then oxidized by a buffered chloramine-T reagent for 25 min before the addition of Ehrlich’s reagent.  
Sample absorbance was measured at 550 nm (Tecan), and the collagen content was obtained by 
interpolation along a standard curve of bovine collagen I (Sigma). 
Additionally matrix deposition was visualized histologically. Cryosectioned samples were stained 
with Hematoxylin and Eosin (H&E, n=3) to stain for cells and matrix. Collagen I and III were also 
evaluated using immunohistochemistry. Monoclonal antibodies for collagen I (Abcam) and III (Sigma-
Aldrich) were diluted 1:200 in serum-free Protein Block (Dako Cytomation). Samples were treated with 
1% hyaluronidase for 30 min at 37°C and incubated with primary antibody overnight at 4°C. After PBS 
wash, FITC-conjugated secondary antibody (Invitrogen) was added and incubated for 1 hour. Cell nuclei 
were stained with DAPI (Invitrogen). Images were obtained using confocal microscopy with 350 nm and 




3.2.8 Alkaline Phosphatase Activity and Mineralization 
After scaffold homogenization samples were assayed for alkaline phosphatase (ALP) activity 
(n=5) using a colorimetric assay based on the hydrolysis of p-nitrophenyl phosphate (pNP). On ice, 50 µl 
of sample was added to pNP-PO4 solution (Sigma) and incubated at for thirty minutes at 37°C. The 
absorbance at 405 nm was read using a Tecan microplate reader. ALP activity is reported normalized to 
incubation time and the post-homogenization cell number. 
Mineral deposition was also visualized through histological staining.  Samples were fixed in 10% 
neutral buffered formalin + 1% cetylpyridinium chloride overnight. The solution was replaced with 0.01M 
cacodylic acid and stored at 4°C until sectioning. Samples were embedded in 5% polyvinyl alcohol (PVA) 
for sectioning through freezing in a dry ice ethanol bath and sectioned to 7 µm thickness with a cryostat 
(Bright Instrument Company, Model OFT). Sectioned samples were collected on glass slides coated with 
Haupt’s Solution (2% gelatin, 1.9% phenol, 15% glycerol). Scaffold sections on glass slides were 
immersed in DI water for 1 hour to remove traces of PVA. Von Kossa was used to stain for phosphate 
(n=3) and alizarin red for calcium (n=3). Samples were imaged using a brightfield microscope (Zeiss 
Axiovert 25). 
3.2.9 Gene Expression 
Gene expression (n=5) was measured using quantitative reverse transcriptase-polymerase chain 
reaction (qRT-PCR).  Total RNA was isolated via the Trizol extraction method (Invitrogen).  Isolated RNA 
was reverse-transcribed into complementary DNA (cDNA) with the SuperScript First-Strand Synthesis 
System (Invitrogen), and the cDNA product was subsequently amplified and quantified through real-time 
PCR using SYBR Green Supermix (Invitrogen). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
served as the house-keeping gene. All genes were amplified for 50 cycles in a thermocycler (iCycler iQ 
Real-Time PCR Detection System, BioRad). See Table 3.1 for primer sequences used and amplicon 
sizes. Normalized expression levels were calculated based on the difference between threshold cycles of 




3.2.10 Statistical Analysis 
Results are reported as mean ± standard deviation, with n equal to the number of replicates per 
group. Statistical analyses were performed with JMPIN (4.0.4, SAS Institute, Inc.). Multi-way analysis of 
variance (ANOVA) was used to determine the effects of scaffold fiber alignment and composition, and 
culturing time on cell response (cell alignment, proliferation, matrix deposition, ALP activity). A two-way 
ANOVA was used to determine the effects of scaffold fiber alignment and composition on gene 
expression at each time point as well as as-fabricated mechanical properties and fiber alignment. The 
Tukey-Kramer post hoc test was used for all pair-wise comparisons, and significance was attained at 
p<0.05. 
3.3 Results 
3.3.1 Scaffold Characterization 
Electrospinning parameters including polymer-to-solvent ratio, solvent type, solution flow rate, 
needle gauge, and the distance from the needle tip to the collector were varied in order to yield fibers of 
similar diameter (Table 3.2). Mechanical properties, including Young’s Modulus (Y), Ultimate Tensile 
Strength (UTS) and Ductility of as-fabricated scaffolds are summarized in Table 3.2.  PLGA-Aligned 
scaffolds are the stiffest (highest Y) but the least ductile, while PCL-Unaligned scaffolds have the lowest 
Y but are the most ductile. Scaffold UTS is greater for aligned fiber scaffolds regardless of polymer, with 
PLGA-Aligned having the highest UTS. MA, AD, and MVL all indicated that aligned fibers were 
significantly more organized than unaligned fibers for both PLGA and PCL groups. 




3.3.2 Cell Organization, Morphology, and Proliferation 
Live/dead staining reveals that cells attach on all substrates and proliferate to near confluence 
after 4 weeks of culture. Cell alignment, including Mean Vector Angle (MA), Angular Deviation (AD) and 
Mean Vector Length (MVL) are quantified (Figure 3.3). Effect of Fiber Alignment: Initially, cells display an 
elongated morphology on aligned nanofibers only. Over time, localized areas of cell alignment on the 
randomly oriented substrates as well as the monolayer are observed. At day 1 cell alignment is greater on 
both PLGA and PCL aligned nanofibers (AD, MVL) compared to the respective unaligned substrates and 
monolayer culture (MA, AD, MVL). At days 7 and 14 significant differences in cell alignment are still noted 
between PCL-Aligned and PCL-Unaligned (MVL), while cell alignment is similar between the PLGA 
groups after one week of culture. Effect of Fiber Composition: No significant differences in cell alignment 
are observed based on fiber composition if fiber alignment is the same. In general, cells on all nanofibers 
and monolayer substrates become more organized with time and only minor differences were observed 
among all groups by day 28. 
PDL-FB proliferated significantly on all scaffold groups through the 4-week culture period, with no 
effects observed based on fiber alignment or composition. Cell proliferation is similar among all scaffold 
groups and exceeded that of monolayer culture by day 28. 
3.3.3 Matrix Deposition 
A significant increase in total collagen is observed for PLGA-Unaligned and both PCL groups 
through the 4 week culture period. Effect of Fiber Alignment:  On day 14 collagen deposition on PLGA-
Aligned nanofibers is greater than PLGA-Unaligned, while no difference is noted between the PCL 
groups. Effect of Fiber Composition:  At day 28, collagen is greater on PCL-Unaligned compared to 
PLGA-Unaligned, while no difference is noted between aligned groups. 
Hematoxylin and eosin (H&E) staining at day 28 confirms matrix deposition on all groups. Effect 
of Fiber Alignment:  Greater staining is observed on the PLGA-Aligned scaffolds, while staining is more 
intense for unaligned compared to aligned for PCL. Effect of Fiber Composition:  A greater degree of 
staining and matrix penetration through the scaffold depth is observed on the PCL groups compared to 
the PLGA groups of similar fiber alignment. In particular H&E staining on the PCL-Unaligned scaffolds is 




The deposition of collagen I and III at day 28 was evaluated using immunohistochemistry, in 
which a greater degree of fluorescence is observed for collagen III compared to collagen I for all scaffold 
groups. Effect of Fiber Alignment:  For both collagen I and III, greater staining is observed on the aligned 
scaffolds compared to unaligned for both polymer compositions. Effect of Fiber Composition:  For both 
collagens a greater degree of fluorescence and penetration through the scaffold is observed on the PCL 
groups compared to the PLGA groups of similar fiber alignment. 
 3.3.4 Mineralization 
Alkaline phosphatase activity normalized to cell number and reaction time is reported in Figure 
3.4 for scaffold groups and monolayer. Similar trends over time are observed between all scaffold groups 
and monolayer, in which there is a significant decrease in ALP activity from day 1 to 7, followed by a 
mean increase in activity with culture time. Since all groups display a peak ALP activity at day 1, earlier 
timepoints were taken in order to obtain insight into peak ALP activity. A peak ALP activity is observed at 
3 hours for PLGA-Unaligned only, while baseline activity is observed for all other groups at 3, 6, and 
8hours of culture. Effect of Fiber Alignment: ALP activity on PLGA-Unaligned is significantly greater than 
PLGA-Aligned on days 1 and 14, while no differences are observed between the PCL groups based on 
alignment. Early ALP analysis indicates significantly greater activity on PLGA-Unaligned compared to 
PLGA-Aligned scaffolds at 3 and 6 hours of culture. Effect of Fiber Composition: ALP activity on PLGA-
Unaligned scaffolds is significantly greater than PCL-Unaligned scaffolds at 3 and 6 hours and days 1 and 
14, while no such differences are observed between the aligned scaffolds of differing composition.  
Alizarin red and Von Kossa staining were performed on samples after 28 days of culture to 
visualize calcium and phosphate deposition respectively. Positive staining is apparent on all groups on 
the cell seeded surface of the scaffold. Effect of Fiber Alignment: Unaligned scaffolds displayed more 
intense staining compared the respective aligned scaffold. Effect of Fiber Composition: Dense staining 
was observed on the surface of the PLGA groups while a more diffuse staining was noted on the 




3.3.5 Gene Expression 
The expression of the periodontal marker periostin is observed on all scaffold groups at days 1 
and 7. The expression of the fibroblastic markers collagens I and III were also quantified. Effect of Fiber 
Alignment: The expression of periostin is downregulated on PLGA-Aligned compared PLGA-Unaligned at 
days 1 and 7. Similarly periostin is downregulated on PCL-Aligned compared to PCL-Unaligned at day 7. 
Collagen expression is upregulated on PCL-Unaligned compared to PCL-Aligned at days 1 and 7 for 
collagen I, and day 1 for collagen III. Effect of Fiber Composition:  Periostin is downregulated on PLGA-
Aligned compared to PCL-Aligned at day 1. The expression of collagen I is upregulated on PCL-
Unaligned compared to PLGA-Unaligned at days 1 and 7, while collagen III is upregulated on PCL 
scaffolds compared to the respective PLGA scaffolds. 
The expression of integrins α2 and β1 was also evaluated. Effect of Fiber Alignment: An 
upregulation of α2 is observed at day 1 on unaligned scaffolds compared to the aligned scaffolds of 
similar composition, while β1 is upregulated on PCL-Aligned compared to PCL-Unaligned at days 1 and 
7. Effect of Fiber Composition:  An upregulation in β1 is observed at days 1 and 7 on PCL-Aligned 
compared to PLGA-Aligned. 
3.4 Discussion 
This study explored the use of polymer fiber based scaffolds for regeneration of the periodontal 
ligament. Four scaffold modalities were evaluated in which both polymer type (PLGA and PCL) and fiber 
orientation (aligned and unaligned) were varied. Electrospinning parameters were optimized to keep fiber 
diameter consistent between groups. Scaffolds were characterized for tensile mechanical properties, with 
PCL scaffolds most similar the elastic modulus of the native human periodontal ligament, which has been 
reported to range from 0.12-3 MPa111,205. The native failure strength is similar to unaligned scaffolds, and 
has been measured to range from 0.3-3 MPa99.  
Initial cell alignment was guided by scaffold fiber organization, with periodontal ligament cells 
displaying an elongated and organized morphology on the aligned fibers only, regardless of polymer type. 
This is expected as cells attach and interact with their substrates through focal adhesions which are 
associated with cytoskeletal actin stress fibers and thus control cell shape114,195. Interestingly, cells on all 




which no significant differences of cell alignment parameters were observed after 4 weeks of culture. This 
phenomenon may be mimetic of the development and maturity of the native periodontal ligament, in 
which collagen fibers begin as a loose and unstructured tissue that thickens into defined, organized fiber 
bundles upon tooth eruption and occlusive loading72. 
Cells grew similarly on all scaffold groups with no significant differences in cell number based on 
either polymer type or fiber alignment. This has been observed in similar studies, in which no differences 
in proliferation were observed based on the fiber alignment of PLGA scaffolds for periodontal ligament 
cells85 or tendon fibroblasts122, as well as of PCL fibers for mesenchymal stem cells and meniscal 
fibrochondrocytes9. On the other hand, differences in cell growth have been observed for MSCs between 
PCL and PLGA unaligned fibers107. The authors cite the physical instability of PLGA compared to PCL 
which can hinder cell ingrowth, as the reason for this. Electrospun PLGA scaffolds undergo shrinkage and 
contraction when placed in cell culture conditions. In this study, we utilized custom clamps to counteract 
contraction, therefore the cell culture area remains fairly consistent between scaffold groups and over 
time. For these reasons, differences in cell growth based on polymer type were not observed in this 
study. Finally, cell number on scaffolds exceeded that of the monolayer by day 28. While both scaffolds 
and monolayer have a similar surface area of approximately 1 cm2, fiber scaffolds on the other hand, 
represent a three-dimensional system, as cells are able to penetrate and grow through the depth of the 
scaffolds, resulting in greater cell proliferation. 
Regarding periodontal ligament cell biosynthesis, matrix deposition, and expression of 
periodontal (fibroblastic) markers were predominately affected by polymer type, as both were enhanced 
on PCL scaffolds (aligned and unaligned), compared to PLGA. Gene expression results for collagens 
indicated an upregulation of collagen type I on PLGA-Unaligned at days 1 and 7 and collagen type III on 
PCL scaffolds compared to PLGA on day 1. The early upregulation of collagen expression has been 
observed in gene expression studies of rat flexor tendon healing141. Early collagen type III deposition is 
important in establishing the initial wound structure to provide an early substrate for subsequent healing 
events. In contrast, collagen type I comprises the majority of mature ligaments and contributes to the 
mechanical properties of connective tissues57.   Importantly, collagen deposition was supported on all 




Histological and immunohistochemical staining at day 28 are in agreement with gene expression results 
and suggested enhanced synthesis on PCL scaffolds compared to PLGA. On the other hand, 
mineralization was controlled by both polymer type and fiber organization. Mineral deposition, as 
visualized by von Kossa and Alizarin red staining, was enhanced on PLGA fibers compared to PCL of 
either fiber orientation, while ALP activity was enhanced on PLGA-Unaligned fibers compared to all other 
groups. 
Finally, as integrin proteins are key mediators of cell-substrate, including extracellular matrix as 
well as biomaterial58, interactions, the expression of the α2 and β1 subunits were evaluated. Significantly 
greater α2 expression was noted on unaligned fibers (both PLGA and PCL), while β1 was consistently 
upregulated on PCL-Aligned fibers. The α2β1 integrin heterodimer mediates cell attachment to 
collagen182, which suggests that these substrates are mimetic of the native collagen matrix and may serve 
as suitable substrates to guide and promote periodontal healing. 
Collectively these results indicate that periodontal ligament cell response is dependent on both 
polymer type and fiber alignment. PCL is an optimal polymer for the regeneration of the ligament phase, 
as it stimulates matrix deposition and maintenance of the periodontal ligament phenotype, while 
mineralization potential and mineral deposition is diminished. Electrospun PCL scaffolds also have similar 
mechanical properties to the native human periodontal ligament205. Finally PCL-Aligned scaffolds display 
an architecture mimetic of the principle fiber bundles of the periodontal ligament, making it an ideal 
substrate ligament regeneration. In contrast, there was enhanced ALP activity and mineral deposition on 
PLGA scaffolds. Thus PLGA-Aligned scaffolds will be utilized in future studies which will explore scaffold 
optimization for integration with the periodontal hard tissues.  
3.5 Conclusion 
This study demonstrated that electrospun polymer fibers serve as a suitable substrate to guide 
periodontal healing. PCL fibers supported matrix deposition and a periodontal fibroblast phenotype 
necessary for periodontal ligament regeneration, while PLGA fibers supported mineral deposition required 
to facilitate soft-to-hard tissue regeneration. As aligned fibers promoted a physiologic cell alignment and 




optimized in the next study to promote periodontal ligament regeneration. Accordingly PLGA-Aligned 


















Strength (MPa) Ductility (%) 
PLGA - 
Aligned 0.65 ±0.17 356 ±54.7^ 12.7 ±1.97^ 33.8 ± 2.62^ 
PCL –  
Aligned 0.62 ±0.10 38.9 ± 2.39
# 24.1 ±8.02^ 64.8 ± 17.0^ 
PLGA - 
Unaligned 0.74 ± 0.16 54.5 ± 5.06
# 3.40 ± 0.33* 104 ± 24.4^ 
PCL - 
Unaligned 0.66 ±0.24 9.83 ± 1.03
# 3.15 ±0.42* 197 ± 9.25^ 
Table 3.3: Effect of Polymer Chemistry and Fiber Alignment on PDL Cell Response: Scaffold 
Fiber Diameter and Mechanical Properties Fiber diameter values are an average of measurements 
taken from SEM images, n=3 independent regions imaged at 1 and 2.5K magnification, 20 
measurements per image. Mechanical properties of as fabricated scaffold (n=6).  Significant difference 































































































































Figure 3.1: Effect of Polymer Chemistry and Fiber Alignment on PDL 
Cell Response: Scaffold Morphology and Fiber Alignment  SEM 
micrographs of scaffolds show aligned and unaligned fibers. MVA (0° = 
aligned), AD (0° = aligned) and MVL (1 = aligned) indicate that aligned fibers 
are significantly more organized than unaligned fibers for both PLGA and PCL 
scaffolds. Significant difference between: ^ all other groups, # groups, (n=6, 
p<0.05) 
Figure 3.2 Effect of Polymer Chemistry and Fiber 
Alignment on PDL Cell Response: Cell 
Alignment All groups become more aligned with 
time. At day 1 cells were most organized and 
polarized on aligned fibers, with cells slowest to align 
on PCL-Unaligned scaffolds. MVA (0° = aligned), AD 
(0° = aligned), and MVL (1 = aligned) Significant 
































Figure 3.3: Effect of Polymer Chemistry and 
Fiber Alignment on PDL Cell Response: Cell 
Viability and Proliferation Confocal micrographs 
show cell attachment and proliferation on all 
substrates No differences in cell number between 
scaffold groups. Cell number on scaffold is 
significantly greater than monolayer at day 28. 
Significant difference between: ^ all other groups, 


























































Figure 3.4: Effect of Polymer Chemistry and Fiber Alignment on PDL Cell Response: Matrix 
Deposition and Mineralization All groups stain positive for matrix, and collagen I and III, with more 
prominent staining on PCL scaffolds and greatest staining on PCL-Aligned. ALP activity is significantly 
greater on PLGA-Unaligned compared to all other groups on days 1 and 14. Alizarin red and von 
Kossa stains at day 28 indicate enhanced mineral on PLGA scaffolds compared to PCL. Significant 
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Figure 3.5: Effect of Polymer Chemistry and Fiber Alignment on PDL Cell Response: 
Expression of Periodontal Markers Expression of fibroblastic markers collagen I and III are 
enhanced on PCL scaffolds compared to PLGA at days 1 and 7.  Expression of the periodontal 
marker, periostin, is observed for all groups. Integrin α2 is enhanced on unaligned compared to 
aligned on day 1, while β1 is upregulated on PCL-Aligned scaffolds compared to all other groups. 















CHAPTER 4: EFFECT OF MINOCYCLINE DOSE 
AGAINST PERIODONTOPATHIC BACTERIA AND 
















To further promote healing, antibiotics will be incorporated into the PCL-Aligned scaffolds 
optimized for ligament regeneration in the previous study. The scaffolds will thus allow for the sustained 
and localized delivery of antibiotics to control the growth of residual bacteria at the wound. This will 
enhance healing, as the presence of periodontal pathogens on GTR membranes has been associated 
with reduced clinical attachment gain136,160,166,206. In this study, drug release from fibers will be 
characterized and antibiotic-containing scaffolds will be evaluated against relevant periodontopathic 
bacteria to ensure that antibiotic efficacy is maintained through the electrospinning process. In addition to 
being efficacious in controlling bacterial growth, minocycline-containing scaffolds should not exhibit 
cytotoxic effects to PDL cells. As such, to promote the ideal healing environment the optimized scaffold 
should support PDL formation, as well as treat the cause of the disease. Thus this study will also evaluate 
the effect of low and high dose antibiotic containing scaffolds on PDL cell response as well as examine 
the effects of minocycline on PDL cells cultured in monolayer 
4.1.1 Background and Motivation 
A major complication of periodontal therapies is the presence of plaque-associated pathogens. 
Plaque colonization of GTR membranes for example, has been associated with decreasing attachment 
gains136,160,166,206. Furthermore, conventional anti-infective therapies focus only on controlling the growth 
of microbial pathogens123,176,200, with little emphasis on the regenerative aspects of tissue healing. 
Minocycline hydrochloride is a semi-synthetic tetracycline that has demonstrated efficacy as a topical 
treatment against periodontal pathogens113,175 at concentrations which do not affect the survival, and 
gene and protein expression of PDL fibroblasts140,190. Tetracyclines function by inhibiting protein synthesis 
and are effective against anaerobes and facultative organisms. Of the tetracyclines, minocycline appears 
to be particularly effective in the inhibition of gram-negative facultative anaerobes, which are the 
pathogens most common to periodontal disease69. Additionally, upon systemic administration, 
tetracyclines are found to concentrate in gingival fluid and are known to bind to the tooth surface, where it 
can be released in its active form73,164.  
Conventional anti-infective therapies have focused on eliminating inflammation and controlling the 




limited by the dilution effect, requiring high dosages in order to be effective69, which can potentially result 
in  side-effects such as hypersensitivity and gastrointestinal intolerance, as well as the development of 
resistant bacterial strains. Localized delivery mechanisms, including the implantation of drug formulations 
into periodontal pockets, allow for lower, targeted doses of antimicrobials to be administered. Although 
achieving and maintaining therapeutic drug levels for an adequate time has presented challenges68,180. It 
has been suggested that 7-10 days of exposure is required to achieve long term changes in the bacterial 
flora181. Minocycline hydrochloride encapsulated in PLGA microspheres (Arestin®) for sustained release 
is used clinically as an adjunct to scaling and root planing for treatment of adult periodontitis. Due to its 
demonstrated efficacy and clinical use, it was decided to incorporate minocycline hydrochloride into the 
PCL-Aligned fiber scaffolds developed in the previous study to achieve a sustained and localized 
antibiotic release system. 
Another critical aspect that must be considered for tissue healing is that antibacterial agents 
administered directly to the site of infection should result in little to no cytotoxicity and also support host 
cell phenotype. Conversely, to be therapeutically effective, antibiotics must be administered at levels 
greater than the minimum inhibitory concentration required to arrest 90% of bacterial growth (MIC90). It is 
reported that the MIC90 of MC against P. gingivalis, P. intermedia, and A. actinomycetemcomitans, 
pathogens common to destructive periodontal disease, ranges from 0.031-2 µg/mL (0.06-4 µM)121. 
Considering also the effects to host cells, the maximum concentration of MC that has minimal adverse 
effects to human PDL cell survival, and mRNA and protein expression, has been shown to be at least 25 
times the MIC90189. Minocycline functions by impairing ribosomal protein synthesis. It has been suggested 
that the difference in sensitivity between mammalian cells and bacteria to tetracycline, is that mammalian 
cells lack the active transport system found in bacteria, and the ribosomal target is less sensitive35. Thus 
to guarantee optimal PDL healing, it is necessary to ensure that the antibiotic releasing scaffold has no 
adverse effects to PDL cell growth or phenotype. 
4.1.2 Objectives 
Minocycline hydrochloride (MC) antibiotic at two concentrations (2 and 5% w/w) will be 
incorporated into PCL-Aligned scaffolds via electrospinning94. These concentrations were selected based 




periodontal pathogens. Antibiotic containing polymer fibers will result in sustained and localized drug 
release. The efficacy of MC scaffolds in reducing the count of periodontal pathogens will then be 
explored. A dose dependent response is expected in controlling bacterial growth. PDL cell response to 
PCL-MC scaffolds, including growth, mineralization potential, and matrix deposition, will then be 
evaluated. No adverse effects to cell viability or phenotype are anticipated for the duration of culture. 
Finally this study examines the effect of minocycline antibiotic dose on the response of PDL cells in 
monolayer culture. At day 1 of culture, cells will be dosed with a low and high treatment, equivalent to the 
total amount of MC incorporated into the low and high dose scaffolds, as well as a clinical dose, 
equivalent to the total amount of MC incorporated into Arestin®. No adverse effects to cell viability or 
phenotype are anticipated for the low and high treatments, while cell growth and phenotype is expected to 
be altered by the clinical dose group. 
4.2 Materials and Methods 
4.2.1 Scaffold Fabrication 
4.2.1.1 PCL-Aligned 
An 18% (w/v) PCL solution was prepared by dissolving PCL into 3:2 mixture of DCM:DMF. The 
solution was mixed overnight, vortexed for ~1 hour prior to electrospinning, and the entire solution loaded 
into a 5 mL syringe with a 23 gauge stainless steel blunt-tip needle. A voltage of 9-10 kV was applied to 
the needle tip and a pump flow rate of 1 mL/hr was used. Fibers were collected on a grounded rotating 
mandrel (2500 rpm), 13 cm from the needle tip. The entire polymer solution was electrospun to fabricate 
scaffolds of thickness ranging from 0.08-0.11 mm as measured with a digital caliper. 
4.2.1.2 PCL-Minocycline 
A 2% (w/w) or 5% (w/w) MC (Sigma-Aldrich) solution was prepared by dissolving the antibiotic 
into a 3:2 mixture of DCM:DMF. PCL polymer granules were added to 18% w/v. The solution was mixed 
overnight and vortexed ~1 hour prior to electrospinning. For electrospinning, the entire solution was 
loaded into a 5 mL syringe with a 23 gauge stainless steel blunt-tip needle. A voltage of 10-13 kV was 
applied to the needle tip and a pump flow rate of 1 mL/hr was used. Fibers were collected on a grounded 
rotating mandrel (2500 rpm), 13 cm from the needle tip. The entire polymer solution was electrospun to 




4.2.2 Scaffold Characterization 
4.2.2.1 Scanning Electron Microscopy and Fiber Diameter 
Fiber diameter and morphology of as-fabricated scaffolds were determined. Scaffolds were 
imaged using scanning electron microscopy (SEM, 1 kV, 10 µA Hitachi 4700). Prior to imaging, a 
conductive gold-palladium coating was applied to the scaffold surface via sputter coating (Cressington 
108auto). Fiber diameter was measured using ImageJ (National Institutes of Health). Fiber diameter 
values are an average of measurements taken from 3 independent regions of the mesh imaged at 1 and 
2.5 K (n=6images/group), with 20 measurements per image. 
4.2.2.2 Fourier Transform Infrared Spectroscopy 
Infrared spectra (n=3) were obtained with a Fourier transform infrared attenuated total reflection 
(FTIR-ATR) spectrometer (Frontier FTIR, PerkinElmer). Spectra were collected from 380-4000 cm-1 using 
4 scans with a resolution of 4. 
4.2.3 Antibiotic Incorporation into Scaffolds 
Scaffolds were cut to 1 cm2 using a biopsy punch and the thickness and weight measured. One 
milliliter of DCM was added, and the samples vortexed to dissolve the scaffold. The solvent was then 
allowed to evaporate completely in a chemical fume hood.  Samples were resuspended in 1 mL of PBS 
and incubated at 37°C on an orbital shaker for 24 hours. The absorbance at 405 nm was read using a 
Tecan microplate reader. Drug release was calculated using a standard curve (absorbance vs 
concentration of free drug in PBS). 
4.2.4 Antibiotic Release 
Scaffolds were cut to 1 cm2 using a biopsy punch and the thickness measured to 0.08 ± .02 mm 
using digital calipers. After sterilization by UV 356 nm (each side 15 min), scaffolds were immersed in 1 
mL PBS and incubated under humidified conditions at 37°C, 5% CO2. At the specified time intervals, all 
the PBS was removed and replaced with 1 mL of fresh PBS. Samples absorbance at 405 nm was read 
using a Tecan microplate reader. Drug release was calculated using a standard curve (absorbance vs 
concentration of free drug in PBS). The concentration of drug released from the initial time point to the 




4.2.5 Growth Inhibition – Agar Diffusion 
Porphyromonas gingivalis (P.g., ATCC No. 33277) was grown anaerobically (Bio-Bag, BD) at 
37°C on brucella blood agar Plates (BBA, BD BBL), and Aggregatibacter actinomycetemcomitans (A.a., 
ATCC No.29522) was grown at 37°C, 5% CO2 on tryptic soy agar plates (BD BBL). After one week, 
cultures were resuspended to 1x108 cells / mL (0.5 McFarland Standard) in sterile DI H2O. A 50 µL aliquot 
of the cell suspension was spread on the respective plates. Minocycline containing and antibiotic-free 
scaffolds were cut into 1 cm2 disks and sterilized by UV radiation. The scaffolds were then placed onto 
the inoculated agar and incubated under the appropriate culture conditions. The zone of inhibition4 (ZOI) 
and area of inhibition was measured after 72 hours (n=6) using ImageJ (National Institutes of Health).  
Plaque samples from diseased patients were obtained and placed in dental transport medium 
(Anaerobe Systems). Samples were stored at room temperature for no more than 5 hours prior to 
processing.  Plaque samples were added to 500 µl of brain heart infusion broth (Anaerobe Systems), 
homogenized (Microson XL-2000) for 30 seconds, and 250 µl was used to inoculate BBA plates. Plates 
were incubated under anaerobic conditions 37°C for 7 days and used for growth inhibition testing 
following the procedure outlined above. Sample ZOI and area of inhibition was recorded after 1, 3, 5, and 
7 days (n=6) using ImageJ. 
4.2.6 Cell Seeding and Culture 
Electrospun scaffolds were cut to 1 x 1.8 cm and secured using custom-made clamps, resulting in 
an effective cell culture surface area of 1 cm2. To enhance surface reactivity, scaffolds were air plasma 
treated (Harrick Plasma PDC-32G) at high RF setting for 1 min. Scaffolds were then sterilized by UV 356 
nm (each side 15 min) and soaked overnight in F/S medium with 20% FBS. Human PDL cells (passage 
4-5) were seeded on scaffolds at a density of 30,000 cells/cm2 (3 M cells/mL, 10 µl), and allowed to attach 
for 20 min under humidified conditions at 37ºC, 5% CO2 before the addition of F/S medium supplemented 
with 50 µg/mL ascorbic acid (Sigma-Aldrich). 
For monolayer studies human PDL cells were seeded at 30,000 cells/well on a 48 well (1 cm2) 
plate served as controls. After 1 day of culture, cells were dosed with 50 µg/mL, 250 µg/mL, or 1 mg/mL 
(low, high, clinical) MC in F/S media. Cells were maintained at 37°C, 5% CO2 and media was exchanged 




4.2.7 Live/Dead Cell Viability 
Cell viability (n=3) was visualized using Live/Dead staining (Molecular Probes). Scaffolds were 
stained following the manufacturer’s suggested protocol. Samples were imaged using confocal 
microscopy (Olympus Fluoview FV1000) at excitation wavelengths of 488 nm and 568 nm. 
4.2.8 Cell Proliferation 
Cell proliferation (n=5) was determined by measuring total DNA content using the PicoGreen 
dsDNA assay (Invitrogen) following the manufacturer’s protocol. Scaffolds were rinsed twice in PBS and 
stored in 500 µl of 0.1% Triton-X (Sigma-Aldrich) at -30°C. Immediately before the analysis, samples 
were thawed and homogenized (Microson XL-2000) for 20 sec. Fluorescence was measured using a 
Tecan microplate reader with an excitation wavelength of 485 nm and an emission wavelength of 535 nm. 
A conversion factor of 8 pg DNA/cell was used to determine cell number. 
4.2.9 Collagen Production 
Collagen production (n=5) was quantified using a modified hydroxyproline assay153. Samples 
were first dessicated (CentriVap, Labconco, Kansas City, MO) and digested for 18 hr at 65°C in a solution 
of 20 µL/mL papain (Sigma-Aldrich), buffered in 0.1 M sodium acetate, 10 mM cysteine HCl, and 50 M 
ethylenediaminetetraacetate.  A 250 µl aliquot of the digest was concentrated by dessication.  Samples 
were subsequently hydrolyzed in 10 µl of 10N NaOH and autoclaved for 25 min.  The hydrolysate was 
then oxidized by a buffered chloramine-T reagent for 25 min before the addition of Ehrlich’s reagent.  
Sample absorbance was measured at 550 nm (Tecan), and the collagen content was obtained by 
interpolation along a standard curve of bovine collagen I (Sigma). 
4.2.10 Alkaline Phosphatase Activity 
After scaffold homogenization samples were assayed for alkaline phosphatase (ALP) activity 
(n=5) using a colorimetric assay based on the hydrolysis of p-nitrophenyl phosphate (pNP). On ice, 50 µl 
of sample was added to pNP-PO4 solution (Sigma) and incubated for thirty minutes at 37°C. The 
absorbance at 405 nm was read using a Tecan microplate reader. ALP activity is reported normalized to 




4.2.11 Statistical Analysis 
Results are reported as mean ± standard deviation, with n equal to the number of replicates per 
group. Statistical analyses were performed with JMPIN (4.0.4, SAS Institute, Inc.). A two-way analysis of 
variance was used to determine the effects of antibiotic concentration and time on the bacterial zone of 
inhibition and PDL cell response (proliferation, ALP activity, matrix deposition). The Tukey-Kramer post 
hoc test was used for all pair-wise comparisons, and significance was attained at p<0.05. 
4.3 Results 
4.3.1 Scaffold Characterization 
SEM micrographs of MC-loaded scaffolds are shown in Figure 4.1. A consistent bead-free 
morphology is achieved, similar to plain PCL scaffolds. The average fiber diameter of drug loaded 
scaffolds is 574 ± 140 nm and 552 ± 207 nm for the low and high dose scaffolds respectively, similar to 
antibiotic-free scaffolds (620 ± 100 nm).  
Scaffolds were characterized using FTIR-ATR to confirm drug incorporation (Figure 4.1). 
Characteristic MC bands154 at 1615 cm-1 (N=N stretch), 1580 cm-1 (N-H bending), and 1198 cm-1 (O-H 
bending) are observed in the spectra for both the high and low dose groups. Increasing peak intensity is 
noted with increased drug loading. The PCL bands6 at 1720 cm-1 and 1160 cm-1, characteristic of C=O 
and C-O bonding, are present for all groups. 
4.3.2 Minocycline Release 
 Minocycline incorporated into scaffolds, as determined by total extraction, is 122 ± 12 µg and 52 ± 
1.1 µg for high and low dose scaffold respectively (Figure 4.2). Minocycline loaded fibers show a burst 
release during the first 8 hours, with the total release (high: 120 ± 5 µg, low: 56 ± 1.1 µg) approximating 
the total drug incorporated into the scaffold. 
4.3.3 Inhibition of Periodontopathic Bacteria 
Minocycline containing scaffolds are effective in inhibiting the growth of known periodontal 
pathogens P. gingivalis and A. actinomycetemcomitans, as well as bacteria harvested from patients 




bacteria tested at all time points. For patient plaque bacteria cultured over the course of 7 days, the ZOI 
and area of inhibition is unchanged after three days of culture for both low and high dose scaffolds. 
Bolus injections of antibiotic were adsorbed onto PCL scaffolds at amounts equivalent to the high 
and low dose scaffolds. Minocycline provided as a bolus is also effective in inhibiting the growth of 
bacteria (Figure 4.4). A significant difference between groups is only noted at days 7 and 10, due to the 
variability in ZOI during the prior time points. Thus bolus doses result in greater inconsistencies in the 
zone of inhibition compared to the sustained release PCL-MC scaffolds. 
4.3.4 PCL-MC Scaffolds: Cell Viability and Proliferation 
Cells attached to all substrates and display an elongated morphology after one day of culture 
(Figure 4.5). Viable cells are noted on all substrates and at all time points from confocal microscope 
images of live/dead stained samples. Cell number is significantly greater on control (0%, PCL) samples 
compared to the high (5% w/w) dose scaffold at days 7 and 14. After 28 days of culture, cell number 
among all groups is significantly different from each other, with the greatest number of cells on control 
PCL scaffolds and the least number of cells on the high dose PCL-MC scaffold. 
4.3.5 PCL-MC: Scaffolds Cell Biosynthesis 
Collagen production is detected on all samples but there are no differences noted between 
groups and over time. Alkaline phosphatase activity for all groups peaks after one day of culture (Figure 
4.6). A significant decrease in ALP activity over time was noted between days 3 and 7 for all groups. ALP 
activity is significantly enhanced on high dose PCL-MC scaffold compared to PCL control at days 1 and 7.  
4.3.6 Monolayer: Cell Viability and Proliferation 
Cell growth is similar for control, low, and high dose groups, while there are significantly less cells 
on the clinical treatment group at days 14 and 28. Confocal micrographs show that cell morphology on 
the clinical group is altered after the cells are dosed with antibiotic, with a rounded shape observed at day 
3 compared to spindle shape at day 1 (Figure 4.7). Cells begin to display an elongated morphology at day 




4.3.7 Monolayer: Cell Biosynthesis 
Baseline collagen levels were detected on all groups, with no significant differences in collagen 
production between treatment groups. ALP activity is significantly enhanced on the clinical group at day 3 
compared to all other groups.  This may be due to interference from MC antibiotic which absorbs light at 
UV 405 nm, the absorbance required for the ALP activity assay. At days 14 and 28 ALP activity on the 
clinical group is significantly lower compared to all other groups. Enzyme activity on the high treatment 
group is significantly greater than the low group at day 28.  
4.4 Discussion 
This study explored the incorporation of minocycline-hydrochloride antibiotic into electrospun PCL 
scaffolds to support periodontal healing. Given that a major complication of periodontal therapies is the 
presence of plaque-associated pathogens136,160,166,206, the objective of this study was to incorporate 
antibiotics into PCL-Aligned scaffolds at low (2% w/w) and high (5% w/w) doses to facilitate optimal 
periodontal healing. 
Scanning electron microscope images demonstrated that the inclusion of minocycline into PCL 
scaffolds did not alter fiber morphology or diameter. Antibiotic incorporation was confirmed by FTIR-ATR, 
which showed the presence of characteristic minocycline peaks that increased in intensity with greater 
antibiotic incorporation. The total minocycline released over time was similar to the total amount 
incorporated into the scaffolds, which were 122 µg and 52 µg for high and low dose scaffolds 
respectively. Antibiotic release profiles for both groups were similar, in which an initial burst release of 
nearly all incorporated minocycline was observed during the first 8 hours. Antibiotic release from polymer 
matrices is typically guided by three mechanisms: release of surface-loaded drug, followed by diffusion, 
and then polymer erosion. This would result in an initial burst release followed by a slow and steady 
release71. Given the release profiles of the PCL-MC scaffolds used here, it is likely that most of the 
antibiotic is contained on the surface of the polymer fibers. 
In order to determine if antibiotic activity was maintained during the electrospinning process as 
well as to demonstrate efficacy, PCL-MC scaffolds were evaluated against known periodontopathic 
strains of bacteria as well as bacteria harvested from patient plaque samples. Both low and high antibiotic 




actinomycetemcomitans, as well as pathogens harvested from diseased tissue. A dose-dependent 
inhibitory response was observed for P. gingivalis and harvested bacteria samples. Minocycline, a 
tetracycline derivative, is effective against anaerobes and facultative organisms, pathogens which are 
most common to periodontal disease69. Of the strains of bacteria investigated here, P. gingivalis is an 
obligate anaerobe and A. actinomycetemcomitans is an aerobic organism. Furthermore, the bacteria 
harvested from dental plaque samples were cultured in an anaerobic environment for 7 days prior to the 
initiation of inhibition studies, also performed in an anaerobic environment. These populations therefore 
consisted of anaerobic species. The effectiveness of the PCL-MC scaffolds against the growth of 
harvested bacteria is particularly promising given that periodontal disease is caused by a diverse 
population of pathogens rather than a single pathogenic species. Finally PCL-MC scaffolds were effective 
against bacterial growth for 7 days, with very small changes in ZOI noted after 3 days, indicating the long 
term effectiveness of the scaffolds in inhibiting growth. The results reported thus demonstrate that 
antibiotic activity is maintained through the electrospinning process and that both low and high dose 
scaffolds are effective in controlling the growth periodontopathic bacteria, including clinically relevant 
strains of bacteria.  
To promote an ideal environment for periodontal healing, antibiotics administered to control 
pathogenic growth must also not demonstrate adverse effects to host cell growth or phenotype. This 
study incorporated minocycline antibiotic into electrospun polycaprolactone fibers to achieve a localized 
and sustained delivery system. Advantages of such systems are that generally lower concentrations of 
antibiotics can be utilized compared to systemic delivery, which must compensate for the dilution effect. 
Additionally controlled release systems affords longer term efficacy, necessary given a suggested 7-10 
days of antibiotic exposure is required to achieve long term changes in the bacterial flora181. The purpose 
of this study was to ensure the cytocompatibility of PCL-MC fibers with human periodontal ligament 
derived cells. Two concentrations of antibiotics were incorporated into fibers, and both have 
demonstrated efficacy against clinical relevant periodontopathic flora. 
A dose dependent effect on cell growth was observed based on antibiotic incorporated into 
scaffolds. Significantly greater cell growth on control (0%) compared to high dose (5% w/w) scaffolds was 




than the low dose (2% w/w) scaffold. A dose dependent effect on cell survival has also been observed for 
PDL cells cultured in monolayer139, although it should also be noted that at least 65% cell survival was 
observed for minocycline concentrations equivalent to the high dose scaffold used in this study, and 
others have also  observed 100% survival for equivalent concentrations used here189. The differences in 
growth for this study could be explained by the initial differences in cell attachment between scaffolds with 
and without antibiotic. Although cell number was not significantly different between control and antibiotic 
containing scaffolds at day 1, the mean cell number was greater on control scaffolds. This could have 
resulted in the observed differences in cell number with culture time. It has been reported that the 
inclusion of tetracycline into electrospun polycaprolactone fibers results in changes in contact angle94, 
indicative of changes in surface chemistry which could potentially affect cell attachment. It should also be 
noted that cell proliferation over time was observed on all scaffold groups, with and without antibiotic, 
indicating that minocycline containing scaffolds indeed support cell growth. Finally, monolayer studies 
have also been performed in which a bolus quantity of minocycline, equivalent to the theoretical antibiotic 
incorporated into scaffolds, was provided to cells. These studies demonstrated no long term differences in 
cell number were observed between control (no antibiotic) and low and high dose equivalent groups, 
further demonstrating minocycline cytocompatibility with periodontal ligament cells at the concentrations 
evaluated.  
Collagen production and ALP activity were also quantified as indicators of PDL cell phenotype. 
Alkaline phosphatase activity was enhanced on high dose scaffolds compared to control scaffolds at days 
1 and 14, while there were no differences observed at days 3, 7, 14 and 28 and no differences at all time 
points the low dose scaffold. Minocycline is a chelator and binds to root surfaces69, thus this calcium 
sequestering property may be the cause of the enhanced ALP activity seen in the higher dose group. 
There were no differences in collagen production on scaffolds with and without antibiotic. These results 
are similar to Suzuki et al., in which no differences in the expression of genes for ALP and type I 
procollagen was observed for monolayer culture of a periodontal ligament fibroblast cell line treated with 
minocycline at concentrations from 30-1000 µM189. The same study quantified ALP and collagen 
production at 48 hours using western blot and also observed no differences for minocycline 




approximately 50 µg and 120 µg for low and high dose scaffolds respectively, equivalent to 50 µM and 
120µM, which are within the range explored in literature. Finally, while there were no observed 
differences in collagen production over time for any of the groups, the mean values did trend higher with 
time. Future studies could explore methods to promote cellular collagen deposition, including varying the 
seeding density. 
This study demonstrated the cytocompatibility of antibiotic releasing scaffolds with PDL cells in 
regards to cell growth and phenotype. Although there were observed differences in proliferation at later 
timepoints which may have been a result of differences in initial cell attachment, in the clinical 
implementation of this system, which relies on cell migration followed by attachment to the scaffold, this 
may not be an issue. Given the burst release observed, in which nearly 90% of the antibiotic is released 
within the first 24 hours, by the time cells migrate to the scaffold, nearly all of the antibiotic will be 
removed from the scaffold system. Thus cell attachment may not be impeded in the clinical scenario. On 
the other hand, these differences in surface chemistry as well as cell attachment need to be evaluated to 
confirm this conjecture. Thus the low and high dose scaffolds evaluated in this study both represent 
viable systems to promote the regeneration of the periodontal ligament and illicit a similar cell response to 
antibiotic free scaffolds. 
This effects of minocycline on PDL cell survival and phenotype in monolayer culture was also 
assessed. The low, high, and clinical doses of antibiotic are equivalent to the low and high dose PCL-MC 
scaffolds, and the total minocycline contained in Arestin®, a clinically used treatment for periodontitis. 
Cells were dosed with antibiotic at day 3, due to the burst release observed in PCL-MC scaffolds, in 
which nearly 99% of incorporated antibiotic is released within 3 days. The results indicated a dose 
dependent response to the antibiotic, as total cell number decreases with increasing antibiotic dose. This 
was observed at days 3 and 14, although the differences in cell number were not always statistically 
different, the values trended in this manner. These results are similar to Suzuki et al., who observed no 
differences in cell survival when PDL cells were dosed with 100 µM minocycline and ~65% survival with a 
300 µM dose.189 In this study, the low and high doses are equivalent to 100 µM and 500 µM. By day 28 in 
this study, there were no differences in cell number between the control and the low and high doses. The 




hours of culture/dosing. In contrast, the clinical dose (2000 µM) resulted in significantly lower cell number 
compared to all the other groups at days 14 and 28. It should be noted that Arestin® consists of 
minocycline incorporated into bioresorbable PLGA microspheres, resulting in the controlled release of 1 
mg of the antibiotic over a 3 month period.  
In terms of cell biosynthesis, there were no differences in ALP activity or collagen deposition 
between the control, low, and high dose. Similar results were also observed in the Suzuki study, in which 
no differences in gene expression and production of ALP and collagen I were observed for minocycline 
concentrations up to 1000 µM (expression) and 100 µM (production/western blot). The high ALP activity 
observed at day 3 for the clinical group is likely a result of excess antibiotic in the sample, as the λmax 
absorbance for  minocycline is 352 nm209, while the ALP assay measures absorbance at 405 nm. The 
high ALP activity may also be a result of the normalization by cell number, as the total ALP on day 3 for 
the clinical group did not differ greatly from the other groups. 
 While there was a slight dose dependent effect on PDL cell proliferation between the control 
(antibiotic free) and the low and high dose groups, these results were only observed in the short term, 
and by day 28 there were no differences in cell number between groups. Importantly there were no 
observed differences in phenotype, as ALP activity and collagen production were similar between these 
groups. These results thus demonstrate that a bolus quantity of minocycline, provided at levels equivalent 
to low and high dose PCL-MC scaffolds, is compatible with PDL cells and supports growth and the PDL-
cell phenotype. 
4.5 Conclusion 
In order to support optimal periodontal ligament regeneration, the purpose of this study was to 
incorporate minocycline antibiotic into the PCL scaffolds optimized from the previous study. Minocycline 
was incorporated into electrospun scaffolds at two different doses (2%, 5% w/w) without affecting fiber 
morphology. Antibiotic release was characterized by a rapid initial release and displayed a similar 
behavior between groups. In a dose dependent manner, both low and high dose scaffolds effectively 
inhibited the growth of P. gingivalis and A. actinomycetemcomitans, as well as anaerobic bacteria 
harvested from plaque samples from diseased patients. Both low and high dose scaffolds demonstrated 




Minocycline containing scaffolds were also evaluated for periodontal ligament cell response in 
this study. It was demonstrated that antibiotic containing scaffolds have a minor impact on periodontal 
ligament cell phenotype, with no effect on collagen deposition but a slightly enhanced ALP activity on high 
dose scaffolds. A dose dependent effect on cell number was noted, although this may be a result of an 
altered surface chemistry which may influence initial cell attachment. Importantly all scaffolds supported a 
similar degree of cell proliferation over time. Thus a periodontal ligament regenerative scaffold that both 
provides an ideal environment for ligament healing as well as addresses residual infection at the wound 
site has been developed. This scaffold, which consists of minocycline releasing polycaprolactone fibers at 







Figure 4.1: Effect of Minocycline Dose Against Periodontopathic Bacteria: Scaffold Fiber 
Morphology and Diameter, and Antibiotic Incorporation SEM micrographs show a bead free 
morphology for scaffolds with and without antibiotic. Fiber diameter is consistent between groups (n=6 
images, 10 measurements per image) FTIR of as-fabricated scaffolds shows characteristic MC peaks: 
1615 cm
-1
 (N=N stretch), 1580 cm
-1
 (N-H bending), and 1198 cm
-1
 (O-H bending) in both the low and 























































































Figure 4.2: Effect of Minocycline Dose Against Periodontopathic Bacteria: Total Minocycline 
Incorporation and Release Significantly greater MC in high (5% w/w) dose scaffold compared to low 
(2% w/w) scaffold. Total incorporation is similar to theoretical values, 100 µg and 45 µg for high and 
low dose respectively  A burst release is observed during the first 8 hours and total release 
approximates that of the total MC incorporation into scaffolds. Significant difference between: ^ all 







Figure 4.3: Effect of Minocycline Dose Against Periodontopathic Bacteria: Inhibition of 
Periodontopathic Bacteria PCL-MC Scaffolds High dose scaffolds resulted in significantly greater 
ZOIs compared to low dose for Porphyromonas gingivalis (P.g.), and anaerobic bacteria harvested 
from plaque samples. Both MC containing scaffolds inhibited the growth of Aggregatibacter 
actinomycetemcomitans (A.a.) to a similar degree. Positive growth was noted for all bacteria cultured 
in the presence of the control scaffold, PCL (0%). Images are representative of culture growth after 72 
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Figure 4.4: Effect of Minocycline Dose Against 
Periodontopathic Bacteria: Inhibition of 
Periodontopathic Bacteria with Bolus Injection 
Bolus injections of antibiotic were adsorbed onto 
scaffolds and effects against bacteria from plaque 
samples assessed. ZOI is significantly greater on 
the high dose group compared to the low dose at 
days 5 and 7. ZOIs for both groups remain constant 



























Figure 4.5: Effect of Minocycline Dose on 
PDL Cell Response: Cell Viability and 
Proliferation Confocal micrographs show 
similar attachment between groups and 
proliferation is noted on all substrates. PDL cell 
number is significantly greater on PCL control 
compared to high dose MC scaffolds at days 7, 
14, and 28. Significant difference between: # 








































Figure 4.6: Effect of Minocycline Dose on PDL Cell Response: Matrix Deposition and Alkaline 
Phosphatase Activity Collagen deposition is noted on all groups, with no differences between groups 
and over time. ALP activity peaks at day 1 for all groups. ALP activity is enhanced on high dose MC 
scaffolds compared to all other groups and PCL control at days 1 and 7 respectively. Significant 




























Figure 4.7: Effect of Minocycline Dose 
on PDL Cell Response in Monolayer 
Culture: Cell Viability and Proliferation 
Diminished cell growth is noted in the 
clinical treatment group. All other groups 
proliferate to confluence. Cell number is 
lower in the clinical treatment group 
compared to all other groups at days 14 
and 28. Significant difference between: # 




















































Figure 4.8: Effect of Minocycline Dose on PDL Cell Response in Monolayer Culture: Matrix 
Deposition and Alkaline Phosphatase Activity Collagen deposition is noted on all groups and there 
are no differences between groups and over time. In the clinical treatment group, ALP activity is 
enhanced at day 3 compared to all other groups, while it is significantly lower than all other groups at 
day 28. For the high treatment MC group, ALP activity is significantly lower compared to the control at 
day 14 and greater than the low treatment group at day 28. Significant difference between: # groups, * 
















CHAPTER 5: EFFECT OF FIBER DIAMETER ON 

















The studies detailed in the previous chapters resulted in an optimized scaffold to promote PDL 
regeneration. Successful periodontal healing on the other hand requires regeneration of the PDL, bone, 
and cementum, as well as achieving soft-to-hard tissue integration. Thus the focus of the following 
chapters will be the investigation of scaffold design parameters for integration with the hard tissue of the 
periodontium. We will harness the inherent repair capacity of periodontal derived cells, which have 
demonstrated the ability to synthesize and remodel the three connective tissues of the periodontium167. 
Scaffold design cues, in this study specifically fiber diameter, will be explored to guide the growth, 
differentiation, and biosynthesis of PDL-derived cells to achieve soft-to-hard tissue integration. In chapter 
2 we saw that cells cultured on PLGA-Aligned scaffolds displayed enhanced ALP activity and mineral 
deposition. Aligned, organized fibers also mimic the Sharpey’s fiber insertions found at the PDL-
cementum and PDL-alveolar bone interfaces. Accordingly, the fiber diameter of PLGA-Aligned scaffolds 
will be explored in this chapter. 
5.1.1 Background and Motivation 
Periodontal ligament fibers insert into the tooth root cementum on one end, and into the alveolar 
bone on the other, terminating in Sharpey’s fibers that insert into the mineralized tissues. The diameter of 
the collagen fiber bundles that comprise the periodontium vary depending on location within the tissue. 
Close to the cementum the bundles are 3-10 μm, while near the alveolar wall they range from 10-20 μm, 
and within the ligament itself the bundles are 1-4 μm in diameter21. Studies have shown that scaffold fiber 
diameter is an important design parameter for functional connective tissue repair. Erisken et al. 
demonstrated that nanofiber scaffolds enhanced human tendon fibroblast proliferation and matrix 
deposition, while microfiber scaffolds promoted the expression of fibroblastic markers52. Bashur et al. 
found that fiber diameter affected NIH 3T3 cell morphology and spreading, in which cell area, aspect 
ratio, and length of the long axis are diminished on sub-micron fibers13. Mesenchymal stem cells have 
also demonstrated sensitivity to fiber diameter, in which the expression of ligament markers was 
upregulated on 280 nm diameter scaffolds compared to 820 nm and 2.3 µm14. As fiber diameter has been 




fiber diameter can be explored as a mechanism to guide cell differentiation and promote interface tissue 
healing. 
5.1.2 Objectives 
This study optimizes electrospinning condition to fabricate PLGA-Aligned fibers approximately 3 
and 7 µm in diameter. Cell response on small and large micron fiber diameter scaffolds will be compared 
to culture on nanofiber scaffolds and tissue culture plastic (monolayer). It is hypothesized that the larger, 
micron-sized fibers will promote PDL cell differentiation toward an osteoblastic phenotype, specifically via 
enhanced ALP activity, necessary to promote interface regeneration. 
5.2 Materials and Methods 
5.2.1 Scaffold Fabrication 
5.2.1.1 PLGA Nanometer 
A 54% (w/v) polymer-DMF solution was prepared, and the solution mixed overnight. Prior to 
electrospinning, 100% ethanol was added and the solution vortexed for an additional 1-1.5 hours. The 
entire solution was loaded into a 5 mL syringe with an 18 gauge stainless steel blunt-tip needle. A voltage 
of 8-10 kV was applied to the needle tip and a pump flow rate of 1 mL/hr was used. Fibers were collected 
on a grounded rotating mandrel (2500 rpm) placed 13 cm from the needle tip. The entire polymer solution 
was electrospun to fabricate scaffolds of thickness ranging from 0.09-0.14 mm as measured with a digital 
caliper. 
5.2.1.2 PLGA Micrometer 
 For the 3 and 7 µm fiber diameter scaffolds, a 70% (w/v) polymer in a 1:4 solution of 
Acetone:DMF was prepared and the solution mixed overnight. Prior to electrospinning, 100% ethanol was 
added and the solution vortex for an addition 1-1.5 hours. The entire solution was loaded into a 5 mL 
syringe with either an 18 gauge (3 µm) or 20 gauge (7 µm) stainless steel blunt-tip needle. A voltage of 15 
kV was applied to the needle tip and a pump flow rate of 1 mL/hr (3 µm) or 5 mL/hr (7 µm) was used. 
Fibers were collected on a grounded rotating mandrel (3 µm:  2500 rpm, 7 µm: 2000 rpm) placed 13 cm 




5.2.2 Cell Seeding and Culture 
Electrospun scaffolds were cut to 1 x 1.8 cm and secured using custom-made clamps, resulting in 
a cell culture surface area of 1 cm2. Scaffolds were UV 356 nm sterilized (each side 15 min) and 
incubated (37°C, 5%CO2) overnight in F/S medium with 20% FBS to promote cell attachment. 
Human PDL cells were seeded on scaffolds at a density of 30,000 cells/cm2 (3 M cells/mL, 10 µl), 
and allowed to attach for 20 min under humidified conditions at 37ºC, 5% CO2 before the addition of F/S 
medium supplemented with 50 µg/mL ascorbic acid (Sigma-Aldrich). Cells were maintained at 37°C, 5% 
CO2 and media was exchanged every 2-3 days.  
5.2.3 Live/Dead Cell Viability 
Cell viability (n=3) was visualized using Live/Dead staining (Molecular Probes). Both monolayer 
and scaffolds were stained following the manufacturer’s suggested protocol. Samples were imaged using 
confocal microscopy (Olympus Fluoview FV1000) at excitation wavelengths of 488 nm and 568 nm.  
5.2.4 Cell Proliferation 
Cell proliferation (n=5) was determined by measuring total DNA content using the PicoGreen 
dsDNA assay (Invitrogen) following the manufacturer’s protocol. Scaffolds were rinsed twice in PBS and 
stored in 500 µl of 0.1% Triton-X (Sigma-Aldrich) at -30°C. Immediately before the analysis, samples 
were thawed and homogenized (Microson XL-2000) for 20 sec. Fluorescence was measured using a 
Tecan microplate reader with an excitation wavelength of 485 nm and an emission wavelength of 535 nm. 
A conversion factor of 8 pg DNA/cell was used to determine cell number. 
5.2.5 Collagen Production 
Collagen production (n=5) was quantified using a modified hydroxyproline assay153. Samples 
were first dessicated (CentriVap, Labconco, Kansas City, MO) and digested for 18 hr at 65°C in a solution 
of 20 µL/mL papain (Sigma-Aldrich), buffered in 0.1 M sodium acetate, 10 mM cysteine HCl, and 50 M 
ethylenediaminetetraacetate.  A 250 µl aliquot of the digest was concentrated by dessication.  Samples 
were subsequently hydrolyzed in 10 µl of 10N NaOH and autoclaved for 25 min.  The hydrolysate was 




Sample absorbance was measured at 550 nm (Tecan), and the collagen content was obtained by 
interpolation along a standard curve of bovine collagen I (Sigma). 
5.2.6 Alkaline Phosphatase Activity 
After scaffold homogenization samples were assayed for alkaline phosphatase (ALP) activity 
(n=5) using a colorimetric assay based on the hydrolysis of p-nitrophenyl phosphate (pNP). On ice, 50 µl 
of sample was added to pNP-PO4 solution (Sigma) and incubated at 37°C until a color change was noted. 
The absorbance at 405 nm was read using a Tecan microplate reader. ALP activity is reported 
normalized to incubation time and the post-homogenization cell number. 
5.2.7 Statistical Analysis 
Results are reported as mean ± standard deviation, with n equal to the number of replicates per 
group. Statistical analyses were performed with JMPIN (4.0.4, SAS Institute, Inc.). A two-way analysis of 
variance was used to determine the effect of fiber diameter and culture time on cell response 
(proliferation, ALP activity, matrix deposition).  The Tukey-Kramer post hoc test was used for all pair-wise 
comparisons, and significance was attained at p<0.05. 
5.3 Results 
5.3.1 Scaffold Characterization 
 Aligned nano and microfiber scaffolds were fabricated with 0.65 ± 0.17 µm, and 3.29 ± 0.58 µm 
and 6.77 ± 1.96 µm fiber diameters respectively. Fiber diameters for all three scaffold groups are 
significantly different from each other. 
5.3.2 Cell Viability and Proliferation 
 Cells attach and elongate along the long axis of fibers for all groups, while no such alignment is 
visible in monolayer culture. Cells number increases significantly over time for both micron-diameter 
scaffolds at days 7, 14, and 28. There is significant growth for the monolayer group at day 14 but a 
decrease in cell number at day 28 is noted. Cell number is significantly greater on both microfiber 




5.3.3 Cell Biosynthesis 
Mean collagen for all three scaffold groups increases with time, and collagen production is 
enhanced on both microfiber scaffolds compared to the nanofiber group at day 28. There is a significant 
increase in collagen production on the 7 µm group at days 7 and 28. All groups peak in ALP activity at 
day 1, and decline significantly between days 1 and 7. Enzyme activity is significantly greater on all 
scaffolds compared to monolayer at day 1. Among scaffold groups, enhanced enzyme activity is noted on 
the nanofiber group at days 1, 7, and 14 compared to both microfiber groups.  
5.4 Discussion 
 This study explored the effect of scaffold fiber diameter on the response of PDL cells for the 
purpose of facilitating soft-to-hard tissue integration. The diameter of the collagen fiber bundles 
(Sharpey’s fibers) that insert into alveolar bone and cementum from the PDL are significantly larger (3-20 
µm) than those of the ligament proper (1-4 µm). Scaffold fiber diameter was therefore explored as a 
means to promote the osteoblastic differentiation of periodontal ligament cells. 
In this study PLGA scaffolds with fiber diameters of approximately 0.65, 3.3, and 6.8 µm were 
fabricated. The 6.8 µm scaffold represented the upper limit of fiber diameter that could be feasibly 
electrospun. Among electrospinning parameters, varying the polymer concentration has the greatest 
impact on fiber formation, including fiber diameter171. In general, there is a positive relationship between 
polymer concentration or solution viscosity and fiber diameter. However there remains an upper limit on 
solution viscosity beyond which results in difficultly controlling the solution flow rate. PLGA fibers with 
greater fiber diameters have been reported, although these were fabricated using other techniques84. 
While cell attachment on all scaffold groups was similar, by day 28 cell number was significantly 
greater on the microfiber scaffolds. Comparing these results with that of human tendon fibroblast cultured 
on PLGA scaffolds of varying fiber diameter, Erisken et al. saw an opposite trend, in which cell 
proliferation decreased with increasing fiber diameter52. On the other hand, the largest diameter explored 
in that study was 1.8 µm, while in this study the microfibers were 3.3 and 6.8 μm. In comparison, Bashur 
et al. saw no differences in cell density of NIH 3T3 fibroblasts cultured on unaligned PLGA meshes with 
fiber diameters ranging from 0.14-3.6 µm. Collectively these results indicate that the response of 




type. There are currently no studies which explore the effects of periodontal ligament derived cells or 
periodontal ligament fibroblasts to scaffold fiber diameter. In biochemical analysis of human periodontal 
tissue performed in this lab, H&E staining has revealed a cell distribution concentrated at the interface 
areas with the cementum and bone. It has also been reported that with tooth movement, the areas of 
highest metabolic activity are found at the fiber insertions near the cementum and bone79—this may 
explain the higher cell density at the interfaces, as well as the enhanced cell number on the microfiber 
scaffolds. Collagen quantitation data also indicated enhanced matrix deposition on microfibers compared 
to nanofibers after 28 days of culture, indicative of increased metabolic activity on the substrates. 
Alkaline phosphatase activity, as a measure of osteogenic potential, was enhanced on all 
scaffolds compared to monolayer culture, and significantly greater on the nanofiber compared to the 
microfiber scaffolds. Periodontal cells are known to display a high basal ALP activity12, and the enhanced 
ALP activity on the fiber substrates compared to tissue culture plastic may be due to the biomimetic 
structure of fibrous scaffold to the native periodontal tissue. While in this study, ALP activity was 
enhanced on nanofibers compared to microfibers, Badami et al. observed no differences in ALP activity 
for MC3T3 osteoprogenitor based on the fiber diameter of unaligned PLA fibers8. Additionally while ALP 
activity is closely associated with the mineralization process, it does not always necessitate 
mineralization, and often a supportive medium is required for the initiation of mineral nodule 
formation12,106.  
These results indicate that periodontal ligament fibroblast response is influenced by scaffold fiber 
diameter. Specifically, culture on microfiber scaffolds can result in increased cell proliferation and matrix 
deposition, with a concurrent decrease in ALP activity compared to nanofiber scaffold. As an osteoblastic 
phenotype is characterized by high ALP activity, nanofiber scaffolds represent the optimal fiber diameter 
for the interface phase of the composite scaffold. On the other hand, as mentioned previously an 
osteoconductive medium is often required for periodontal ligament mediated matrix mineralization to 
occur. As such future studies will explore the inclusion of calcium phosphates into scaffolds to further 





 To promote an osteoblastic phenotype of periodontal ligament cells, the fiber diameter of PLGA 
scaffolds was varied. Cell proliferation and phenotype were affected by fiber diameter, in which growth 
and collagen deposition was enhanced on 3.3 and 6.8 µm scaffolds compared to submicron (0.65 µm) 
scaffolds. Mineralization potential as measured by alkaline phosphatase activity was enhanced on 
nanofiber scaffolds compared to microfiber. On the other hand, as enhanced alkaline phosphatase 
activity does not necessitate matrix mineralization. Therefore the next studies will explore modifications to 
PLGA nanofiber scaffolds to promote periodontal soft-to-hard tissue interface regeneration. Specifically 































Figure 5.1: Effect of Fiber Diameter on PDL 
Cell Response: Scaffold Morphology, Cell 
Viability, and Proliferation Nano and micro 
fibers have a smooth bead free morphology. 
Scaffold fiber diameters are significantly 
different from each other (n=6, 10 
measurements per image) Cells attach and 
elongate along fibers. Significant proliferation 
over time is noted on all scaffolds and 
monolayer. Cell number is significantly greater 
on microfiber scaffolds compared to nanofibers. 
Significant difference between: ^ all other 





    
  
Figure 5.2: Effect of Fiber Diameter on PDL Cell Response: Matrix Deposition and Alkaline 
Phosphatase Activity Collagen production is enhanced on microfiber scaffolds compared to 
nanofiber at day 28. ALP activity peaks at day 1 for all groups and is greater on scaffolds than on 
monolayer.  Enzyme activity is enhanced on nanofiber scaffolds compared to microfibers at days 1, 7, 






























































CHAPTER 6: EFFECT OF CALCIUM PHOSPHATE 

















To promote periodontal regeneration and integration, calcium phosphate (CaP) bioceramics such 
as hydroxyapatite (HA), calcium sulfate, and tricalcium phosphate can be incorporated into polymer 
scaffolds. These composite scaffolds have shown augmented osteoconductive properties in comparison 
to plain scaffolds170,187. As polymer fibers are mimetic of the native extracellular matrix of the PDL, CaP 
containing fibers mimic the Sharpey’s fibers found at the PDL-cementum and PDL-alveolar bone 
interfaces. This study will explore the incorporation of CaPs of different composition into PLGA aligned 
fibers to differentiate PDL cells into an osteoblastic phenotype to achieve soft-to-hard tissue integration. 
As an alternative to electrospun polymer-CaP fiber composites, in which the biodegradation rate of the 
polymer matrix can limit the availability of mineral, the effect of ceramic surface coatings will also be 
evaluated. Thus this study will explore the effects of both ceramic composition as well as the method of 
ceramic incorporation in fiber scaffolds for the osteogenic differentiation of PDL cells. 
6.1.1 Background and Motivation 
Bone is approximately 70% mineral, while the composition of cementum is about 50% 
mineral131,161. Calcium phosphate biomaterials have been widely utilized for hard tissue regeneration due 
to similarities in composition to bone mineral, bioactivity, and osteoinductive and osteoconductive 
capabilities. Hydroxyapatite is used widely as a bone substitute and as a periodontal therapy 
clinically31,183,207. Coating titanium dental implants with HA has also been explored as a means to enhance 
osseointegration152,163. In contrast to the perfectly stoichiometric crystalline HA (Ca/P 1.67), bone mineral 
is a carbonate-substituted, poorly crystalline apatite22,23. Cementum also is comprised of a substituted 
apatite mineral131. Simulated body fluid (SBF) solutions, which mimic the physiologic ion concentration of 
human blood plasma, have the ability to form apatitic CaPs on immersed osteoinductive materials77 
including polymers98,116. These CaP particles are non-stoichiometric and amorphous77, and are thus 
considered bone-like mineral116. During the SBF immersion process, CaP nucleation occurs on the 
material surface in addition to precipitating in the solution itself (homogenous nucleation)77. The resulting 
mineral precipitate can then be filtered and collected from the solution to be incorporated into polymer 




While it is has been demonstrated that stoichiometric HA is osteoconductive in vivo, the material 
also displays limited bone bioactivity. The bioactivity of CaP materials is related to the 
biodegradation/bioresorption of the material, which is in turn related to the solubility of the ceramic105. 
Considering the majority of CaP ceramics studied, dense stoichiometric HA is one of the slowest to 
dissolve, thus even though the material can intrinsically react with bone tissue, its reaction rate is very 
slow49. Amorphous calcium phosphates on the other hand, are more soluble than HA. Accordingly, the 
extent and rate of bioresorption of amorphous calcium phosphates, such as those produced in the SBF 
deposition process, exceeds that of HA. As a consequence, the bioactivity of amorphous calcium 
phosphate, such as SBF, may be enhanced as well. Thus the first part of this study will explore the 
differences in PDL cell response based on the composition of ceramic particles directly electrospun into 
PLGA fibers, namely crystalline HA will be compared to amorphous SBF.  
Coating surfaces in bioactive ceramics are another way in which polymers can be hybridized to 
facilitate integration with bone as well as promote mineralized tissue formation. Coated polymers are 
typically characterized by a homogenous distribution of ceramic at the polymer surface that may even 
penetrate into porous substrates. Such biomimetic coatings of polymer implants have demonstrated 
osteoconductive properties87 and enhanced cell proliferation and differentiation6,87. 
Originally developed by Kokubo et al., the biomimetic coating process involves soaking materials 
in simulated body fluids, which mimic the inorganic ion concentration of human blood plasma, at 
physiological pH and temperature. In general this process is based on the biomineralization process that 
occurs when CaO-SiO2-based glasses and glass-ceramics are placed in the body98. As this process 
requires a substantial incubation time in order to induce CaP nucleation, as well as to achieve a CaP 
layer of considerable thickness, Habibovic et al.77 proposed a modification to the method. Given that rate 
of growth of the ceramic layer increases with increasing ion concentration98, and taking advantage of the 
increased solubility of calcium phosphate in acidic conditions and precipitation at neutral pH, a 
supersaturated SBF solution is produced by the introduction of CO2 gas into the solution. As CO2 is 
gradually released from the solution naturally, CaP precipitation on the polymer surface occurs uniformly 
in a matter of hours. An additional advantage of this method is that no chemical pretreatment of the 




Table 6.1: Components of SBF 
Solution77, 500mL 
 
CaP, the second part of this study will explore the effects of the method of mineral incorporation on PDL 
cell response, specifically SBF surface coatings compared to SBF mineral incorporated into fibers. 
6.1.2 Objectives 
The objective of this study is to incorporate HA and SBF ceramic particles into PLGA aligned 
polymer fibers (PLGA-HA, PLGA-SBF) and compare the response of PDL cells based on CaP 
composition. It is expected that culture on mineral-polymer composite scaffolds will result in a cell 
response distinct from mineral-free scaffolds, including the expression of osteoblastic markers, and 
enhanced mineralization potential and mineral deposition. Furthermore, this response will be more 
pronounced on PLGA-SBF scaffolds compared to PLGA-HA because of its biomimetic properties to bone 
and cementum mineral. The effect of method of mineral incorporation will also be explored, in which cell 
response to SBF-coated scaffolds will be compared to that of SBF mineral incorporated into polymer 
fibers. Because of differences in substrate surface properties and chemistry, it is anticipated that ceramic-
coated scaffolds (SBF-Coated) will induce a cell response distinct from electrospun PLGA-SBF scaffolds. 
Specifically, due to the increased presence of mineral on the substrate surface, culture on SBF-Coated 
scaffolds will promote the osteoblastic differentiation of PDL cells, including enhanced expression of 
osteoblastic markers and mineralization potential. 
6.2 Materials and Methods 
6.2.1 Scaffold Fabrication 
6.2.1.1 Simulated Body Fluid Mineral and SBF-Coated Scaffold Fabrication 
For production of the SBF solution (Figure 6.1), a beaker was 
filled with 500 mL of deionized water maintained at 37°C. NaCl, 
MgCl2•6H2O, and CaCl2•2H2O were added, with each component 
allowed to dissolve before addition of the next. Carbon dioxide gas was 
bubbled into the solution until a pH<4 was achieved. With CO2 bubbling 
into the solution, Na2HPO4•2H2O and NaHCO3 were added. Once the 
pH was below 6.2, PLGA scaffolds were immersed into the solution. 
The solution was stirred and maintained at 37°C for 24 hours. Scaffolds 









were rinsed twice in DI water, allowed to dry in a fume hood overnight, and stored in a vacuum desiccator 
until use. Additionally, the resulting SBF solution was filtered (Whatman 1) for SBF mineral precipitate, the 
filter allowed to dry completely, and mineral powder harvested for electrospinning. Refer to Table 6.1 for 
composition of the SBF solution (all components from Sigma-Aldrich). 
6.2.1.2 PLGA 
A 54% (w/v) polymer-DMF solution was prepared, and the solution mixed overnight. Prior to 
electrospinning, 100% ethanol was added and the solution vortexed for an additional 1-1.5 hours. The 
entire solution was loaded into a 5 mL syringe with an 18 gauge stainless steel blunt-tip needle. A voltage 
of 8-10 kV was applied to the needle tip and a pump flow rate of 1 mL/hr was used. Fibers were collected 
on a grounded rotating mandrel (2500 rpm) placed 13 cm from the needle tip. The entire polymer solution 
was electrospun to fabricate scaffolds of thickness ranging from 0.09-0.14 mm as measured with a digital 
caliper. 
6.2.1.3 PLGA-HA and PLGA-SBF 
For HA or SBF containing aligned PLGA scaffolds (PLGA-HA, PLGA-SBF), the evening prior to 
electrospinning, 380 mg of HA (Nanocero, Lot#1LN011AB) or SBF ceramic (see Section 6.2.1.1) was 
dissolved in 1 mL of DMF and the solution placed in a water bath sonicator (FS20, Fisher Scientific) for 1 
hour. In a separate vial, 2 g of PLGA was dissolved in a 1:3 solution of DMF:DCM, and the polymer-
solvent solution was vortexed for an hour. The Ceramic-DMF solution was subsequently added to the 
PLGA solution and the solution mixed overnight. The solution was vortexed for ~1 hour prior to 
electrospinning and then loaded into a 5 mL syringe with a 23 gauge stainless steel blunt-tip needle. A 
voltage of ~10 kV was applied to the needle tip and a pump flow rate of 1 mL/hr was used. Fibers were 
collected on a grounded rotating mandrel (2500 rpm), 11 cm from the needle tip. 
6.2.2 Scaffold Characterization 
6.2.2.1 Scanning Electron Microscopy 
Scaffolds were imaged using scanning electron microscopy (SEM, 1 kV, 10 µA Hitachi 4700). 
Prior to imaging, a conductive gold-palladium coating was applied to the scaffold surface via sputter 




6.2.2.2 Fourier Transform Infrared Spectroscopy 
Infrared spectra (n=3) were obtained with a Fourier transform infrared attenuated total reflection 
(FTIR-ATR) spectrometer (Frontier FTIR, PerkinElmer). Spectra were collected from 380-4000 cm-1 using 
4 scans with a resolution of 4. 
6.2.2.3 X-Ray Diffraction 
X-Ray Diffraction (XRD, X’Pert3 Powder, PANalytical) analysis was performed on both scaffolds 
and powders. Spectra were taken for 2θ angles from 20° to 40° with a step size of 0.1, and 60 sec per 
step. Powders were ground using a pestle and mortar prior to analysis and scaffolds were scanned as 
fabricated. 
6.2.3 Cell Seeding and Culture 
Electrospun scaffolds were cut to 1 x 1.8 cm and secured using custom-made clamps, resulting in 
a cell culture surface area of 1 cm2. Scaffolds were UV 356 nm sterilized (each side 15 min) and 
incubated (37°C, 5%CO2) overnight in F/S medium with 20% FBS to promote cell attachment. 
Human PDL cells were seeded on scaffolds at a density of 30,000 cells/cm2 (3 M cells/mL, 10 µl), 
and allowed to attach for 20 min under humidified conditions at 37ºC, 5% CO2 before the addition of F/S 
medium supplemented with 50 µg/mL ascorbic acid (Sigma-Aldrich). Cells were maintained at 37°C, 5% 
CO2 and media was exchanged every 2-3 days.  
6.2.4 Live/Dead Cell Viability 
Cell viability (n=3) was visualized using Live/Dead staining (Molecular Probes). Both monolayer 
and scaffolds were stained following the manufacturer’s suggested protocol. Samples were imaged using 
confocal microscopy (Olympus Fluoview FV1000) at excitation wavelengths of 488 nm and 568 nm. 
6.2.5 Cell Proliferation 
Cell proliferation (n=5) was determined by measuring total DNA content using the PicoGreen 
dsDNA assay (Invitrogen) following the manufacturer’s protocol. Scaffolds were rinsed twice in PBS and 
stored in 500 µl of 0.1% Triton-X (Sigma-Aldrich) at -30°C. Immediately before the analysis, samples 




Tecan microplate reader with an excitation wavelength of 485 nm and an emission wavelength of 535 nm. 
A conversion factor of 8 pg DNA/cell was used to determine cell number. 
6.2.6 Collagen Production 
Collagen production (n=5) was quantified using a modified hydroxyproline assay153. Samples 
were first dessicated (CentriVap, Labconco, Kansas City, MO) and digested for 18 hr at 65°C in a solution 
of 20 µL/mL papain (Sigma-Aldrich), buffered in 0.1 M sodium acetate, 10 mM cysteine HCl, and 50 M 
ethylenediaminetetraacetate.  A 250 µl aliquot of the digest was concentrated by dessication.  Samples 
were subsequently hydrolyzed in 10 µl of 10N NaOH and autoclaved for 25 min.  The hydrolysate was 
then oxidized by a buffered chloramine-T reagent for 25 min before the addition of Ehrlich’s reagent.  
Sample absorbance was measured at 550 nm (Tecan), and the collagen content was obtained by 
interpolation along a standard curve of bovine collagen I (Sigma). 
Additionally matrix deposition was visualized histologically. Cryosectioned samples were stained 
with Picrosirius Red (n=3) for collagen and Hematoxylin and Eosin (H&E, n=3) to stain for cells and 
matrix.  
6.2.7 Alkaline Phosphatase Activity and Mineralization 
After scaffold homogenization samples were assayed for alkaline phosphatase (ALP) activity 
(n=5) using a colorimetric assay based on the hydrolysis of p-nitrophenyl phosphate (pNP). On ice, 50 µl 
of sample was added to pNP-PO4 solution (Sigma) and incubated at 37°C until a color change was noted. 
The absorbance at 405 nm was read using a Tecan microplate reader. ALP activity is reported 
normalized to incubation time and the post-homogenization cell number. 
Mineral deposition was also visualized through histological staining.  Samples were fixed in 10% 
neutral buffered formalin (NBF) + 1% cetylpyridinium chloride (CPC) overnight. The solution was replaced 
with 0.01M cacodylic acid and stored at 4°C until sectioning. Samples were embedded in 5% polyvinyl 
alcohol (PVA) for sectioning through freezing in a dry ice ethanol bath and sectioned to 7 µm thickness 
with a cryostat (Bright Instrument Company, Model OFT). Sectioned samples were collected on glass 
slides coated with Haupt’s Solution (2% gelatin, 1.9% phenol, 15% glycerol). Scaffold sections on glass 




phosphate (n=3) and alizarin red for calcium (n=3). Samples were imaged using a brightfield microscope 
(Zeiss Axiovert 25). 
6.2.8 Sample Preparation for FTIR and XRD 
 Scaffolds were rinsed twice with Hank’s Buffered Saline Solution and fixed with 10% NBF + 1% 
CPC overnight. The solution was replaced with 0.1M cacodylic acid and stored at 4°C. Prior to sample 
analysis a series ethanol dehydration was performed. Samples were allowed to dry in a fume hood and 
placed in a dessicator until analyzed.  Samples were analyzed using FTIR and XRD according to the 
procedures detailed above. 
6.2.9 Media Ions 
6.2.9.1 Calcium 
Media calcium was measured using the Arsenazo Modified Calcium Assay.  Five microliters of 
media sample was diluted into 45 μl of DI H2O.  Two hundred microliters of calcium (AzII) reagent (Pointe 
Scientific, Inc.) was added to each sample and standard, and after 5 min the absorbance at 620 nm was 
read using a Tecan microplate reader. Results are reported normalized to 2 mL used for cell culture. 
6.2.9.2 Phosphate 
Media phosphate was measured using the Phosphate Colorimetric Assay (BioVision), by diluting 
2.4 μl of sample into 197.6 μl of DI H2O. Thirty microliters of phosphate reagent was added to all samples 
and standards, and the solutions mixed by pipetting up and down 20 times. After a 30 min incubation, the 
absorbance at 620 nm was read using a Tecan microplate reader. Results are reported normalized to 2 
mL used for cell culture. 
6.2.10 Gene Expression  
Gene expression (n=5) was measured using quantitative reverse transcriptase-polymerase chain 
reaction (qRT-PCR).  Total RNA was isolated via the Trizol extraction method (Invitrogen).  Isolated RNA 
was reverse-transcribed into complementary DNA (cDNA) with the SuperScript First-Strand Synthesis 
System (Invitrogen), and the cDNA product was subsequently amplified and quantified through real-time 
PCR using SYBR Green Supermix (Invitrogen). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 




Real-Time PCR Detection System, BioRad). See Table 6.2 for primer sequences used and amplicon 
sizes. Normalized expression levels were calculated based on the difference between threshold cycles of 
the gene of interest and GAPDH.  
6.2.11 Statistical Analysis 
Results are reported as mean ± standard deviation, with n equal to the number of replicates per 
group. Statistical analyses were performed with JMPIN (4.0.4, SAS Institute, Inc.). A two-way analysis of 
variance (ANOVA) was used to determine the effect of mineral type or method of mineral incorporation 
and culture time on cell response (proliferation, ALP activity, matrix deposition) and media ion 
concentration. A one-way ANOVA was used to determine the effects of mineral type or method of mineral 
incorporation on gene expression at each time point. The Tukey-Kramer post hoc test was used for all 
pair-wise comparisons, and significance was attained at p<0.05. 
6.3 Results 
6.3.1 Mineral and Scaffold Characterization 
SEM micrographs of scaffolds show visible mineral nodules (yellow arrows) within PLGA-HA and 
PLGA-SBF fibers. The fiber morphology among groups, with and without mineral, is consistently aligned 
and bead-free. SBF-Coated scaffolds are completely coated and the aligned fiber morphology is 
maintained as well. As-fabricated scaffolds and ceramic powders were characterized by FTIR. The 
characteristic PLGA peaks92,119 at 1751 cm-1 (ester carbonyl), 1455 cm-1 (methyl), 1083cm-1, and 1185 
cm-1 (ether) are visible in PLGA, PLGA-HA, and PLGA-SBF scaffolds, while only the ester carbonyl peak 




is visible in the SBF-Coated spectra, with the other peaks masked by the stronger phosphate signal. 
Analysis of ceramic powders revealed bands95 at 1400-1500 cm-1 and 875 cm-1 attributed to CO32-, as 
well as absorption bands6,95 at 1040-1090cm-1 and 561-601 cm-1 corresponding to PO43- groups. 
Phosphate peaks are also visible in the PLGA-HA, PLGA-SBF, and SBF-Coated spectra, confirming 
mineral incorporation. Only the phosphate band at 561-601 cm-1 is visible in the PLGA-SBF spectra, with 
the other band masked by the stronger PLGA signal. The XRD pattern of HA powder (Figure 6.2) 
consisted of diffraction lines consistent with HA. While the peaks are defined, which is characteristic of a 
crystalline structure, the split reflections are not complete, indicating that HA was not fully crystalized82. 
On the other hand, the broad halo centered at 2θ = 30.9° for the SBF powder, corresponds to the 
overlapping 211, 112, 300 crystal planes, and is characteristic of an amorphous apatitic structure77. 
Visible in the XRD spectra of the SBF-Coated scaffold is the 211 reflection characteristic of calcium 
phosphate. 
6.3.2 Cell Viability and Proliferation 
Calcium Phosphate Composition: 
 Cells attached on all groups and cell number increases significantly on PLGA-HA on days 7, 14, 
and 28 and on PLGA-SBF on day 28 (Figure 6.3). Although the average cell number increases over time 
for the PLGA group, the differences with time are not statistically significant. Comparing cell proliferation 
between groups, cell number is enhanced on PLGA-HA scaffolds on days 14 and 28 compared to PLGA 
and PLGA-SBF groups. 
Method of Calcium Phosphate Incorporation: 
Although cells adhered to SBF-Coated scaffolds, cell growth is not detectable through the culture 
duration. Cell growth on PLGA-SBF scaffolds is similar to that on PLGA scaffolds, and both are 
significantly greater than the SBF-Coated scaffold at days 14 and 28. 
6.3.3 Cell Biosynthesis 
Calcium Phosphate Composition: 
Collagen deposition is significantly enhanced on PLGA-HA scaffolds compared to all other groups 




confirmed with H&E and Picrosirius red histology (Day 28), demonstrating enhanced matrix deposition on 
mineral containing scaffolds compared to PLGA control. Additionally, matrix stains are slightly enhanced 
in the PLGA-SBF group compared to PLGA-HA. FTIR analysis of cell seeded samples detects the 
presence of collagen, amide I and II bands, 1659 cm-1  and 1555 cm-1 respectively20, in all groups at both 
timepoints. The peaks increase in intensity between days 1 and day 28, corresponding to increasing 
collagen deposition over time.  
ALP activity peaks at day 1 for all groups with no significant differences between groups over 
time. There is positive von Kossa and Alizarin red staining on the mineral containing scaffolds. 
Additionally mineral staining is observed within the scaffold for the PLGA-SBF group, confirming the 
incorporation of mineral. Positive calcium staining (Alizarin red) is observed on PLGA scaffolds, although 
to a lesser degree. FTIR analysis of scaffold at days 1 and 28 show detectable phosphate peaks (1040-
1090cm-1 and 561-601 cm-1, grey boxes) in PLGA-HA and PLGA-SBF groups at both timepoints, 
indicating the stability of the mineral in the scaffold for the 28 day culture period. Phosphate peaks appear 
slightly smaller at day 28 compared to day 1 samples.  
Method of Calcium Phosphate Incorporation: 
Collagen deposition is significantly greater on SBF-Coated and PLGA-SBF scaffolds compared to 
PLGA control at day 28. This is also reflected in matrix histology stains, H&E and Picrosirius red, at day 
28. The presence of collagen is detected by the amide I and II bands, 1659 cm-1  and 1555 cm-1 
respectively20, in all groups at both timepoints, with larger peaks at day 28 corresponding to increasing 
collagen deposition over time. 
Peak ALP activity occurs before day 1 for all groups other than the SBF-Coated scaffolds, which 
peaked at day 1. ALP activity on SBF-Coated scaffolds is significantly greater than all other groups at 6 
hours and day 1. SBF-Coated and PLGA-SBF scaffolds stain positive for phosphate and calcium via von 
Kossa and Alizarin red stains, respectively, at day 28. FTIR analysis of scaffolds at days 1 and 28 
indicate detectable phosphate peaks (1040-1090cm-1 and 561-601 cm-1, grey boxes) in SBF-Coated and 
PLGA-SBF groups at both timepoints, indicating the stability of the mineral in the scaffold over the 28 
culture duration. Phosphate peaks appear slightly smaller at day 28 compared to day 1 samples for 




6.3.4 Media Ions 
Calcium Phosphate Composition: 
 There are no changes in media calcium for the duration of culture for any of the groups. Calcium 
is significantly greater on PLGA-SBF, compared to all other groups on day 21, and compared to PLGA-
HA on days 10 and 24. Media phosphate had an increasing trend for PLGA and PLGA-HA during the first 
two weeks of culture and then levels off. For PLGA-SBF, it decreases between day 3 and 7, then 
increases until day 14, and levels off. Media phosphate is significantly greater on PLGA-SBF compared to 
the other groups at days 3, 17, and 21. 
Method of Calcium Phosphate Incorporation: 
Media calcium had a decreasing trend over time for the SBF-Coated group through the culture 
duration. Media calcium is significantly greater on SBF-Coated compared to PLGA-SBF on days 3 and 7, 
while at later time points (day 21, 24, 28) it is significantly lower. Media phosphate differs between all 
groups at day 3, with SBF-Coated being the greatest and PLGA being the least. Significantly greater 
phosphate is detected from the SBF-Coated groups compared to the other groups at days 7 and 10. 
6.3.5 Gene Expression 
Calcium Phosphate Composition: 
 Periodontal markers, periostin and collagen I, are upregulated on PLGA-SBF scaffolds compared 
to the other groups at day 14, while periostin is downregulated on PLGA-HA at day 1. In terms of the 
osteoblastic markers, bone sialoprotein (BSP) is upregulated on PLGA-SBF compared to PLGA-HA at 
day 1, and the mean expression of osteocalcin (OC) trended higher on PLGA-SBF compared to the other 
groups at day 7. At day 14 both BSP and osteopontin are significantly downregulated on PLGA-SBF 
compared to all other groups. 
Method of Calcium Phosphate Incorporation: 
The expression of periodontal markers, periostin and collagen, are upregulated on PLGA-SBF 
scaffolds at day 14 compared to PLGA and SBF-Coated groups. While the osteoblastic marker 





 Nanofiber scaffolds containing calcium phosphate ceramic were explored to promote the 
osteogenic differentiation of periodontal ligament cells to achieve soft-to-hard tissue integration. Fibrous 
substrates are mimetic of the native extracellular matrix found at the cementum-PDL and alveolar bone-
PDL interfaces, which consists of collagen fibers that inserts into a mineralized matrix (Sharpey’s fibers). 
As surface chemistry is also a critical aspect of tissue healing, the incorporation of calcium phosphates 
has demonstrated ability to enhance and stimulate bone response3,133,185. Surface reactivity, a 
characteristic of bone bioactive materials, is related to biodegradation, which is in turn related to 
solubility105. Dense stoichiometric hydroxyapatite is one of the slowest ceramics to dissolve, thus its 
reaction rate is very slow49. Amorphous calcium phosphates are more soluble and the extent and rate of 
bioresorption of amorphous calcium phosphates, such as those produced in the SBF deposition process, 
exceeds that of hydroxyapatite. As a consequence, the bioactivity of amorphous calcium phosphate, such 
as SBF, may be enhanced as well. Thus PLGA-HA and PLGA-SBF composite scaffolds were fabricated 
and the response of periodontal ligament cells was assessed in this study. 
 Analysis of the chemical structure of ceramic powders and polymer/ceramic scaffolds revealed 
the presence of both phosphate and carbonate groups in the HA and SBF powders. The presence of 
carbonate indicates the substitution of some phosphate groups. HA and SBF ceramics are thus 
carbonated calcium phosphates, similar to bone-mineral, a carbonated-substituted apatite105. The split 
phosphate bending vibration mode between 561-600 cm-1 in the FTIR spectra for HA powder and PLGA-
HA is indicative of a crystalline compound109. This was confirmed by the XRD pattern, in which defined, 
sharp peaks were visible compared to the broad halo, characteristic of an amorphous structure, observed 
in the SBF powder. 
 Cell growth was supported on polymer fiber scaffolds with and without ceramic, but proliferation 
was significantly enhanced on scaffolds containing hydroxyapatite. Enhanced proliferation on PLGA-HA 
compared to PLGA-SBF scaffolds may be related to the instability of the SBF mineral relative to HA 
during the culture period. Anselme et al. observed that the physicochemical transformation of HA coatings 
during immersion in culture medium prevented human bone-derived cell growth5. This transformation as 




longer periods of time, which resulted in a more crystalline, hydroxyapatite profile as measured by XRD 
analysis. As such, cell growth was enhanced on samples immersed for 15 and 22 days prior to seeding 
compared to samples immersed for shorter times. In this study, media ion analysis revealed significantly 
greater calcium and phosphate from PLGA-SBF compared to PLGA-HA and PLGA, which may indicate 
ion dissolution. FTIR analysis also indicated decreasing intensity of phosphate bands in the PLGA-SBF 
scaffolds with culture time. Additionally, it has also been reported that ion dissolution can result in local 
modifications in pH, provoking the inhibition of cell attachment and growth5. 
 Mineral chemistry did not affect periodontal ligament cell mineralization potential. Furthermore 
there were no differences in ALP activity between the control scaffold and those with mineral. These 
results are contrary to those of Alliot-Licht et al., who observed a decrease in ALP activity from PDL cells 
cultured in the presence of HA3. It should be noted that, in that study cells were cultured in monolayer, 
while in our study cells were cultured on polymer/ceramic fibers. ALP is an important promoter of 
mineralization because it catalyzes the hydrolysis of inorganic pyrophosphate, a calcification inhibitor, 
while concomitantly increasing the levels of inorganic phosphate67. Since the mineral scaffolds in this 
study serve as a phosphate source for cells, this may obviate the requirement for ALP, potentially 
explaining why there were no observed differences in ALP activity between groups. Importantly, 
mineralization was detected in both PLGA-HA and PLGA-SBF groups through histological staining. Gene 
expression of the mineralization markers bone sialoprotein and osteopontin yielded interesting differences 
based on mineral chemistry. Bone sialoprotein is first expressed at the onset of bone formation and has 
been demonstrated to be a potent nucleator of hydroxyapatite83. Osteopontin, on the other hand, is 
inhibitor of mineral formation67, and functions in the later stages of bone development. Gene expression 
results demonstrated an early upregulation of bone sialoprotein and the downregulation of osteopontin 
after 14 days of culture on PLGA-SBF scaffolds compared to PLGA-HA. These results suggest that 
culture on SBF containing scaffold may mimic the events of natural bone formation. 
Finally, collagen deposition was detected on all groups, with enhanced deposition on PLGA-SBF 
scaffolds compared to the other groups after 28 days of culture. Biological mineralization generally occurs 
through heterogeneous nucleation, in which organic components, such as collagen, serve as nucleation 




osteoprogenitor cells must synthesize a collagenous extracellular matrix before they will differentitate55. 
Enhanced collagen deposition on PLGA-SBF should therefore be beneficial to the repair of mineralized 
tissue as well as to the regeneration of the non-mineralized, collagenous periodontal ligament. 
Collectively these results demonstrate that periodontal cell response can be affected by the 
incorporation of mineral into fiber scaffolds, as well as varying mineral chemistry (amorphous versus 
crystalline). Scaffolds containing simulated body fluid mineral, an amorphous calcium phosphate, 
promoted an osteoblastic phenotype as determined by the deposition of a mineralized matrix, as well as 
the expression of bone related markers. Collagen deposition was also promoted on the substrate, 
essential for the regeneration of the periodontal soft and hard tissues, as well as establishing tissue 
integration. 
The method of mineral incorporation in polymer fiber scaffolds was also explored as a means to 
promote the osteogenic differentiation of PDL cells to promote soft-to-hard tissue integration. Fibrous 
substrates are mimetic of the native extracellular matrix found at the cementum-PDL and alveolar bone-
PDL interfaces, which consists of collagen fibers that inserts into a mineralized matrix (Sharpey’s fibers). 
As an alternative to electrospun polymer-calcium phosphate fiber composites in which the biodegradation 
rate of the polymer matrix can limit the availability of mineral, a surface coating in SBF, an amorphous 
calcium phosphate, was explored and compared to scaffolds electrospun with mineral in this study.  
Scanning electron microscopy images indicated a dense coating formed on fibers, and that the 
overall aligned fiber architecture is preserved. Nodules can also be observed within polymer fibers for the 
PLGA-SBF group, confirming the incorporation of mineral. Analysis of the chemical structure of the SBF 
powder revealed the presence of both phosphate and carbonate groups. The presence of carbonate 
indicates phosphate substitution, thus SBF is a carbonated calcium phosphate, mimetic of bone-mineral, 
which is a carbonated-substituted apatite105. The amorphous nature of the SBF mineral is indicated by the 
incomplete split phosphate bending vibration mode (561-600 cm-1) in the FTIR spectra for the mineral 
powder and SBF containing scaffolds.109. The XRD pattern for SBF powder corroborates this result, 
showing only a halo, characteristic of an amorphous phase. An increase in crystallinity was observed for 




Cells attached on SBF-Coated scaffolds similarly to PLGA and PLGA-SBF. With time, 
proliferation was significantly lower on the SBF-Coated scaffolds compared to the other groups. On the 
other hand, cells are still observed in viability imaging and cell number is sustained, indicating that cells 
are maintained on SBF-Coated scaffolds. The proliferation results observed here are contrary to those 
which indicated similar42 or enhanced40,117 cell proliferation on polymer substrates with biomimetic calcium 
phosphate coatings compared to uncoated controls. It should be noted that these studies were conducted 
using mouse and human osteoblastic cell lines, MC3T3-E1 and Saos-2 respectively, while this study 
utilized human periodontal ligament derived cells representing a mixture of fibroblasts and progenitor 
cells. Discounting the possibility of a physiochemical transformation of the SBF coating as the cause of 
decreased cell proliferation5 observed at days 14 and 28, media ion results indicate that while initially 
calcium and phosphate levels are greater than the PLGA control, after day 10 there were no observed 
differences between groups. This indicates that after a brief period of dissolution during the first 2 weeks 
of culture, the coating stabilized. Thus the duration of instability does not coincide with the period of 
observed differences in cell growth. The transformation of the SBF-Coated samples during culture is 
confirmed by FTIR analysis, in which a split phosphate peak (561-600 cm-1) emerges after one day of 
culture, in comparison to the as-fabricated scaffold in which there is no split peak. 
Cell differentiation was affected by the inclusion of SBF mineral into scaffolds, in which notable 
differences were observed in mineralization potential and gene expression. Early ALP activity was 
significantly enhanced on SBF-Coated scaffolds compared to PLGA and PLGA-SBF. This echoes similar 
findings to Mavis et al., who observed enhanced ALP activity on calcium phosphate coated PCL 
nanofibers compared to uncoated controls117. Alkaline phosphatase is a promoter of mineralization, 
catalyzing the hydrolysis of inorganic pyrophosphate, a calcification inhibitor, while simultaneously 
increasing the levels of inorganic phosphate67 through hydrolysis of β-glycerol phosphate. Additionally, 
enhanced mineral was detected on both PLGA-SBF and SBF-Coated groups compared to PLGA control 
through histological staining, this was particularly noted at the surface of the scaffold in which cells were 
seeded. Gene expression for osteogenic markers indicated upregulation of osteopontin on SBF-Coated 
scaffolds at day 14 compared to all other groups. Increased inorganic phosphate in cementoblasts has 




bone development15,67. It was also observed that osteocalcin expression trended higher on PLGA-SBF 
compared to PLGA and SBF-Coated scaffolds at day 7. Osteocalcin is a protein that also functions in late 
stage bone development55, and matrix mineralization is usually characterized by its expression. 
Interestingly, Chou et al. observed that the presence of mineral in PLGA scaffolds enhanced the 
expression of osteocalcin while no differences were observed in ALP expression compared to the control 
–similar to results observed here.  
Collectively these results indicate that SBF-Coated scaffolds, with increased availability of mineral 
and a matrix similar to that of native mineralized tissue, elicits a cell response characteristic of the later 
stages of bone development. In cells differentiating toward an osteoblast line, when antiproliferation 
signals are enacted, alkaline phosphatase activation is stimulated, in turn enhancing osteopontin 
expression. The expression of osteopontin precedes matrix mineralization16. In this study, low cell 
proliferation, high early ALP activity, and enhanced osteopontin expression were observed, reflecting the 
pattern of osteoblast development. Culture on PLGA-SBF scaffolds, also elicited a cell response 
indicative of the later stages in bone development, including an upregulation in osteocalcin concurrent 
with low ALP expression67. Interestingly both mineral containing scaffolds had a similar level of bone 
sialoprotein expression to PLGA control. Bone sialoprotein is expressed at the onset of bone formation. 
Regardless of the method of mineral incorporation, both SBF containing scaffolds resulted in a cell 
response typical of late stage bone development.  The biomimetic nature of the SBF ceramic to native 
bone mineral, a carbonate-substituted, poorly crystalline apatite, is perhaps the basis for the observed 
cell response. Scaffolds containing SBF mineral are thus capable of promoting the osteoblastic 
differentiation of periodontal ligament cells as well as supporting an osteoblastic phenotype. SBF-coated 
and PLGA-SBF scaffolds are both promising substrates to support periodontal soft-to-hard tissue 
regeneration. 
6.5 Conclusion 
The first part of this study explored the incorporation of hydroxyapatite, a crystalline ceramic, 
compared to simulated body fluid mineral, an amorphous carbonate substituted calcium phosphate, into 
PLGA aligned polymer fibers as a means of promoting the osteoblastic differentiation of periodontal 




profile that resembles the temporal expression pattern of markers of osteoblastic development indicates 
that scaffolds containing an amorphous calcium phosphate may hold promise in promoting regeneration 
of the cementum and alveolar bone, in order to facilitate oft-to-hard tissue healing.  
To further explore the capacity of SBF mineral to promote periodontal healing, this study also 
investigated the method of mineral incorporation into polymer fiber scaffolds, comparing scaffolds with 
mineral electrospun into fibers to scaffolds coated with mineral. Alkaline phosphatase activity and gene 
expression patterns indicate that the presence of SBF mineral in either form elicits a cell response 
analogous to later stages in bone development. Thus both PLGA-SBF and SBF-Coated scaffold are 
capable of promoting an osteoblastic phenotype of periodontal ligament cells and are thus promising 
substrates to support periodontal soft-to-hard tissue regeneration. On the other hand, while SBF-Coated 
scaffold supported PDL cell viability, cells did not proliferate. Thus PLGA-SBF scaffolds, in which mineral 
is directly incorporated into fibers may be a more desirable substrate. The following study will further 
explore this mechanism by investigating the effects of the amount of mineral electrospun into PLGA-SBF 






Figure 6.1: Effect of Calcium Phosphate Incorporation on PDL Cell Response: Fabrication of 
Simulated Body Fluid Scaffolds A supersaturated SBF solution is produced by infusion of CO2 gas, 
lowering the solution pH. Scaffolds are placed in the solution and after a 24 hour incubation, CO2 gas 
is released driving the pH higher, resulting in mineral precipitation in the solution as well as on the 
scaffold surface. The mineral solution is filtered and after drying the mineral is added to the polymer 





Figure 6.2: Effect of Calcium Phosphate Incorporation on PDL Cell Response: Scaffold 
Morphology and Characterization SEM micrographs show aligned fibers and the presence of 
mineral nodules in fibers (yellow arrows) in PLGA-HA and PLGA-SBF scaffolds, while fibers are 
completely coated in mineral in the SBF-Coated group. FTIR characterization shows phosphate 
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present in both ceramic powders and mineral containing scaffolds. The characteristic PLGA peaks are 
present in all groups.  * PLGA, ^ phosphate, • carbonate. XRD patterns for ceramic powders are 
characteristic of crystalline and amorphous apatites for HA and SBF respectively, only the (211) HA 































Figure 6.3: Effect of Calcium Phosphate Incorporation on PDL Cell Response: Cell Viability and 
Proliferation Cell proliferation was noted over time for PLGA, PLGA-HA, and PLGA-SBF, while cell 
number is maintained on the SBF-Coated group. Cell number is significantly greater on PLGA-HA 
compared to all other groups on days 14 and 28, while it is significantly lower on SBF-Coated scaffolds 
compared to PLGA and PLGA-HA on day 14 and compared to all other groups on day 28. Significant 



























Figure 6.4: Effect of Calcium 
Phosphate Incorporation on PDL 
Cell Response: Matrix Deposition 
and Mineralization Collagen 
deposition is significantly greater on 
SBF-Coated and PLGA-SBF scaffolds 
compared to PLGA control and PLGA-
HA at day 28, this is also reflected in 
H&E and Picrosirius Red stains for 
matrix and collagen respectively. The 
presence of collagen is detected by 





) at both time points for 
all groups, with peaks increasing in 
intensity at day 28. ALP activity is 
significantly greater on SBF-Coated 
scaffolds compared to all other groups 
at 6 hour and day 1. All groups peak in 
ALP activity prior to day 1. Positive von 
Kossa and Alizarin red staining is 
observed for PLGA-HA, PLGA-SBF, 
and SBF-Coated scaffolds at day 28. 
Phosphate peaks (grey boxes) are 
present at days 1 and 28 for mineral 
containing scaffolds. Significant 
difference between: ^ all other groups, 
# groups, * consecutive timepoints 


































































Figure 6.5: Effect of Calcium Phosphate Incorporation on PDL Cell Response: Media Ions 
Media calcium had a decreasing trend over time for the SBF-Coated group, while it remained stable 
for all other groups. There is a significant difference between SBF-Coated and PLGA-SBF at days 3, 
24, and 28, and media calcium for the SBF-Coated group is significantly different from all other groups 
at day 7. Media calcium was significantly greater for the PLGA-SBF group compared to all other 
groups at day 21. Media phosphate is significantly greater for PLGA-SBF and SBF-Coated compared 
to PLGA and PLGA-HA at day 3, while at days 10 and 17 it is significantly lower for PLGA-HA 
compared to all other groups and compared to PLGA-SBF respectively. At day 21 there is a significant 
difference between PLGA-SBF and SBF-Coated scaffolds. Significant difference with respective group 
and a: PLGA, b: PLGA-HA, c: PLGA-SBF, d: SBF-Coated, e: PLGA and PLGA-HA, f: PLGA-SBF and 
SBF-Coated, g: PLGA-HA and PLGA-SBF, h: PLGA-HA and SBF-coated, ^ all other groups; over time 






Figure 6.6: Effect of Calcium Phosphate 
Incorporation on PDL Cell Response: 
Expression of Periodontal and Osteoblastic 
Markers On day 1, the expression of the 
periodontal marker periostin is downregulated on 
PLGA-HA compared to all other groups. Also on 
day 1, there is an upregulation on SBF-Coated 
scaffolds of the periodontal marker collagen I 
compared to PLGA-SBF, bone sialoprotein (BSP, 
osteoblastic marker) compared to PLGA-HA, and 
osteopontin (OP, osteoblastic marker) compared 
to PLGA. Collagen I is upregulated on PLGA-HA 
compared to PLGA-SBF on day 7. Periostin is 
significantly upregulated on PLGA-HA and PLGA-
SBF compared to all other groups on day 14, with 
greater expression on PLGA-SBF compared to 
PLGA-HA. Collagen I is upregulated on PLGA-
SBF compared to all other groups at day 14. 
Finally OP is upregulated on SBF-Coated 
scaffolds compared to all other groups, and on 
PLGA-HA compared to PLGA-SBF at day 14. 
Significant difference between: ^ all other groups, 


















































































CHAPTER 7: EFFECT OF CALCIUM PHOSPHATE 
















 The advantage of an amorphous calcium phosphate (SBF) over crystalline hydroxyapatite was 
demonstrated in the previous chapter, in which culture on PLGA-SBF fibers enhanced mineralized matrix 
deposition, as well as upregulated bone related markers. Surface coatings in SBF mineral presents cells 
with a greater concentration of mineral in comparison to mineral incorporation through electrospinning, in 
which availability can be limited by the polymer biodegradation rate. It was also demonstrated in Chapter 
6 that SBF-Coated scaffold enhanced mineralization potential as well as upregulated the expression of 
the osteoblastic marker osteopontin. On the other hand, cell growth was limited on the SBF-Coated 
scaffolds compared to the electrospun mineral-polymer composite scaffold (PLGA-SBF). This study 
investigates the effects of mineral dose in PLGA-SBF scaffolds, aiming to combine the positive cell 
responses elicited on electrospun mineral-polymer composite scaffolds with those on the SBF-Coated 
scaffolds, in which the availability of mineral is enhanced. 
7.1.1 Background and Motivation 
 The mineral content of bone is approximately 70%, while that of cementum is slightly lower at 
50%131,161. The mineral content of polymer fiber scaffolds has been previously shown to direct the 
osteogenic differentiation of mesenchymal stem cells185. In this study 15%, 25%, and 35% w/w HA was 
incorporated into blend PCL-PLGA electrospun scaffolds. Enhanced ALP activity and upregulation of 
osteoblastic markers was noted on the 25% and 35% HA scaffolds. On the other hand, there exists an 
upper limit to the amount of mineral that can be incorporated into scaffolds, as increasing mineral content 
alters solution viscosity and conductivity, leading to unfavorable electrospinning conditions and as a 
result, poor fiber morphology (ie beading, breaks, variations in fiber diameter). 
7.1.2 Objectives 
A low, medium, and high dose of SBF mineral will be incorporated into aligned PLGA fibers. This 
scaffold should promote the differentiation of PDL derived cells toward an osteogenic phenotype, 
including the upregulation of osteoblastic markers131 and enhanced mineralization potential. It is 
hypothesized that a higher mineral dose will present the optimal conditions for the osteogenic 




7.2 Materials and Methods 
7.2.1 Scaffold Fabrication 
7.2.1.1 PLGA 
A 54% (w/v) polymer-DMF solution was prepared, and the solution mixed overnight. Prior to 
electrospinning, 100% ethanol was added and the solution vortexed for an additional 1-1.5 hours. The 
entire solution was loaded into a 5 mL syringe with an 18 gauge stainless steel blunt-tip needle. A voltage 
of 8-10 kV was applied to the needle tip and a pump flow rate of 1 mL/hr was used. Fibers were collected 
on a grounded rotating mandrel (2500 rpm) placed 13 cm from the needle tip. The entire polymer solution 
was electrospun to fabricate scaffolds of thickness ranging from 0.09-0.14 mm as measured with a digital 
caliper. 
7.2.1.2 Simulated Body Fluid Mineral Fabrication 
For production of the SBF solution a beaker was filled with 
500 mL of deionized water maintained at 37°C. NaCl, MgCl2•6H2O, 
and CaCl2•2H2O were added, with each component allowed to dissolve  
before addition of the next. Carbon dioxide gas was bubbled into the 
solution until a pH<4 was achieved. With CO2 bubbling into the 
solution, Na2HPO4•2H2O and NaHCO3 were added. Once the pH was 
below 6.2, the solution was stirred and maintained at 37°C for 24 
hours. The resulting solution was filtered (Whatman 1) for SBF mineral 
precipitate, the filter allowed to dry completely, and mineral powder harvested for electrospinning. Refer 
to Table 7.1 for composition of the SBF solution (all components from Sigma-Aldrich). 
7.2.1.3 PLGA-SBF 
For PLGA-SBF scaffolds, SBF ceramic (16, 24 39% w/w, low, medium, high) was dissolved in 
1mL of DMF and the solution placed in a water bath sonicator (FS20, Fisher Scientific) for 1 hour. In a 
separate vial, 2g of PLGA was dissolved in a 1:3 solution of DMF:DCM, and the polymer-solvent solution 
was vortexed for an hour. The ceramic solution was added to the PLGA solution, mixed for an hour and 
then loaded into a 5 mL syringe with a 23 gauge stainless steel blunt-tip needle. A voltage of ~10 kV was 












applied to the needle tip and a pump flow rate of 1 mL/hr was used. Fibers were collected on a grounded 
rotating mandrel (2500 rpm), 11 cm from the needle tip. 
7.2.2 Scaffold Characterization 
7.2.2.1 Scanning Electron Microscopy 
Scaffolds were imaged using scanning electron microscopy (SEM, 1 kV, 10 µA Hitachi 4700). 
Prior to imaging, a conductive gold-palladium coating was applied to the scaffold surface via sputter 
coating (Cressington 108auto).  
7.2.2.2 Thermogravimetric Analysis 
To determine mineral content, scaffold ash weight was measured by thermogravimetric analysis 
(TGA, TA Q-500, TA Instruments). 
7.2.3 Cell Seeding and Culture 
Electrospun scaffolds were cut to 1 x 1.8 cm and secured using custom-made clamps, resulting in 
a cell culture surface area of 1 cm2. Scaffolds were UV 356 nm sterilized (each side 15 min) and 
incubated (37°C, 5%CO2) overnight in F/S medium with 20% FBS to promote cell attachment. 
Human PDL cells were seeded on scaffolds at a density of 30,000 cells/cm2 (3 M cells/mL, 10 µl), 
and allowed to attach for 20 min under humidified conditions at 37ºC, 5% CO2 before the addition of F/S 
medium supplemented with 50 µg/mL ascorbic acid (Sigma-Aldrich). Cells were maintained at 37°C, 5% 
CO2 and media was exchanged every 2-3 days.  
7.2.4 Live/Dead Cell Viability 
Cell viability (n=3) was visualized using Live/Dead staining (Molecular Probes). Both monolayer 
and scaffolds were stained following the manufacturer’s suggested protocol. Samples were imaged using 
confocal microscopy (Olympus Fluoview FV1000) at excitation wavelengths of 488 nm and 568 nm. 
7.2.5 Cell Proliferation 
Cell proliferation (n=5) was determined by measuring total DNA content using the PicoGreen 
dsDNA assay (Invitrogen) following the manufacturer’s protocol. Scaffolds were rinsed twice in PBS and 




were thawed and homogenized (Microson XL-2000) for 20 sec. Fluorescence was measured using a 
Tecan microplate reader with an excitation wavelength of 485 nm and an emission wavelength of 535 nm. 
A conversion factor of 8 pg DNA/cell was used to determine cell number. 
7.2.6 Collagen Production 
Collagen production (n=5) was quantified using a modified hydroxyproline assay153. Samples 
were first dessicated (CentriVap, Labconco, Kansas City, MO) and digested for 18 hr at 65°C in a solution 
of 20 µL/mL papain (Sigma-Aldrich), buffered in 0.1 M sodium acetate, 10 mM cysteine HCl, and 50 M 
ethylenediaminetetraacetate.  A 250 µl aliquot of the digest was concentrated by dessication.  Samples 
were subsequently hydrolyzed in 10 µl of 10N NaOH and autoclaved for 25 min.  The hydrolysate was 
then oxidized by a buffered chloramine-T reagent for 25 min before the addition of Ehrlich’s reagent.  
Sample absorbance was measured at 550 nm (Tecan), and the collagen content was obtained by 
interpolation along a standard curve of bovine collagen I (Sigma). 
7.2.7 Alkaline Phosphatase Activity 
After scaffold homogenization samples were assayed for alkaline phosphatase (ALP) activity 
(n=5) using a colorimetric assay based on the hydrolysis of p-nitrophenyl phosphate (pNP). On ice, 50 µl 
of sample was added to pNP-PO4 solution (Sigma) and incubated at 37°C until a color change was noted. 
The absorbance at 405 nm was read using a Tecan microplate reader. ALP activity is reported 
normalized to incubation time and the post-homogenization cell number. 
7.2.8 Gene Expression  
Gene expression (n=5) was measured using quantitative reverse transcriptase-polymerase chain 
reaction (qRT-PCR).  Total RNA was isolated via the Trizol extraction method (Invitrogen).  Isolated RNA 
was reverse-transcribed into complementary DNA (cDNA) with the SuperScript First-Strand Synthesis 
System (Invitrogen), and the cDNA product was subsequently amplified and quantified through real-time 
PCR using SYBR Green Supermix (Invitrogen). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
served as the house-keeping gene. All genes were amplified for 50 cycles in a thermocycler (iCycler iQ 




sizes. Normalized expression levels were calculated based on the difference between threshold cycles of 
the gene of interest and GAPDH. 
7.2.9 Statistical Analysis 
Results are reported as mean ± standard deviation, with n equal to the number of replicates per 
group. Statistical analyses were performed with JMPIN (4.0.4, SAS Institute, Inc.). A two-way analysis of 
variance (ANOVA) was used to determine the effect SBF dose and culture time on cell response 
(proliferation, ALP activity, matrix deposition) and media ion concentration. A one-way ANOVA was used 
to determine the effects of SBF dose on gene expression at each time point. The Tukey-Kramer post hoc 
test was used for all pair-wise comparisons, and significance was attained at p<0.05. 
7.3 Results 
7.3.1 Scaffold Characterization 
 Scanning electron microscope images show the presence of ceramic nodules in all mineral-
containing scaffolds, while the control fibers are smooth and continuous. With increasing SBF 
incorporation, the presence of mineral nodules increases. Thermogravimetric analysis indicates that 10, 
13, and 17% w/w mineral is incorporated into low, medium, and high dose scaffolds respectively (p<0.05). 
7.3.2 Cell Viability and Proliferation 
Cell attachment, viability, and growth is unaffected by the incorporation of mineral into PLGA 
scaffolds or the mineral dose. Cells proliferation is noted over time on monolayer culture, and cell number 
is significantly greater than all scaffold groups on days 7 and 14. 




7.3.3 Cell Biosynthesis 
Collagen deposition is significantly greater on scaffolds compared to monolayer. After 14 days of 
culture, collagen deposition on the medium and high dose scaffolds trend higher than that of the low dose 
and control. Furthermore, matrix deposition on the medium dose scaffold significantly exceeds that of the 
low dose group at day 14. Peak ALP activity occurs on day 1 for both monolayer and scaffolds. Enhanced 
activity is consistently detected on scaffolds compared to monolayer at all time points. At day 1 
mineralization potential is enhanced on the medium dose scaffold compared to low and control, and on 
the high dose scaffold compared to the mineral-free control. 
7.3.4 Gene Expression 
The expression of osteopontin is upregulated on the high dose scaffold compared to medium 
dose at day 7, while on day 14 it is upregulated on the low dose scaffold compared to all other groups. 
There are no differences in bone sialoprotein and osteocalcin expression between groups at either time 
point. 
7.4 Discussion 
This study explored the effects of SBF ceramic dose in PLGA fiber scaffolds to promote an 
osteoblastic phenotype of PDL cells in order to augment soft-to-hard tissue healing. Ceramic doses of 0, 
10, 13, and 17% were evaluated. Varying mineral concentrations were explored based on the fact that the 
bone and cementum matrices are comprised of approximately 70 and 50% mineral respectively, as well 
as the favorable cell response on SBF-Coated scaffolds, which effectively represents a matrix of 100% 
mineral, in the previous chapter. 
Cell attachment and proliferation were unaffected by mineral dose or the inclusion of mineral. The 
periodontal ligament contains a heterogeneous cell population that is capable of synthesizing and 
remodeling both soft and mineralizing connective tissues. The close proximity of this soft tissue to bone 
also makes this tissue unique. Thus as the in vivo niche for periodontal derived cells is an environment of 
both soft and mineralized connective tissues, the presence of mineral or mineral concentration may 




Interestingly, there was a dose dependent effect on ALP activity. Alkaline phosphatase activity is 
a promoter of mineralization, catalyzing the hydrolysis of inorganic pyrophosphate, a calcification inhibitor, 
while simultaneously increasing the levels of inorganic phosphate67 through hydrolysis of β-glycerol 
phosphate. This leads to a supersaturated state and the subsequent precipitation of calcium phosphate 
salts in the collagenous substrate. As such, high levels of ALP activity are characteristic of an osteoblast 
phenotype. Furthermore, in a quantitative assessment of the distribution of ALP activity within the 
periodontium of rat molars, the highest activity was found in the areas adjacent to the alveolar bone and 
cementum74. Thus our results indicate that increasing mineral dose in polymer fiber scaffolds results in an 
enhanced osteoblastic phenotype. 
The presence of a multipotent stem cell population in the periodontal ligament was demonstrated 
by Seo et al., in which cells were capable forming cementum-like tissue in vivo167. We have previously 
demonstrated (Chapter 2) that a population of human periodontal ligament cells used herein expresses 
the progenitor markers STRO-1 and CD-146. Using human mesenchymal stem cells Subramony et al. 
discovered a dose dependent effect of hydroxyapatite incorporated into PCL-PLGA blend scaffolds on 
early ALP activity. In line with those results, it is likely that the SBF mineral is eliciting a similar response 
from the PDL progenitor cells used here, in which ALP activity is a function of ceramic dose. 
Another critical aspect of tissue healing is matrix production. It was observed that the average 
collagen deposition was higher on the medium and high dose scaffolds compared to the low dose and 
control. While the deposition of collagen and other matrix proteins is necessary for ligament healing201, in 
mineralizing tissues matrix accumulation is requisite for osteoblast-specific gene expression55. 
Collectively these results indicate that PDL cell response is modulated by the incorporation of 
SBF mineral in a dose dependent manner. Specifically 13% and 17% ceramic doses promoted early ALP 
activity as well as matrix production compared to 10% and mineral free scaffolds. 
7.5 Conclusion 
Exploring the effect of varying ceramic dose in PLGA fibers on periodontal ligament cell 
response, the results of this study indicate that 13% and 17% w/w SBF promote an osteoblast-like 
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optimization studies were performed with the medium dose (13%) fibers, PLGA-SBF electrospun 
scaffolds with 13% SBF will be utilized for the hard tissue integration phase of the composite scaffold. 
 
 Figure 7.1: Effect of Calcium Phosphate 
Dose on PDL Cell Response: Scaffold 
Characterization Thermogravimetric 
analysis confirms SBF mineral incorporation 
at low, medium, and high doses, 
corresponding to 10, 13, and 17% w/w 
respectively. All groups were significantly 
difference from each other, (n=3, p<0.05) 
Figure 7.2: Effect of Calcium Phosphate Dose on PDL Cell Response: Scaffold Morphology, 
Cell Viability, and Proliferation Scanning electron microscopy shows SBF mineral within fibers. Cells 
remain viable over time on all scaffold groups and there were no differences in cell number between 




















   
  
Figure 7.3: Effect of Calcium Phosphate Dose on PDL Cell Response: Matrix Deposition and 
Alkaline Phosphatase Activity Collagen production is enhanced on the mineral-free group compared 
to all other groups on day 7, while at day 14 matrix deposition was higher on the medium dose 
scaffolds compared to low dose. ALP activity peaks at day 1 for all groups and enzyme activity is 
enhanced on medium and high dose scaffolds compared to the low and mineral-free groups after one 
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Figure 7.4: Effect of Calcium Phosphate Dose on PDL Cell Response: Expression of 
Osteoblastic Markers On day 7 osteopontin (OP) is upregulated on the high dose scaffold compared 
to medium dose, while on day 14 OP is upregulated on the low dose scaffold compared to all other 
groups. There are no differences in bone sialoprotein (BSP) and osteocalcin (OC) expression at either 















CHAPTER 8: EFFECT OF POLYMER-CALCIUM 


















To facilitate the predictable regeneration and maintenance of periodontal tissues, the scaffold 
must also support the growth and phenotype of all relevant cells, including osteoblasts, the resident cell 
type of the cementum and alveolar bone. In this study, the soft-to-hard tissue integration scaffold 
optimized from chapters 5-8 will be used to culture human osteoblasts in order to ensure that cell 
phenotype is maintained. 
8.1.1 Background and Motivation 
 Osteoblasts comprise the cellular component of the alveolar bone while in the cementum it is 
cementoblasts. An optimized soft-to-hard tissue integration scaffold should thus also support the 
phenotype of the differentiated cell populations of the mineralized tissues of the periodontium. Although 
there exist differences between osteoblasts and cementoblasts, the primary function of both is the 
maintenance and production of a mineralized matrix. Furthermore, bone and cementum tissues are 
similar in their organic constituents (collagen and proteoglycans), crystal type, development, remodeling 
capabilities, and chemical composition. It is therefore expected that a scaffold that will support the growth 
and maintain the phenotype of one mineralized tissue cell type should support that of the other. 
8.1.2 Objectives 
 Primary human osteoblasts are cultured on PLGA-SBF and SBF-Coated scaffolds and cell 
response is assessed. It is expected that osteoblast proliferation is supported, and that cells retain their 
characteristics, including enhanced ALP activity and the production of a collagenous matrix25,46,91. 
8.2 Materials and Methods 
8.2.1 Human Osteoblast Cell Isolation and Culture 
Human osteoblasts were isolated from explant culture of bone tissue obtained from patients 
(institutional review board exempt). Under sterile conditions, the tissue was rinsed in Dublecco’s modified 
Eagle’s medium (DMEM, Cellgro-Mediatech), with 10% fetal bovine serum (FBS, Atlanta Biologicals), 2% 
amphotericin B (AmpB, Cellgro-Mediatech), 1% penicillin streptomycin (P/S, Cellgro-Mediatech), and 
0.5% gentamicin/sulfate (G/S, Cellgro-Mediatech), and trimmed to ~5mm blocks using a sterile scalpel 




conditions at 37ºC, 5% CO2 for 15-20 min, after which fully supplemented medium (F/S medium: 10% 
FBS, 1% non-essential amino acids (NEAA, Cellgro-Mediatech), 1% P/S, 0.1% AmpB, and 0.1% G/S) 
was added. Media was changed every 3-4 days. Once confluence was reached, the tissues were 
removed and placed onto new culture plates. These first migration cells were discarded. Upon 
subsequent migrations, once the cells surrounding the tissues reached confluence, the cells were 
removed by trypsin/EDTA (Cellgro-Mediatech) treatment and replated. Only second and third migration 
cells were used for analysis.  
8.2.2 Scaffold Fabrication 
8.2.1.1 Simulated Body Fluid Mineral and SBF-Coated Scaffold Fabrication 
Aligned PLGA scaffolds were secured using custom-made 
clamps. Scaffolds were immersed in a simulated body fluid (SBF) 
solution for 24 hours, resulting in a calcium phosphate coating77. Refer 
to Table 8.1 for composition of the SBF solution (all components from 
Sigma-Aldrich). For production of the SBF solution, a beaker was filled 
with 500 mL of deionized water maintained at 37°C. NaCl, 
MgCl2•6H2O, and CaCl2•2H2O were added, with each component 
allowed to dissolve before addition of the next. Carbon dioxide gas was 
bubbled into the solution until a pH<4 was achieved. With CO2 bubbling into the solution, Na2HPO4•2H2O 
and NaHCO3 were added. Once the pH was below 6.2, PLGA scaffolds were immersed into the solution. 
The solution was stirred and maintained at 37°C for 24 hours. Scaffolds were rinsed twice in DI water, 
allowed to dry in a fume hood overnight, and stored in a vacuum desiccator until use. Additionally, the 
resulting SBF solution was filtered (Whatman 1) for SBF mineral precipitate, the filter allowed to dry 
completely, and mineral powder harvested for electrospinning. 
8.2.2.2 PLGA-SBF 
For PLGA-SBF scaffolds, 380 mg of SBF ceramic was dissolved in 1 mL of DMF and the solution 
placed in a water bath sonicator (FS20, Fisher Scientific) for 1 hour. In a separate vial, 2 g of PLGA was 
dissolved in a 1:3 solution of DMF:DCM, and the polymer-solvent solution was vortexed for an hour. The 
ceramic solution was added to the PLGA solution, mixed for an hour and then loaded into a 5 mL syringe 












with a 23 gauge stainless steel blunt-tip needle. A voltage of ~10 kV was applied to the needle tip and a 
pump flow rate of 1 mL/hr was used. Fibers were collected on a grounded rotating mandrel (2500 rpm), 
11 cm from the needle tip. 
8.2.3 Cell Seeding and Culture 
Electrospun scaffolds were cut to 1 x 1.8 cm and secured using custom-made clamps, resulting in 
a cell culture surface area of 1 cm2. Scaffolds were UV 356 nm sterilized (each side 15 min) and 
incubated (37°C, 5%CO2) overnight in F/S medium with 20% FBS to promote cell attachment. 
Human osteoblasts cells were seeded on scaffolds at a density of 30,000 cells/cm2 (3 M cells/mL, 
10 µl), and allowed to attach for 20 min under humidified conditions at 37ºC, 5% CO2 before the addition 
of F/S medium supplemented with 50 µg/mL ascorbic acid (Sigma-Aldrich). Following one week of 
culture, cells were fed with F/S medium supplemented with 50 µg/mL ascorbic acid and 3mM β-
glycerophosphate (Sigma-Aldrich). Cells were maintained at 37°C, 5% CO2 and media was exchanged 
every 2-3 days.  
8.2.4 Live/Dead Cell Viability 
Cell viability (n=3) was visualized using Live/Dead staining (Molecular Probes). Both monolayer 
and scaffolds were stained following the manufacturer’s suggested protocol. Samples were imaged using 
confocal microscopy (Olympus Fluoview FV1000) at excitation wavelengths of 488 nm and 568 nm. 
8.2.5 Cell Proliferation 
Cell proliferation (n=5) was determined by measuring total DNA content using the PicoGreen 
dsDNA assay (Invitrogen) following the manufacturer’s protocol. Scaffolds were rinsed twice in PBS and 
stored in 500 µl of 0.1% Triton-X (Sigma-Aldrich) at -30°C. Immediately before the analysis, samples 
were thawed and homogenized (Microson XL-2000) for 20 sec. Fluorescence was measured using a 
Tecan microplate reader with an excitation wavelength of 485 nm and an emission wavelength of 535 nm. 




8.2.6 Collagen Production 
Collagen production (n=5) was quantified using a modified hydroxyproline assay153. Samples 
were first dessicated (CentriVap, Labconco, Kansas City, MO) and digested for 18 hr at 65°C in a solution 
of 20 µL/mL papain (Sigma-Aldrich), buffered in 0.1 M sodium acetate, 10 mM cysteine HCl, and 50 M 
ethylenediaminetetraacetate.  A 250 µl aliquot of the digest was concentrated by dessication.  Samples 
were subsequently hydrolyzed in 10 µl of 10N NaOH and autoclaved for 25 min.  The hydrolysate was 
then oxidized by a buffered chloramine-T reagent for 25 min before the addition of Ehrlich’s reagent.  
Sample absorbance was measured at 550 nm (Tecan), and the collagen content was obtained by 
interpolation along a standard curve of bovine collagen I (Sigma). 
8.2.7 Alkaline Phosphatase Activity 
After scaffold homogenization samples were assayed for alkaline phosphatase (ALP) activity 
(n=5) using a colorimetric assay based on the hydrolysis of p-nitrophenyl phosphate (pNP). On ice, 50 µl 
of sample was added to pNP-PO4 solution (Sigma) and incubated at 37°C until a color change was noted. 
The absorbance at 405 nm was read using a Tecan microplate reader. ALP activity is reported 
normalized to incubation time and the post-homogenization cell number. 
8.2.8 Statistical Analysis 
Results are reported as mean ± standard deviation, with n equal to the number of replicates per 
group. Statistical analyses were performed with JMPIN (4.0.4, SAS Institute, Inc.). A two-way analysis of 
variance (ANOVA) was used to determine the effect of method mineral incorporation and culture time on 
cell response (proliferation, ALP activity, matrix deposition).  The Tukey-Kramer post hoc test was used 
for all pair-wise comparisons, and significance was attained at p<0.05. 
8.3 Results 
8.3.1 Cell Viability and Proliferation 
Osteoblasts attached to and remained viable on SBF-Coated scaffolds, with cell number 




groups. Cell number is significantly greater on monolayer compared to the scaffold groups, and on PLGA-
SBF compared to SBF-Coated after 21 days of culture. 
8.3.2 Cell Biosynthesis 
Mean collagen content is greater on scaffolds compared to monolayer throughout the duration of 
culture. Significantly greater collagen is detected on SBF-Coated compared to PLGA-SBF on day 21. 
Alkaline phosphatase activity peaks prior to day 1 for all groups, and there is enhanced enzyme 
activity on scaffolds compared to monolayer. Interestingly, ALP activity is consistently enhanced on the 
SBF-Coated scaffolds compared to PLGA-SBF. 
8.4 Discussion 
 It was previously demonstrated that SBF mineral-composite scaffolds, namely PLGA-SBF and 
SBF-Coated scaffolds, are capable of promoting an osteoblastic phenotype of PDL cells. Building upon 
those results, this study explored the response of human osteoblast to SBF-containing scaffolds. As 
osteoblasts and cementoblasts are the resident cell populations of the alveolar bone and cementum 
respectively, it is important to ensure that the periodontal regenerative scaffold will support the phenotype 
of these cells. Although only osteoblasts were evaluated in this study, the debate still exists whether 
cementoblasts represent a unique phenotype or whether they are simply uniquely-positioned 
osteoblasts12,25,110. Furthermore, it is still debated whether these two mineralizing cells types have a 
common precursor in the periodontal ligament. On the other hand, given that both cell types reside in a 
matrix of similar organic, mineral and chemical composition131,165, it is likely that a matrix that will support 
the viability and phenotype of one cell type should support that of the other. It was therefore decided to 
utilize osteoblasts in this study to demonstrate biocompatibility. 
Osteoblasts attached to both PLGA-SBF and SBF-Coated scaffolds with similar efficiency, but 
while cells proliferated on PLGA-SBF fibers, cell number was maintained on the coated fibers throughout 
the 21 day culture period. Lu et al. observed that there is a threshold mineral content which is optimal for 
osteoblast growth, namely that growth was promoted on PLGA scaffolds containing 10 and 25% bioactive 
glass compared to 50%109. In our study, the PLGA-SBF fibers contained approximately 13% w/w mineral 




 In terms of effects on cell biosynthesis, all groups displayed an early peak ALP activity. This 
attribute is characteristic of calcifying tissue, in which ALP is typically expressed early in development55,67. 
Furthermore, ALP activity is promoted on SBF-Coated scaffolds compared to the PLGA-SBF group 
throughout the culture period. Similarly collagen matrix deposition is enhanced on SBF-Coated scaffolds 
compared to PLGA-SBF as well. All scaffolds displayed enhanced mineralization potential and collagen 
production compared to culture on monolayer. 
A distinct relationship between cell growth and a differentiation related phenotype has been 
established for primary osteoblast cultures. Namely a decline in cell proliferation, followed by collagen 
matrix accumulation that precedes the expression of differentiation related proteins such as ALP.  
Additionally, while ALP activity levels peak early in development, matrix deposition will continue to 
increase throughout the entire culture period55. In our study, this pattern of cell growth and phenotype is 
promoted on both mineral containing scaffold groups albeit on SBF-Coated scaffolds to a greater degree. 
Moreover, the support of these attributes on polymer-fiber scaffolds compared to monolayer may further 
be an indication of the critical role that the extracellular matrix has to osteoblast differentiation. For 
example, in studies with ascorbic acid-deficient cells, which results in abnormal collagen fibrillogenesis, 
levels of ALP and bone sialoprotein are reduced56,149. It is hypothesized that this is due to the interaction 
between type  I collagen and specific integrins, which function to initiate intracellular signaling pathways 
that promote osteoblast-specific gene expression55. Thus fiber scaffolds, which are mimetic of the 
collagenous extracellular matrix, may also stimulate similar cellular pathways. Collectively these results 
indicate that polymer-mineral composite scaffolds are a promising substrate to support osteoblast growth 
and phenotype, necessary for the healing and maintenance of the periodontal soft-to-hard tissue 
interface. 
8.5 Conclusion 
 To confirm the compatibility of the optimized hard tissue interface scaffold with the resident cells 
of the mineralized tissues of the periodontium, this study evaluated the response of osteoblasts to PLGA-
SBF and SBF-Coated fiber scaffolds. A growth profile and phenotype consistent with mineralizing 
osteoblasts, including enhanced alkaline phosphatase activity concurrent with an early peak in activity, as 




results confirm that SBF containing scaffolds support the viability and phenotype of osteoblasts, 
necessary to facilitate soft-to-hard tissue integration. Given that lack of cell proliferation on SBF-Coated 
scaffolds, PLGA-SBF scaffolds may be a more desirable substrate to support tissue healing. Thus PLGA-
SBF scaffolds represent the optimal substrate to support hard tissue integration and will be used in Aim 3, 
in which a multi-phased scaffold will be fabricated and evaluated. 
Success criteria for aim 2, scaffold optimization to promote hard tissue integration, is a substrate 
that promotes an osteogenic phenotype of PDL-derived cells, including the expression of osteoblastic 
markers (bone sialoprotein, osteocalcin, osteopontin), enhanced mineralization potential, and the 
deposition of a mineralized matrix. This was assessed through statistically significant differences in 
quantitative data sets. In regards to the effectiveness of the strategies explored in each study of aim 2 
relative to one another, the inclusion of a mineral source into polymer fiber scaffolds has a greater effect 
on cell response compared to that of fiber diameter and mineral dose. This was assessed by the relative 
differences observed in the quantitative data (ALP activity and osteoblastic marker expression) compared 
to PLGA nanofibers, a control group that was included in each study of aim 2. Summary tables of 






























Figure 8.1: Effect of Polymer-Calcium Phosphate Composite Scaffold on Osteoblast Response: 
Cell Viability and Proliferation Cell proliferation was noted over time for monolayer, while cell 
number is maintained on the scaffold groups. Significant difference between: # groups, * consecutive 






Figure 8.2: Effect of Polymer-Calcium Phosphate Composite Scaffold on Osteoblast Response: 
Matrix Deposition and Alkaline Phosphatase Activity Collagen deposition is significantly greater on 
SBF-Coated scaffolds compared to both monolayer and PLGA-SBF at day 21, while on days 1 and 7 it 
is significantly greater on SBF-Coated compared to monolayer. ALP activity peaks prior to day 1 for all 
groups, and activity on monolayer is consistently lower than that of the scaffold groups. Among the 
scaffold groups, enzyme activity is promoted on SBF-Coated. Significant difference between: # 


























































CHAPTER 9: EFFECT OF COMPOSITE MULTI-

















The studies in the previous chapters optimized design parameters for regeneration of the PDL 
(Chapters 3 and 4) and for achieving soft-to-hard tissue integration (Chapters 5-7). Methods for 
fabrication of a composite scaffold that combines the optimized elements from the previous studies will be 
developed in this study with the objective to produce an scaffold for integrative periodontal regeneration. 
This study will also evaluate the in vitro response of PDL cells to the composite scaffold. 
9.1.1 Background and Motivation 
The ultimate goal for periodontal therapies is the regeneration of both mineralized and soft 
tissues, as well as achieving physiologic tissue integration which in turn reestablishes tooth anchorage 
and functionality. While traditional tissue engineering efforts have predominately focused on regeneration 
of a single tissue, multi-tissue designs recapitulate the native spatial and composition inhomogeneity 
present at the periodontal interfaces. It was demonstrated that aligned PCL fibers support optimal PDL 
regeneration, while scaffolds with SBF mineral promoted optimal soft-to-hard tissue healing. It is 
hypothesized that a scaffold optimized for PDL healing in addition to facilitating heterogeneous tissue 
integration will achieve the goal of functional periodontal regeneration. Therefore, in this study methods 
for fabrication of a composite scaffold which incorporates these optimized elements will be established. 
Finally, to evaluate the ability of the composite scaffolds to promote functional periodontal regeneration 
this study will also assess the in vitro response of PDL cells to the scaffolds. 
9.1.2 Objectives 
The objective of this study is to develop methods to fabricate a composite multi-phased scaffold. 
The PDL portion of the scaffold will consist of aligned PCL fibers to support soft tissue regeneration, while 
the hard tissue integration region of the scaffold will consist of PLGA-SBF fibers. The structure and 
composition of the constructs will be characterized and the composite scaffold will then be seeded with 
PDL cells to evaluate cell response. A cell response similar to those achieved in the previous optimization 
studies is expected, namely the support of cell proliferation and the deposition of matrix and mineralized 
matrix on the PCL and mineral containing phases respectively. The composite scaffold should also 




9.2 Materials and Methods 
9.2.1 Integrative Scaffold Fabrication: Sol-gel Sintering 
PLGA-SBF and PCL aligned scaffolds were first fabricated. For PLGA-SBF fibers, 380 mg of 
ceramic was dissolved in 1 mL of DMF and the solution placed in a water bath sonicator (FS20, Fisher 
Scientific) for 1 hour. In a separate vial, 2 g of PLGA was dissolved in a 1:3 solution of DMF:DCM, and 
the solution vortexed for an hour. The ceramic solution was added to the PLGA solution, mixed for an 
hour and then loaded into a 5 mL syringe with a 23 gauge stainless steel blunt-tip needle. A voltage of 
~10 kV was applied, a pump flow rate of 1 mL/hr was used, and fibers were collected on a grounded 
rotating mandrel (2500 rpm), 11 cm from the needle tip.  For PCL fibers, an 18% (w/v) PCL solution was 
prepared by dissolving PCL into 3:2 mixture of DCM:DMF. The solution was mixed overnight, vortexed for 
~1 hour prior to electrospinning, and the entire solution loaded into a 5 mL syringe with a 23 gauge 
stainless steel blunt-tip needle. A voltage of 9-10 kV was applied, a pump flow rate of 1 mL/hr was used, 
and fibers were collected on a grounded rotating mandrel (2500 rpm), 13 cm from the needle tip. 
To fabricate the composite scaffold, PCL fibers (1 x 8 cm) were wrapped in a custom mold. The 
PCL fibers as well as two 1 x 4 cm sections of PLGA-SBF mesh was wetted with a sol-gel solution (16:1 
tetramethylorthosilicate (Sigma):water). PLGA-SBF scaffold sections were placed on the top and bottom 
of the PCL fibers in the mold, the structure compressed, and allowed to dry overnight under ambient 
conditions (Figure 9.1). For testing, 0.5 x 0.6 cm sections of the composite structure were excised. 
9.2.2 Scaffold Characterization: Scanning Electron Microscopy and Energy Dispersive X-Ray Analysis 
Scaffolds were imaged using scanning electron microscopy (SEM, 1 kV, 10 µA Hitachi 4700). 
Samples were imaged at a cross-section by sectioning frozen samples (LN2, 3 minutes) with a frozen 
knife. A gold-palladium coating was applied to the scaffold surface using a sputter coater (Cressington 
108auto) prior to imaging. Elemental analysis (n=3) using Energy Dispersive X-Ray Analysis (EDXA, 
Princeton Gamma Tech) was performed on coated scaffolds. An accelerating voltage of 15-20 kV was 
applied to achieve an acquisition dead time of ~30% and ~3000 counts per second (CPS). For line scans, 




9.2.3 Cell Seeding and Culture 
Prior to seeding scaffolds were UV 356 nm sterilized (each side 15 min) and incubated (37°C, 
5%CO2) overnight in F/S medium with 20% FBS to promote cell attachment. Human PDL cells at a 
concentration of 1M cells/mL were dynamically seeded onto scaffolds using orbital shaking (speed 3, 
Talboys). Cells were allowed to attach for 20 min under humidified conditions at 37ºC, 5% CO2 before 
transfer to fresh F/S medium supplemented with 50 µg/mL ascorbic acid (Sigma-Aldrich). Cells were 
maintained at 37°C, 5% CO2 and media was exchanged every 2-3 days.  
9.2.4 Live/Dead Cell Viability and Alignment 
Cell viability (n=2) was visualized using Live/Dead staining (Molecular Probes). Samples were 
stained following the manufacturer’s suggested protocol. Samples were imaged using confocal 
microscopy (Olympus Fluoview FV1000) at excitation wavelengths of 488 nm and 568 nm 
9.2.5 Cell Proliferation 
Cell proliferation (n=5) was determined by measuring total DNA content using the PicoGreen 
dsDNA assay (Invitrogen) following the manufacturer’s protocol. Scaffolds were rinsed twice in PBS and 
stored in 500 µl of 0.1% Triton-X (Sigma-Aldrich) at -30°C. Immediately before the analysis, samples 
were thawed and homogenized (Microson XL-2000) for 20 sec. Fluorescence was measured using a 
Tecan microplate reader with an excitation wavelength of 485 nm and an emission wavelength of 535 nm. 
A conversion factor of 8 pg DNA/cell was used to determine cell number. 
9.2.6 Collagen Production 
Collagen production (n=5) was quantified using a modified hydroxyproline assay153. Samples 
were first dessicated (CentriVap, Labconco, Kansas City, MO) and digested for 18 hr at 65°C in a solution 
of 20 µL/mL papain (Sigma-Aldrich), buffered in 0.1 M sodium acetate, 10 mM cysteine HCl, and 50 M 
ethylenediaminetetraacetate.  A 250 µl aliquot of the digest was concentrated by dessication.  Samples 
were subsequently hydrolyzed in 10 µl of 10N NaOH and autoclaved for 25 min.  The hydrolysate was 




Sample absorbance was measured at 550 nm (Tecan), and the collagen content was obtained by 
interpolation along a standard curve of bovine collagen I (Sigma). 
Additionally matrix deposition was visualized histologically. Cryosectioned samples were stained 
(n=3) with Hematoxylin and Eosin to stain for cells and matrix, and Picrosirius Red for collagen.  
9.2.7 Alkaline Phosphatase Activity and Mineralization 
After scaffold homogenization samples were assayed for alkaline phosphatase (ALP) activity 
(n=5) using a colorimetric assay based on the hydrolysis of p-nitrophenyl phosphate (pNP). On ice, 50 µl 
of sample was added to pNP-PO4 solution (Sigma) and incubated at 37°C until a color change was noted. 
The absorbance at 405 nm was read using a Tecan microplate reader. ALP activity is reported 
normalized to incubation time and the post-homogenization cell number. 
Mineral deposition was also visualized through histological staining.  Samples were fixed in 10% 
neutral buffered formalin + 1% cetylpyridinium chloride overnight. The solution was replaced with 0.01M 
cacodylic acid and stored at 4°C until sectioning. Samples were embedded in 5% polyvinyl alcohol (PVA) 
for sectioning through freezing in a dry ice ethanol bath and sectioned to 7 µm thickness with a cryostat 
(Bright Instrument Company, Model OFT). Sectioned samples were collected on glass slides coated with 
Haupt’s Solution (2% gelatin, 1.9% phenol, 15% glycerol). Scaffold sections on glass slides were 
immersed in DI water for 1 hour to remove traces of PVA. Von Kossa was used to stain for phosphate 
(n=3) and alizarin red for calcium (n=3). 
9.2.8 Statistical Analysis 
Results are reported as mean ± standard deviation, with n equal to the number of replicates per 
group. Statistical analyses were performed with JMPIN (4.0.4, SAS Institute, Inc.). A two-way analysis of 
variance (ANOVA) was used to determine the effect of a composite scaffold and culture time on cell 
response (proliferation, ALP activity, matrix deposition). The Tukey-Kramer post hoc test was used for all 





9.3.1 Scaffold Characterization 
The Integrative PDL scaffold is shown in Figure 9.2. To promote hard tissue integration, PLGA-
SBF fibers are used. The aligned PCL matrix is designed so that fibers insert perpendicularly into the 
PLGA-SBF regions of the composite scaffold. As seen in the SEM images, scaffold fiber morphology is 
maintained through the sol-gel sintering process, and the PCL and PLGA-SBF layers are well integrated 
with each other 
9.3.2 Cell Viability and Proliferation 
Cell attachment and viability was evaluated on all phases of the Integrative PDL Scaffold, 
including PDL (Phase A), PDL-Cementum integration (Phase B), and PDL-Alveolar Bone integration 
(Phase C) (Figure 9.3). Live/dead staining for cell viability indicates the presence of cells on all phases of 
the Integrative PDL scaffold at day 1, demonstrating good cell attachment. Cells persist on all three 
phases of the construct over the two week culture period. Similarly, cells are detected on the Single 
Phase PCL control at all time points. Cells display an aligned morphology and spread along the long axis 
of the polymer fibers on the PDL phase (Phase A) of the Integrative PDL scaffold. Cell number on the 
Integrative PDL scaffold is significantly greater than the Single Phase scaffold on days 1 and 7. Cell 
number remains constant on the Single Phase scaffold with time, while there is a significant decrease on 
the Integrative PDL scaffold between day 7 and 14. 
9.3.3 Cell Biosynthesis 
Collagen deposition is significantly greater on the Integrative PDL scaffold compared to the Single 
Phase PCL scaffold on day 1, and there is a significant increase in collagen over time on the Single 
Phase scaffold at day 14. Picrosirius red and H&E staining for collagen and matrix respectively were 
performed at day 14. Positive collagen and matrix staining is noted on both scaffolds and on all phases of 
the Integrative PDL scaffold. Staining on the hard tissue integration phases (Phase B and C) of the 
Integrative PDL scaffold is more diffuse than on the PDL phase (Phase A). 
 Alkaline phosphatase activity is significantly greater on the Single Phase PCL scaffold compared 




phosphate respectively indicate the presence of mineral nodules in Phase B and C of the Integrative PDL 
scaffold and diffuse staining in Phase A as well as in the Single Phase PCL control. 
9.4 Discussion 
Composite scaffolds which mimic the spatial changes in structure and composition across distinct 
tissue regions are required for the regeneration of complex tissues. The periodontium, consisting of 
collagenous periodontal ligament fibers that connect two mineralized tissues, the tooth root cementum 
and alveolar bone, is such a tissue. In this study, methods were developed to fabricate a multi-tissue 
scaffold capable of promoting soft and hard tissue regeneration and facilitating tissue integration. The 
scaffold contained regions optimized for periodontal ligament regeneration as well as soft-to-hard tissue 
integration. The ligament region consisted of PCL aligned fibers, and the interface region consisted of 
electrospun PLGA-SBF fibers. Mimetic of the native periodontium, PCL fibers were oriented to insert 
perpendicularly into the mineral-containing region of the composite structure. Scaffold fiber morphology 
was maintained through the sol-gel sintering processes. Cells attachment was guided by the underlying 
scaffold fiber architecture, in which PDL cells displayed an elongated morphology and organized along 
the long axis of PCL fibers in Phase A of the Integrative PDL scaffold. In the native periodontal ligament, 
fibroblasts are oriented parallel to the collagen fibers19. Thus the Integrative PDL Scaffold utilized in this 
study is mimetic of the native structure of the periodontium and effectively promotes physiological cell 
orientation. 
Matrix deposition was supported on all phases of the Integrative PDL Scaffold. Deposition on 
Phase A of the composite scaffold was similar to the Single Phase PCL control. Collagen is essential for 
the normal architecture of the PDL, which is comprised of predominately of collagen I and III 32,81. It was 
demonstrated in Chapter 3 that the matrix deposited by PDL cells cultured on PCL aligned fibers, 
identical to the one’s used here, is comprised of both collagen I and III. Collagen deposition was also 
observed on the hard tissue integration phases of the composite scaffold. Collagen matrix accumulation 
is critical aspect of both cementum and alveolar bone formation and is a requisite precursor for 
mineralization. Specifically, during cementum development collagen fibrils (fringe fibers) are secreted by 
cementum-associated cells, which then undergo a slow mineralization process41,131. While not explored in 




healing. Initially during wound healing the collagenous matrix consists of mainly collagen III, eventually 
maturing to collagen I, which imparts mechanical strength to connective tissues. Thus assessing changes 
in the scaffold mechanical properties with time may provide insight into matrix development and thus 
healing. 
Alkaline phosphatase activity was enhanced on the Single Phase PCL scaffolds compared to the 
Integrative PDL Scaffold. The Integrative PDL Scaffold is a composite of both PLGA-SBF and PCL 
phases, on the other hand, based on the assay used in this study one cannot isolate the region specific 
alkaline phosphatase activity. It is known that high levels of alkaline phosphatase activity is typically 
characteristic of both a cementoblastic41 as well as well as an osteoblastic67 phenotype. On the other 
hand,  Alliot-Licht et al. observed a decrease in alkaline phosphatase activity from PDL cells cultured in 
the presence of hydroxyapatite ceramic3. Since the mineral-containing phases of the Integrative PDL 
Scaffold serves as a phosphate source for cells this may obviate the requirement for alkaline 
phosphatase, potentially explaining why there was a decrease in enzyme activity in the composite 
scaffold group compared to the control. Importantly, histological staining for calcium and phosphate 
indicated the presence of mineral in the hard tissue integration regions of the composite scaffold, while 
the PDL region remained mineral-free. 
A composite scaffold with regions optimized for periodontal ligament regeneration as well as soft-
to-hard tissue integration was developed in this study. Analysis of the scaffold structure demonstrated 
that the fibrous scaffold morphology was maintained, and that PCL and PLGA-SBF scaffold phases were 
well integrated. Additionally, culture of PDL cells on the scaffold demonstrated that the Integrative PDL 
Scaffold supported cell viability as well as a phase specific phenotype. On the other hand, the Single 
Phase PCL scaffold only supported the deposition of a collagenous matrix. The following study will utilize 
a tooth-in-bone explant model to assess the interaction between the composite scaffold with the native 
tissue, specifically in regards to integration strength. 
9.5 Conclusion 
An Integrative PDL Scaffold with optimized elements to promote ligament regeneration as well as 
soft-to-hard tissue integration was developed in this study. Periodontal ligament cells attached to and 




of collagenous and mineralized matrices on the PDL and hard-tissue integration regions of the composite 
scaffold respectively. The following study will evaluate the Integration PDL Scaffold in an explant model to 





Figure 9.1: Effect of Composite Multi-Phased Scaffold on PDL Cell Response: Integrative PDL 
Scaffold Fabrication A rectangular section of PCL fibers is wrapped around a custom mold (Panel 2). 
The PCL scaffold and a rectangular section of PLGA-SBF scaffold are wetted with a sol-gel solution 
(Panel 3). The PLGA-SBF fibers applied to the PCL-mold and the composite structure compressed 






Figure 9.2: Effect of Composite Multi-Phased Scaffold on PDL Cell Response: Integrative PDL 
Scaffold Morphology The top panel is a schematic representation of the composite scaffold structure 
highlighting PLGA-SBF regions to promote PDL-cementum and PDL-alveolar bone interface 
regeneration, and PCL region to promote PDL regeneration. C: Cementum, B: Alveolar Bone. The 
bottom panel shows a detailed view of the composite scaffold in which fiber morphology is maintained 





Figure 9.3: Effect of Composite Multi-Phased 
Scaffold on PDL Cell Response: Cell Viability and 
Proliferation Viable cells are detected on both 
mineral-free (A: PCL) and mineral-containing (B, C: 
PLGA-SBF) phases of the Integrative PDL Scaffold 
and Single Phase PCL control. Cell number is 
significantly greater on the Integrative PDL Scaffold at 
days 1 and 7 compared to Single Phase PCL. There is 
a decrease in cell number between days 7 and 14 on 
the Integrative PDL Scaffold group. Significant 
difference between: # groups, * consecutive 

































































Figure 9.4: Effect of Composite Multi-Phased Scaffold on PDL Cell Response: Matrix 
Deposition and Mineralization There was significantly greater collagen on the Integrative PDL 
Scaffold compared to the Single Phase PCL control at day 1, and a significant increase in matrix 
between days 7 and 14 for the control. Picrosirius red and H&E staining at day 14 confirm the 
deposition of a collagenous matrix on both groups. Enhanced ALP activity was observed on Single 
Phase PCL compared to the Integrative PDL Scaffold at days 1 and 7. Histological evaluation at day 
14 shows positive Alizarin red and von Kossa staining on the PLGA-SBF region of the Integrative PDL 
Scaffold (B and C) and diffuse staining on the PCL (A) region of the composite scaffold and on the 
Single Phase PCL control. Significant difference between: # groups, * consecutive timepoints (n=5, 















CHAPTER 10: EVALUATION OF INTEGRATIVE 

















The ultimate goal for periodontal therapies is the regeneration of mineralized and soft tissues, as 
well as achieving physiologic tissue integration which, in turn, reestablishes tooth anchorage and 
functionality. While traditional tissue engineering efforts have predominately focused on regeneration of a 
single tissue, multi-tissue designs recapitulate the native spatial and composition inhomogeneity present 
at the periodontal interfaces. Toward the development of such a composite scaffold, it was demonstrated 
that aligned PCL fibers support optimal PDL regeneration, while scaffolds with SBF mineral promoted 
optimal soft-to-hard tissue healing. Methods were then developed for fabrication of a composite scaffold, 
which incorporated these optimized elements. PLGA-SBF/PCL/PLGA-SBF scaffolds were joined together 
through a sol-gel sintering process. The previous study demonstrated the in vitro capacity for these 
composite scaffolds to support cell proliferation and a cell phenotype guided by phase-specific cues. 
10.1.1 Background and Motivation 
To assess the translational potential of the composite scaffold it will be evaluated in a in vitro 
tooth-in-bone explant model. A swine-tooth model will be used due to similarities in anatomy, 
development, physiology, pathophysiology, and disease occurrence between human and swine in the 
oral maxillofacial region196. Similar to the strategy employed by barrier membranes, the scaffold should 
maintain a space which allows for the recruitment of PDL cells and undifferentiated progenitor cells from 
the remaining healthy PDL tissues into the wound area. Additionally, the composite scaffold is optimized 
to provide chemical and structural cues to promote the repair of an organized PDL region, as well as the 
integration with the mineralized tissues of the periodontium. In this study, the potential of the scaffold to 
support tissue healing and integrate with the native tooth and bone will be evaluated. 
10.1.2 Objectives 
This study focuses on establishing a tooth-in-bone explant model for the in vitro evaluation of the 
composite scaffold. The capacity of the composite scaffold to integrate with the host tissue will be 
evaluated through histology and mechanical evaluation. A Single Phase PCL group and scaffold free 
defect will serve as controls. It is hypothesized that the composite scaffold will result in improve scaffold to 




10.2 Materials and Methods 
10.2.1 Integrative Scaffold Fabrication: Sol-gel Sintering 
PLGA-SBF and PCL aligned scaffolds were first fabricated. For PLGA-SBF fibers, 380 mg of 
ceramic was dissolved in 1 mL of DMF and the solution placed in a water bath sonicator (FS20, Fisher 
Scientific) for 1 hour. In a separate vial, 2 g of PLGA was dissolved in a 1:3 solution of DMF:DCM, and 
the solution vortexed for an hour. The ceramic solution was added to the PLGA solution, mixed for an 
hour and then loaded into a 5 mL syringe with a 23 gauge stainless steel blunt-tip needle. A voltage of 
~10 kV was applied, a pump flow rate of 1 mL/hr was used, and fibers were collected on a grounded 
rotating mandrel (2500 rpm), 11 cm from the needle tip.  For PCL fibers, an 18% (w/v) PCL solution was 
prepared by dissolving PCL into 3:2 mixture of DCM:DMF. The solution was mixed overnight, vortexed for 
~1 hour prior to electrospinning, and the entire solution loaded into a 5 mL syringe with a 23 gauge 
stainless steel blunt-tip needle. A voltage of 9-10 kV was applied, a pump flow rate of 1 mL/hr was used, 
and fibers were collected on a grounded rotating mandrel (2500 rpm), 13 cm from the needle tip. 
To fabricate the composite scaffold, PCL fibers (1 x 8 cm) were wrapped in a custom mold. The 
PCL fibers as well as two 1 x 4 cm sections of PLGA-SBF mesh was wetted with a sol-gel solution (16:1 
tetramethylorthosilicate (Sigma):water). PLGA-SBF scaffold sections were placed on the top and bottom 
of the PCL fibers in the mold, the structure compressed, and allowed to dry overnight under ambient 
conditions (Figure 10.1). For testing, 0.5 x 0.6 cm sections of the composite structure were excised. 
10.2.2 Explant Harvest  
Mandibles from fresh, immature porcine heads (Green Village Packing Co.) were dissected free 
and any adhering soft tissue was removed. Samples were trimmed using a band saw and sterilized by 
soaking in soapy water for 40 minutes followed by 70% ethanol for 20 minutes. Using a low speed bone 
saw (Isomet Buhler), 1 mm thick transverse sections of molars with PDL and surrounding alveolar bone 
were cut. Samples were further trimmed using a razor blade hit with a hammer. Sample dimensions were 
measured using ImageJ (National Institutes of Health), including the circumference of the PDL (inner and 
outer, 3 measurements each), and the ligament width, measured at 12 points equally distributed around 




10.2.3 Defect Preparation and Scaffold Implantation 
Prior to seeding scaffolds were UV 356 nm sterilized (each side 15 min) and incubated (37°C, 
5%CO2) overnight in F/S medium with 20% FBS to promote cell attachment. Human PDL cells at a 
concentration of 1M cells/mL/scaffold were dynamically seeded onto scaffolds using orbital shaking 
(speed 3, Talboys). Cells were allowed to attach for 20 min under humidified conditions at 37ºC, 5% CO2 
before implantation. Periodontal defects were created using a drill (0.5 mm, Dremel) (Figure 10.1). A cell-
seeded composite scaffold was trimmed to size and placed in the defect. Samples were incubated (37°C, 
5%CO2) in F/S medium supplemented with 50 µg/mL ascorbic acid (Sigma-Aldrich) and media was 
exchanged every 2-3 days. 
10.2.4 Mechanical Testing 
 Mechanical testing (n=5) was performed using methods adapted Mandel et al.99,100,111. The bone 
portion of the specimen was fastened between two plates of a sample holder (Figure 10.2). In order to 
ensure that only the PDL was deformed, a metal rod fit to the dimensions of the tooth root was used for 
downward load application at 0.22 mm/min using a materials testing machine (Instron model 5848). To 
avoid drying during testing samples were immersed in PBS. Samples were loaded until failure, and the 
load-deformation recorded continuously. Shear stress was calculated as force normalized to PDL 
circumference and sample thickness, strain was calculated as deformation normalized by the ligament 
width. From stress-strain curves, the maximum shear stress and failure strain energy density (area 
between stress-strain curve and x-axis to point of breaking) were calculated. The tooth was pushed out of 
the alveolar bone in an extrusive (eruptive) direction, and all samples were examined after testing to 
ensure that the tooth or bone was not fractured during testing. Samples in which such failure was noted 
were excluded from analysis. 
10.2.5 Histology 
Explants were rinsed in PBS and fixed in neutral buffered formalin with 1% cetylpyridinium 
chloride (Sigma) overnight. Following fixation samples were embedded in poly-methylmethacrylate 
(PMMA, Sigma). The samples were sectioned (7µm) with a Leica sliding microtome (SM2500S, Leica 




Sections were stained for cell nuclei, collagen, and mineral content (n=2). To visualize cell nuclei, 
samples were stained with Weigert’s Hematoxylin followed by eosin for matrix. Picrosirius red was used 
for collagen staining. Masson’s trichrome was used for staining of cell nuclei, collagen, and erythrocytes. 
To visualize mineral content, sections were stained with von Kossa. Samples were imaged using a 
brightfield microscope (Zeiss Axiovert 25) and images were stitched together in in Photoshop (Adobe). 
10.2.6 Statistical Analysis 
Results are reported as mean ± standard deviation, with n equal to the number of replicates per 
group. Statistical analyses were performed with JMPIN (4.0.4, SAS Institute, Inc.). One-way analysis of 
variance was used to determine the effects of the composite scaffold on integration strength (maximum 
shear stress, failure strain energy density). The Tukey-Kramer post hoc test was used for all pair-wise 
comparisons, and significance was attained at p<0.05. 
10.3 Results 
10.3.1 Defect Preparation 
Periodontal defects, which involved the removal of the PDL and some surrounding bone, were 
created. The defects were ellipsodial (Figure 10.2), having a major axis of 2.4 ± 0.4 mm, a minor axis of 
1.5 ± 0.17 mm, and a circumference of 6.8 ± 0.48 mm (n=5). 
10.3.2 Integration Strength 
After 28 days of culture, samples were evaluated for integration strength as measured by the 
maximum stress or stress at failure. The maximum stress of the Integrative PDL Scaffold group is 
significantly greater than the empty control, while there were no differences compared to the Single 
Phase PCL scaffold. There are no significnat differences in the strain energy density between any of the 
groups evaluated. 
10.3.3 Cell Viability 
Viable cells are detected in the tooth and bone regions of the native tissue for all three groups 
(Figure 10.4). Additionally, viable cells are detected in the scaffold regions of both the Integrative PDL 




scaffold free control. Cells are also detected spanning the interface between the scaffold and defect from 
both the tooth-scaffold and tooth-bone sides. 
10.3.4 Tissue Integration 
Samples were evaluated histologically (Figures 10.5-10.8) for integration with the native tissue 
after 28 days of in vitro culture. Matrix and cell nuclei staining by H&E and Trichrome indicate areas of 
integration between the mineral containing phase (PLGA-SBF) of the Integrative PDL Scaffold with the 
native bone, while integration is not as distinct in the Single Phase PCL group. Additionally, cell nuclei 
staining is more pronounced on the Integrative PDL Scaffold compared the control group. Collagen 
visualization by picrosirius red shows similar results in which regions of integration with bone and tooth 
are visible in the Integrative PDL scaffold group, while integration is minimal in the Single Phase PCL 
group and gaps between the scaffold and the native tissue are visible. Finally mineral staining by von 
Kossa confirms the presence of mineral in the Integrative PDL Scaffold; this staining is isolated to the 
hard tissue integration phases of the composite scaffold and in particular, the regions of scaffold 
integration with native bone and tooth consist of a mineralized matrix. The Single Phase PCL group is 
negative for mineral. 
10.4 Discussion 
This thesis focuses on the development of a scaffold to promote integrative periodontal 
regeneration through the optimization of scaffold parameters that will promote periodontal ligament as 
well as soft-to-hard tissue integration, resulting in the design of a composite multi-phased scaffold. The 
purpose of this study was to develop a tooth-in-bone explant model to assess, in vitro, the functional 
potential of this Integrative PDL Scaffold via mechanical and histological evaluation. A swine-tooth model 
was utilized in this study due to similarities in anatomy, development, physiology, pathophysiology and 
disease occurrence between human and swine in the oral maxillofacial region196. Traverse sections, with 
bone, periodontal ligament, and tooth were harvested and periodontal defects were created, in which the 
optimized Integrative PDL Scaffold or Single Phase PCL scaffold control was subsequently implanted. 
The Integrative PDL Scaffold repair group demonstrated an enhanced stress at failure in comparison to 




tooth and bone were noted in comparison to the control group, in which only modest gains were 
observed.  
The tooth-in-bone model developed in this study utilized transverse tooth slices, 1 mm in 
thickness. This model was employed rather than that of a complete tooth in order to account for the 
curvature of the tooth root, which results in the varying alignment of PDL fibers and thus uneven 
rupture151. It has been suggested that by using thin (1 mm) sections, all of the fiber bundles would be 
loaded together and this would overcome the effects of a curved surface of attachment150. In this manner 
periodontal defects were created in tooth slices and scaffold mediated healing was evaluated after 28 
days of culture using a mechanical push out test. The maximum shear stress for the optimized, Integrated 
PDL Scaffold was found to be significantly greater than the scaffold free control, indicating enhanced 
healing in the scaffold group. The maximum shear stress of healthy swine PDL tissue evaluated in a 
similar manner was found to be 3.8 MPa48, thus despite the enhanced functional outcome achieved in the 
optimized scaffold group, the values do not yet approach that of the native tissue. (To further note the 
similarities between species, the maximum shear stress for human PDL tissue is 3.0 MPa111.) A potential 
contributing factor to this that was not considered in this study was the age of the animals. It has been 
reported that the structure of the periodontal ligament depends on the eruptional state of a tooth and it is 
recommended that adult pigs (approximately 3 years of age) with completed eruption of secondary teeth 
should be used for such measurement47. Overall, the mechanical testing results appear to have large 
standard deviations, approximating nearly 50% of the average. These large values may be due to the 
regional differences in where the samples were harvested, as it has been reported that failure energy is 
highest in the middle of the root and diminishes coronally and apically. The failure stress also decreases 
slightly in the apical direction, although differences are not as dramatic111. In future studies uniformity of 
sample location along the tooth root may yield more consistent results. It has been reported that samples 
should be taken from the middle third of the root for more consistent periodontal ligament material 
properties48.  
Although the region of failure (cementum-scaffold vs. scaffold-bone) was not explicitly evaluated 
in this study, it is likely the cementum-scaffold interface is weaker. This is based on the inherent 




avascular, additionally the cellularity and remodeling rate of bone exceeds that of cementum24. Overall, 
as bone is relatively more metabolically active it is anticipated that healing is enhanced. The evaluation of 
the specific region of failure can be assessed histologically following push out testing in future studies to 
confirm this. 
 Regions of integration between the Integrative PDL scaffold with the native tooth and bone can 
be seen. Furthermore, these areas of scaffold to hard tissue integration consist of a mineralized matrix. 
On other hand, integration is less pronounced in the Single Phase PCL group. Enhanced hard tissue 
integration in the composite scaffold could be attributed to the inclusion of ceramic Simulated Body Fluid 
particles into the hard tissue integration region of the scaffold. As surface chemistry is a critical aspect of 
tissue healing, the incorporation of calcium phosphates has a demonstrated ability to enhance and 
stimulate bone response3,133,185. Furthermore, amorphous calcium phosphates, like the mineral used in 
this study, have a relatively high surface reactivity, attributed to an enhanced biodegradation and in turn 
solubility, compared to other ceramics105. Thus amorphous calcium phosphates, such as SBF, are known 
to be a relatively bioactive ceramic. While there are regions of scaffold integration with the native tissue in 
the Integrative PDL Scaffold repair group, overwhelmingly the defect area does not contain scaffold 
integrated tissue. This is likely the reason that there were no differences in mechanical properties 
between the scaffold groups. While results in this study were promising, the in vitro explant model utilized 
does have inherent shortcomings, primary of which in the absence of stimulating and modulatory factors 
that would be present in an in vivo setting. Mechanical stimulation, for example, has been shown to 
promote periodontal healing120. Furthermore, the lack of a vasculature system and thus perfusion with 
blood excludes growth factors and immune cells which could enhance healing as well as promote cellular 
migration into the wound space. As an alternative, the subcutaneous implantation of the tooth-in-bone 
explants may better simulate the native wound healing environment and could be a potential avenue to 
explore for augmented healing. 
10.5 Conclusion 
A tooth-in-bone explant model was developed in this study for the in vitro evaluation of an 
optimized Integrative PDL Scaffold.  After 28 days of implantation, failure stress was significantly 




the scaffold and the native bone and tooth was also enhanced in the Integrative PDL Scaffold group 
compared to the Single Phase PCL control. Collectively, these results demonstrate the potential that this 





Figure 10.1: Evaluation of Integrative PDL Scaffold in a Tooth-in-Bone Explant Model: Sample 
Dimensions Sample dimensions were measured for mechanical testing, including the PDL 
circumference taken as an average of the inner and outer circumferences (n=3 each), and PDL width 





Figure 10.2: Evaluation of Integrative PDL Scaffold in a Tooth-in-Bone Explant Model: Explant 
Model and Mechanical Testing Device Molars were harvest form porcine mandibles and 1 mm 
transverse sections with PDL and surrounding bone were cut. Periodontal defects (major axis: 2.4 ± 
0.4 mm, minor axis: 1.5 ± 0.17 mm, circumference 6.8 ± 0.48 mm) were created using a drill and cell 
seeded scaffolds were implanted into the defect. For mechanical testing samples were clamped 
between two plates. A metal rod, fit to the dimensions of the tooth to ensure that only the PDL is 














































Figure 10.3: Evaluation of Integrative PDL Scaffold in a Tooth-in-Bone Explant Model: 
Integration Strength The maximum or failure stress of the Integrative PDL scaffold was significantly 
greater than the empty control. There were no differences between the Single Phase PCL and 
Integrative PDL Scaffolds. Strain energy density, area under the stress-strain curve until failure, was 





Figure 10.4: Evaluation of Integrative PDL Scaffold in a Tooth-in-Bone Explant Model: Cell 
Viability Viable cells were detected on all samples, including the bone and tooth regions of the native 
tissue as well as on implanted scaffolds. Viable cells were detected on the tooth-scaffold and tooth-
bone interface regions for both the Single Phase PCL and Integrative PDL Scaffold. T: Tooth, B: Bone, 





Figure 10.5: Evaluation of Integrative PDL Scaffold in a Tooth-in-Bone Explant Model: Matrix 
and Cell Nuclei Masson’s Trichrome stained samples at day 28 for collagen (green), cell nuclei 
(purple), and cytoplasm and erythrocytes (red). Scaffold integration with bone is visible in the 





Figure 10.6: Evaluation of Integrative PDL Scaffold in a Tooth-in-Bone Explant Model: Matrix 
and Cell Nuclei  Hematoxylin and Eosin H&E stained samples at day 28 for matrix (pink) and cell 
nuclei (purple). Both scaffold groups stain positive for cells and matrix. Cell density appears greater on 
the Integrative PDL Scaffold group. Arrows in the detailed images indicate areas of scaffold integration 
with bone and tooth in the Integrative PDL Scaffold group, as well as some scaffold integration with 





Figure 10.7: Evaluation of Integrative PDL Scaffold in a Tooth-in-Bone Explant Model: Collagen 
Picrosirius red stained samples at day 28 for collagen. Detailed images indicate areas of scaffold 
integration with bone in the Integrative PDL Scaffold group (black arrows), while no such integration is 






Figure 10.8: Evaluation of Integrative PDL Scaffold in a Tooth-in-Bone Explant Model: Mineral 
von Kossa stained samples at day 28 for mineral. Only the PLGA-SBF regions of the Integrative PDL 
Scaffold stain positive for mineral. The areas of scaffold integration with bone stain positive for mineral 
(red arrows), these areas are consistent with the regions of matrix integration with bone . T: Tooth, B: 























Periodontitis is a chronic inflammatory infection elicited from the overgrowth of bacteria harbored 
in tooth-retained plaque. The disease is characterized by the destruction of tooth-supporting structures, 
attachment loss, and can result in complete tooth detachment. The periodontium is comprised of both soft 
(periodontal ligament (PDL), gingiva) and hard (root cementum, alveolar bone) connective tissues. The 
PDL functions to anchor the root cementum to alveolar bone via collagenous fibers which insert into the 
respective mineralized tissues. Current regenerative approaches for treatment of periodontitis do not 
routinely achieve the integration of multiple tissues. The thesis employs the strategy of complex scaffold 
design, which seeks to recapitulate the native spatial and composition inhomogeneity present in 
composite tissue systems. As such, a multi-phased polymer fiber scaffold optimized to promote PDL 
regeneration as well as to facilitate soft-to-hard tissue integration was developed. An antibiotic release 
mechanism was also engineered into the composite scaffold in order to control for residual infection at the 
wound site, thereby augmenting the healing response. 
To achieve this goal, this thesis was divided into 3 specific aims. Aim 1 focused on the 
optimization of a fiber based scaffold system for achieving PDL regeneration. The effect of polymer 
chemistry and fiber organization (Chapter 3) on the response of PDL derived cells was first explored. To 
further promote healing, minocycline antibiotic was incorporated into polymer fibers and efficacy was 
demonstrated against relevant periodontal bacteria and biocompatibility with PDL cells was confirmed 
(Chapter 4). Aim 2 centered on scaffold optimization for promoting hard tissue integration, which included 
fiber diameter (Chapter 5), mineral chemistry (Chapter 6), method of mineral incorporation (Chapter 6), 
and mineral dose (Chapter 7). Osteoblasts were then cultured on the optimized hard tissue integration 
scaffold to ensure biocompatibility (Chapter 8). In Aim 3 a composite scaffold was fabricated combing the 
optimized elements from the previous two aims into a multi-phased system, mimetic of the native 
structure of the periodontium. In vitro PDL cell response was investigated (Chapter 9) and healing was 
then assessed in a tooth-in-bone explant model in vitro (Chapter 10). 
11.1 Aim 1: Scaffold Optimization for Ligament Regeneration 
Aim 1 focused on scaffold design and optimization for regeneration of the PDL. Specifically a 
polymer fiber-based system was utilized to mimic the mature human PDL, which is composed 




alignment (aligned vs unaligned) on PDL cell response was investigated in Chapter 3 and it was 
determined that PCL-Aligned scaffolds supported cell growth and physiologic cell alignment, as well as 
yielded optimal matrix deposition and expression of PDL markers. In Chapter 4, minocycline antibiotic 
was incorporated into polymer fibers to achieve a sustained and localized release system. Two 
concentrations (2%, 5% w/w) of minocycline were incorporated into PCL fibers and a dose dependent 
efficacy was demonstrated against the growth of P. gingivalis, A. actinomycetemcomitans, two 
established periodontal pathogens, as well as pathogens harvested from human periodontal plaque 
samples. Furthermore, sustained efficacy against bacterial growth was demonstrated for up until 7 days. 
Periodontal ligament cells were then cultured on the low and high dose PCL-minocycline scaffolds. A 
dose dependent effect on cell number was noted as well as enhanced ALP activity on high dose scaffolds 
compared to the antibiotic-free control. Thus the results from Aim 1 indicated that PCL-Aligned fibers 
containing 2% minocycline is the optimal scaffold to promote PDL regeneration. 
11.2 Aim 2: Scaffold Optimization for Hard Tissue Integration 
Aim 2 explored scaffold design strategies to guide the growth, differentiation, and biosynthesis of 
PDL cells for the regeneration of and integration with the mineralized tissues of the periodontium. PLGA-
aligned fibers were utilized because this substrate promoted mineralized matrix deposition of PDL cells in 
Chapter 3, and aligned fibers are mimetic of the fiber insertions present at the PDL-cementum and PDL-
alveolar bone interfaces. Fiber diameter was explored in Chapter 5, in which nanofibers were compared 
to fibers on the order of 3 and 7 µm. Culture on nanofibers resulted in enhanced ALP activity. To further 
promote hard tissue integration the incorporation of a hydroxyapatite, a crystalline calcium phosphate 
(CaP), was compared to SBF mineral, an amorphous CaP (Chapter 6). In this study mineral was 
incorporated directly into electrospun PLGA nanofibers. PLGA-SBF scaffolds promoted enhanced 
collagen deposition, concurrent with a gene expression profile that resembles that of osteoblastic 
development compared to PLGA-HA fibers. Also explored in Chapter 6 was the method of mineral 
incorporation, comparing PLGA-SBF fibers (mineral electrospun into fibers) with SBF-Coated PLGA 
fibers. Both groups enhanced collagen deposition compared to the mineral-free control as well as 
promoted the expression of osteoblastic markers. A mineralized matrix deposition was also supported on 




PLGA-SBF. On the other hand, there was negligible cell growth on SBF-Coated scaffold over time. Thus 
PLGA-SBF scaffolds were selected as the optimal scaffold to support hard tissue integration. In Chapter 7 
SBF dose in PLGA scaffolds was explored, in which 3 different mineral doses were incorporated into 
fibers. Results demonstrated that medium dose (13% w/w) scaffolds promoted optimal matrix deposition 
and enhanced alkaline phosphatase activity. Finally, in order to ensure biocompatibility with all relevant 
cell types required for hard tissue regeneration, Chapter 8 demonstrated that SBF containing scaffolds 
support osteoblast viability and phenotype. Cell growth was only supported on PLGA-SBF scaffolds, while 
cell number was maintained on SBF-Coated. In summary, the results from these optimization studies 
indicate that PLGA fibers with 13% SBF mineral incorporated represents the ideal substrate to support 
soft-to-hard tissue regeneration. 
11.3 Aim 3: Fabrication and Evaluation of a Composite Scaffold 
In Aim 3 a sol-gel sintering method was developed to fabricate a multi-phased scaffold consisting 
of elements optimized from the previous two aims. The composite scaffold is mimetic of the structure of 
the native PDL, in which aligned PCL fibers (PDL regeneration) insert perpendicularly into PLGA-SBF 
fibers (hard tissue integration). PDL cell response was evaluated on the composite scaffold in Chapter 9. 
Cells attached and remained viable on all scaffold phases. Additionally, the composite scaffold promoted 
the deposition of collagenous and mineralized matrices on the respective regions of the composite 
scaffold. Finally, a tooth-in-bone explant model was developed in Chapter 10 to evaluate the capacity of 
the composite scaffold to integrate with the host tissue in a periodontal defect. Mechanical testing 
indicated enhanced functional outcomes in the composite scaffold group compared to the empty control. 
Furthermore, histological evaluation identified areas of scaffold integration with host tissue present only in 
the composite scaffold group and not in the single phase PCL control. As a whole, this thesis emphasis 
scaffold design motivated by the native structure and composition of the periodontal tissue. The collective 
results indicate that a scaffold optimized under such criteria results in the support of multi-tissue 





11.4 Future Directions 
11.4.1 In vivo Models 
The composite scaffold optimized in this study demonstrated significant promise for PDL healing, 
and achieving soft-to-hard tissue and scaffold-native tissue integration in vitro. Future avenues of 
exploration include evaluation in more complex models, including subcutaneous and/or in an in vivo 
defect model. The use of such models will more closely mimic clinical scenarios, in addition to the 
providing modulatory factors and stimulation that can contribute to tissue healing, including mechanical 
loading, vascular perfusion, immune cells, growth factors, and cytokines. 
11.4.2 Bioactive Molecule Release 
Growth factors and cytokines are important mediators of innate periodontal wound healing. The 
incorporation of such bioactive molecules into the polymer fiber scaffolds utilized in this study can 
facilitate spatiotemporal release, effectively altering the wound microenvironment to promote tissue 
healing and regeneration. It is envisioned that the methods employed in Chapter 4 for the inclusion of 
minocycline into PCL fibers can also be applied for the incorporation of these molecules. Growth factors 
which have shown promise for periodontal healing include platelet derived growth factor (PDGF), insulin-
like growth factor (IGF), basic fibroblast growth factor, transforming growth factor, bone morphogenetic 
protein, and enamel matrix derivative (proteins belonging to the amelogenin family)38,191. Combination 
growth factor therapies, in particular PDGF and IGF-1, have also demonstrated significant promise. 
Similarly, cytokines such as interleukin-1 (IL-1), IL-4, and tumor necrosis factor-α, are stimulators of 
fibroblast proliferation, migration, and matrix biosynthesis10,147. These molecules are secreted by 
inflammatory cells during the wound-healing process. Polymer scaffold systems, like the one used in this 
study, have demonstrated promise as delivery vehicles for controlling the release and bioavailability of 
these molecules, which will be critical to harnessing their full potential. 
11.5 Innovation and Impact 
In conclusion, a multi-phased polymer fiber scaffold optimized to promote PDL regeneration, 
facilitate soft-to-hard tissue integration, and deliver antibiotics in a sustained manner was developed. 




composite tissue systems, this thesis emphasizes rational scaffold design to develop a multi-phased 
system that facilitates the regeneration of multiple tissues in a coordinated manner, as well as promotes 
tissue integration. The broader implications of this work include the demonstration of complex scaffold 
design strategies as well as the elucidation of interactions between biomaterial substrates and cells, 
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APPENDIX: EFFECT OF HYDROXYAPATITE 


















It was demonstrated in Chapter 2 that cells cultured on PLGA-Aligned scaffolds displayed 
enhanced ALP activity and mineral deposition. Aligned, organized fibers also mimic the Sharpey’s fiber 
insertions found at the PDL-cementum and PDL-alveolar bone interfaces. For these reasons it was 
decided to use PLGA aligned fibers for optimization of the soft-to-hard tissue integration scaffold. This 
study investigates alternative scaffolds for this purpose, exploring the use of PCL scaffolds with 
hydroxyapatite (HA) incorporated into fibers via electrospinning to promote soft-to-hard tissue 
regeneration. 
A.1.1 Background and Motivation 
To promote periodontal regeneration and integration, calcium phosphate (CaP) bioceramics such 
as HA, calcium sulfate, and tricalcium phosphate can be incorporated into polymer scaffolds. These 
composite scaffolds have shown augmented osteoconductive properties in comparison to plain 
scaffolds170,187. As polymer fibers are mimetic of the native extracellular matrix of the PDL, CaP containing 
fibers mimic the Sharpey’s Fibers found at the PDL-cementum and PDL-alveolar bone interfaces. 
Hydroxyapatite is used widely as a bone substitute and as a periodontal therapy clinically31,183,207. Coating 
titanium dental implants with HA has also been explored as a means to enhance osseointegration152,163.  
Hydroxyapatite mineral will be incorporated into PCL aligned fibers to investigate the ability to differentiate 
PDL derived cells into an osteoblastic cell type in order to achieve soft-to-hard tissue integration. 
A.1.2 Objectives 
The objective of this study is to incorporate HA ceramic particles into PCL aligned polymer fibers 
and compare the response of PDL cells to PCL fibers without mineral. It is expected that culture on 
mineral-polymer composite scaffolds will result in a cell response distinct from mineral-free scaffolds, 
including the expression of osteoblastic markers, and enhanced mineralization potential and mineralized 




A.2 Materials and Methods 
A.2.1 Scaffold Fabrication 
A.2.1.1 PCL 
An 18% (w/v) PCL solution was prepared by dissolving PCL into 3:2 mixture of DCM:DMF. The 
solution was mixed overnight, vortexed for ~1 hour prior to electrospinning, and the entire solution loaded 
into a 5 mL syringe with a 23 gauge stainless steel blunt-tip needle. A voltage of 9-10 kV was applied to 
the needle tip and a pump flow rate of 1 mL/hr was used. Fibers were collected on a grounded rotating 
mandrel (2500 rpm), 13 cm from the needle tip. The entire polymer solution was electrospun to fabricate 
scaffolds of thickness ranging from 0.08-0.11 mm as measured with a digital caliper. 
A.2.1.2 PCL-HA 
For PCL-HA scaffolds, the evening prior to electrospinning 171.43 mg of HA was dissolved in 1 
mL of DMF and the solution sonicated 1 hour. In a separate vial, 900 mg of PCL was dissolved in a 1:3 
solution of DMF:DCM, and the polymer-solvent solution vortexed for an hour. The HA-DMF solution was 
subsequently added to the polymer-solvent solution and the solution mixed overnight. The solution was 
vortexed for ~1 hour prior to electrospinning and then loaded into a 5 mL syringe with a 23 gauge 
stainless steel blunt-tip needle. A voltage of ~10 kV was applied to the needle tip and a pump flow rate of 
1 mL/hr was used. Fibers were collected on a grounded rotating mandrel (2500 rpm), 11 cm from the 
needle tip. 
A.2.2 Cell Seeding and Culture 
Electrospun scaffolds were cut to 1 x 1.8 cm and secured using custom-made clamps, resulting in 
an effective cell culture surface area of 1 cm2. PLGA scaffolds were UV 356 nm sterilized (each side 15 
min) and incubated (37°C, 5%CO2) overnight in F/S medium with 20% FBS to promote cell attachment. 
For PCL scaffolds, to enhance surface reactivity scaffold were air plasma treated (Harrick Plasma PDC-
32G) at high RF setting for 1 min. Scaffolds were then sterilized by UV radiation and soaked overnight in 
F/S medium with 20% FBS. 
Human PDL cells were seeded on scaffolds at a density of 30,000 cells/cm2 (3 M cells/mL, 10 µl), 




medium supplemented with 50 µg/mL ascorbic acid (Sigma-Aldrich). Cells were maintained at 37°C, 5% 
CO2 and media was exchanged every 2-3 days.  
A.2.3 Live/Dead Cell Viability 
Cell viability (n=3) was visualized using Live/Dead staining (Molecular Probes). Both monolayer 
and scaffolds were stained following the manufacturer’s suggested protocol. Samples were imaged using 
confocal microscopy (Olympus Fluoview FV1000) at excitation wavelengths of 488 nm and 568 nm. 
A.2.4 Cell Proliferation 
Cell proliferation (n=5) was determined by measuring total DNA content using the PicoGreen 
dsDNA assay (Invitrogen) following the manufacturer’s protocol. Scaffolds were rinsed twice in PBS and 
stored in 500 µl of 0.1% Triton-X (Sigma-Aldrich) at -30°C. Immediately before the analysis, samples 
were thawed and homogenized (Microson XL-2000) for 20 sec. Fluorescence was measured using a 
Tecan microplate reader with an excitation wavelength of 485 nm and an emission wavelength of 535 nm. 
A conversion factor of 8 pg DNA/cell was used to determine cell number. 
A.2.5 Collagen Production 
Collagen production (n=5) was quantified using a modified hydroxyproline assay153. Samples 
were first dessicated (CentriVap, Labconco, Kansas City, MO) and digested for 18 hr at 65°C in a solution 
of 20 µL/mL papain (Sigma-Aldrich), buffered in 0.1 M sodium acetate, 10 mM cysteine HCl, and 50 M 
ethylenediaminetetraacetate.  A 250 µl aliquot of the digest was concentrated by dessication.  Samples 
were subsequently hydrolyzed in 10 µl of 10N NaOH and autoclaved for 25 min.  The hydrolysate was 
then oxidized by a buffered chloramine-T reagent for 25 min before the addition of Ehrlich’s reagent.  
Sample absorbance was measured at 550 nm (Tecan), and the collagen content was obtained by 
interpolation along a standard curve of bovine collagen I (Sigma). 
Additionally matrix deposition was visualized histologically. Cryosectioned samples were stained 






After scaffold homogenization samples were assayed for alkaline phosphatase (ALP) activity 
(n=5) using a colorimetric assay based on the hydrolysis of p-nitrophenyl phosphate (pNP). On ice, 50 µl 
of sample was added to pNP-PO4 solution (Sigma) and incubated at 37°C until a color change was noted. 
The absorbance at 405 nm was read using a Tecan microplate reader. ALP activity is reported 
normalized to incubation time and the post-homogenization cell number. 
Mineral deposition was also visualized through histological staining.  Samples were fixed in 10% 
neutral buffered formalin (NBF) + 1% cetylpyridinium chloride (CPC) overnight. The solution was replaced 
with 0.01M cacodylic acid and stored at 4°C until sectioning. Samples were embedded in 5% polyvinyl 
alcohol (PVA) for sectioning through freezing in a dry ice ethanol bath and sectioned to 7 µm thickness 
with a cryostat (Bright Instrument Company, Model OFT). Sectioned samples were collected on glass 
slides coated with Haupt’s Solution (2% gelatin, 1.9% phenol, 15% glycerol). Scaffold sections on glass 
slides were immersed in DI water for 1 hour to remove traces of PVA. Von Kossa was used to stain for 
phosphate (n=3) and alizarin red for calcium (n=3). 
A.2.7 Fourier Transform Infrared Spectroscopy and X-Ray Diffraction 
Scaffolds were rinsed twice with Hank’s Buffered Saline Solution and fixed with 10% NBF + 1% 
CPC overnight. The solution was replaced with 0.1M cacodylic acid and stored at 4°C. Prior to sample 
analysis, a series ethanol dehydration was performed. Samples were alowed to dry in a fume hood and 
placed in a dessicator until analyzed. Infrared spectra (n=3) were obtained with a Fourier transform 
infrared attenuated total reflection (FTIR-ATR) spectrometer (Frontier FTIR, PerkinElmer). Spectra were 
collected from 380-4000 cm-1 using 4 scans with a resolution of 4. X-Ray Diffraction (XRD, X’Pert3 
Powder, PANalytical) analysis was performed on cell seeded scaffolds. Spectra were taken for 2θ angles 
from 20° to 40° with a step size of 0.1, and 60 sec per step. 
A.2.8 Media Ions 
A.2.8.1 Calcium 
Media calcium was measured using the Arsenazo Modified Calcium Assay.  Five microliters of 




Scientific, Inc.) was added to each sample and standard, and after 5 min the absorbance at 620 nm was 
read using a Tecan microplate reader. Results are reported normalized to 2 mL used for cell culture. 
A.2.8.2 Phosphate 
Media phosphate was measured using the Phosphate Colorimetric Assay (BioVision), by diluting 
2.4 μl of sample into 197.6 μl of DI H2O. Thirty microliters of phosphate reagent was added to all samples 
and standards, and the solutions mixed by pipetting up and down 20 times. After a 30 minute incubation, 
the absorbance at 620 nm was read using a Tecan microplate reader. Results are reported normalized to 
2 mL used for cell culture. 
A.2.9 Gene Expression  
Gene expression (n=5) was measured using quantitative reverse transcriptase-polymerase chain 
reaction (qRT-PCR).  Total RNA was isolated via the Trizol extraction method (Invitrogen).  Isolated RNA 
was reverse-transcribed into complementary DNA (cDNA) with the SuperScript First-Strand Synthesis 
System (Invitrogen), and the cDNA product was subsequently amplified and quantified through real-time 
PCR using SYBR Green Supermix (Invitrogen). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
served as the house-keeping gene. All genes were amplified for 50 cycles in a thermocycler (iCycler iQ 
Real-Time PCR Detection System, BioRad). See Table A.1 for primer sequences used and amplicon 
sizes. Normalized expression levels were calculated based on the difference between threshold cycles of 
the gene of interest and GAPDH. 




A.2.10 Statistical Analysis 
Results are reported as mean ± standard deviation, with n equal to the number of replicates per 
group. Statistical analyses were performed with JMPIN (4.0.4, SAS Institute, Inc.). A two-way analysis of 
variance (ANOVA) was used to determine the effect of calcium phosphate incorporation and culture time 
on cell response (proliferation, ALP activity, matrix deposition) and media ion concentration. A one-way 
ANOVA was used to determine the effect of mineral incorporation on gene expression at each time point.  
The Tukey-Kramer post hoc test was used for all pair-wise comparisons, and significance was attained at 
p<0.05. 
A.3 Results 
A.3.1 Cell Viability and Proliferation 
Cells attachment was similar between groups and proliferation was noted over time. There were 
no differences in cell growth between PCL scaffolds with and without HA. 
A.3.2 Cell Biosynthesis 
Collagen deposition significantly increases over time, with no significant differences observed 
between scaffold groups. This is also reflected in matrix histology stains, H&E and Picrosirius red, at day 
28. The presence of collagen is detected by the amide I and II bands, 1659 cm-1  and 1555 cm-1 
respectively20, in all groups at both timepoints, with larger peaks at day 28 corresponding to increasing 
collagen deposition over time. 
Peak ALP activity occurs before day 1 for all groups. ALP activity was significantly greater at 6 
hours on PCL-HA scaffolds, while at Day 1 it was greater on PCL. ALP activity decreases significantly 
between day 1 and 7 for both groups, and remains at a similar level for the remainder of the study period. 
PCL-HA scaffolds stained positive for phosphate and calcium via von Kossa and Alizarin red stains, 
respectively, at day 28. No such staining was noted on mineral-free scaffolds. FTIR analysis at days 1 
and 28 indicate detectable phosphate peaks (1040-1090cm-1 and 561-601 cm-1, grey boxes) in PCL-HA 
scaffolds at both timepoints, indicating the stability of the mineral in the scaffold over the 28 culture 




A.3.3 Media Ions 
Media calcium remained at baseline levels for both groups over time, and no significant 
differences were noted between groups. Media phosphate differed between groups at days 3 and 14, in 
which levels were higher on PCL-HA and PCL, respectively. There was a significant increase between 
days 3 and 7 on PCL scaffolds, while there was a decrease and then increase in the PCL-HA group from 
days 10 to 14 and 14 to 17, respectively. 
A.3.4 Gene Expression 
The expression of the periodontal marker, periostin, and osteoblastic markers, bone sialoprotein 
and osteopontin, were upregulated on PCL scaffolds compared to PCL-HA at day 14. 
A.4 Discussion and Conclusion 
Nanofiber scaffolds containing hydroxyapatite ceramic were explored to promote the osteogenic 
differentiation of PDL cells to achieve soft-to-hard tissue integration. Fibrous substrates are mimetic of the 
native extracellular matrix found at the cementum-PDL and alveolar bone-PDL interfaces, which consists 
of collagen fibers that inserts into a mineralized matrix (Sharpey’s fibers). As surface chemistry is also a 
critical aspect of tissue healing, the incorporation of calcium phosphates has demonstrated ability to 
enhance and stimulate bone response3,133,185. Thus PCL-HA composite scaffolds were fabricated, and the 
response of PDL cells was assessed and compared to mineral-free PCL fibers. 
 Cell growth was supported on polymer fiber scaffolds with and without ceramic and mean cell 
number was enhanced on PCL-HA scaffolds. While these results were not statistically significant, similar 
results were observed in literature, in which PDL cell culture in the presence of nano-HA enhanced cell 
proliferation compared to control medium186. The presence of HA did not result in major differences in 
mineralization potential between groups. Six hours post seeding, ALP activity was significantly greater in 
the PCL-HA group, while it was greater on PCL at day 1. Alliot-Licht et al. observed that ALP activity is 
inhibited in PDL fibroblasts cultured in the presence of HA particles3 compared to controls, while Sun et 
al. observed the opposite trend186. It should be noted that, in those studies cells were cultured in 
monolayer, while in our study cells were cultured on polymer/ceramic fibers. ALP is an important promoter 




while concomitantly increasing the levels of inorganic phosphate67. Since the mineral scaffolds in this 
study serve as a phosphate source for cells, this may obviate the requirement for ALP, potentially 
explaining why there were no observed differences in ALP activity between groups. Importantly, 
mineralization was detected only on PCL-HA scaffolds through histological staining.  There were no 
differences in collagen production between groups, but both PCL and PCL-HA scaffolds supported 
enhanced collagen deposition with time. Interestingly bone markers were downregulated on PCL-HA 
scaffolds compared to PCL scaffolds after 14 days of culture. 
The collective results of this study demonstrate that PDL cell response is modulated by the 
incorporation of mineral into fiber scaffolds. Overall, while proliferation and matrix deposition were 
supported, gene expression and ALP activity results suggest that PCL scaffolds with HA would not be the 























Figure A.1: Effect of Hydroxyapatite Containing PCL Scaffold on PDL Cell Response: Cell 
Viability and Proliferation Cell proliferation was noted over time for both groups. Significant 


















































































Figure A.2: Effect of Hydroxyapatite 
Containing PCL Scaffold on PDL Cell 
Response: Matrix Deposition and 
Mineralization Collagen deposition 
increases with time, while there were no 
differences observed between groups. 
Positive H&E and Picrosirius Red stains 
for matrix and collagen respectively at 
day 28. ALP activity is significantly 
greater PCL-HA scaffolds compared to 
PCL at 6 hours, while at day 1 PCL 
exceeds PCL-HA. HA containing 
scaffolds stain positive for phosphate 
(von Kossa) and calcium (Alizarin red) at 
day 28. Phosphate peaks (grey boxes) 
are present at days 1 and 28 for HA 
scaffolds. The presence of collagen is 





) at both time 
points for all groups, with peaks 
increasing in size at day 28. Significant 
difference between: # groups, * 
consecutive timepoints (n=5, p<0.05, 





































Figure A.3: Effect of Hydroxyapatite Containing PCL Scaffold on PDL Cell Response: Media 
Ions Media calcium remained at baseline levels for both groups over time, and no significant 
differences were noted between groups. Media phosphate differs significantly between groups at days 
3 and 14. There was a significant increase between days 3 and 7 on PCL scaffolds, while there was a 
decrease and then an increase in the PCL-HA groups from days 10 to 14 and 14 to 17, respectively. 


































Figure A.4: Effect of Hydroxyapatite 
Containing PCL Scaffold on PDL Cell 
Response: Expression of Periodontal and 
Osteoblastic Markers The expression of the 
periodontal marker periostin and osteoblastic 
markers bone sialoprotein and osteopontin are 
upregulated on PCL scaffolds compared to PCL-
HA at day 14. Significant difference between: # 
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